前往化源商城

97-89-2 靶点实验数据

HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: CYP273
Protocol: Tox21 Assay Protocol Summary:

Two ul of enzyme-substrate mix was dispensed into medium binding white/solid 1536-well plates (Greiner Bio-One North America Inc., Monroe, NC) using a BioRaptr Flying Reagent Dispenser (FRD, Beckman Coulter, Brea, CA). Compounds dissolved in DMSO and positive control (furafyllline) were transferred to the assay plates at 23 nl using a Pintool station (Wako, San Diego, CA). The assay plates were incubated at room temperature for 10 min. Then 2 ul of NADPH regeneration solution was added to each well of the assay plates using an FRD and incubated at room temperature for 1 h. The reaction was stopped by adding 4 ul of detection reagent using an FRD and after 20 min incubation at room temperature the luminescence signal was measured using a ViewLux plate reader (Perkin Elmer, Shelton, CT). Data were expressed as relative luminescence units.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000075213 uM-Replicate_1Activity at 0.0000171744 uM-Replicate_1Activity at 0.0000689059 uM-Replicate_1Activity at 0.0001619730 uM-Replicate_1Activity at 0.0003751800 uM-Replicate_1Activity at 0.0007781017 uM-Replicate_1Activity at 0.00212 uM-Replicate_1Activity at 0.00657 uM-Replicate_1Activity at 0.017 uM-Replicate_1Activity at 0.038 uM-Replicate_1Activity at 0.085 uM-Replicate_1Activity at 0.191 uM-Replicate_1Activity at 0.435 uM-Replicate_1Activity at 1.330 uM-Replicate_1Activity at 4.074 uM-Replicate_1Activity at 10.46 uM-Replicate_1Activity at 23.64 uM-Replicate_1Activity at 52.95 uM-Replicate_1Activity at 115.2 uM-Replicate_1Activity at 299.6 uM-Replicate_1Activity at 1087.9 uM-Replicate_1Activity at 2306.0 uM-Replicate_1Activity at 5157.0 uM-Replicate_1Activity at 11530.0 uM-Replicate_1Activity at 25780.0 uM-Replicate_1Activity at 57660.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive0004-3.5643-2.3504-2.9312-2.3657-2.8224-2.60180.03942.8539-0.9099-0.8614-3.0049-2.5808-0.7-3.5643QC'd by SIGMAInactive0
Inactive0004-4.9449-1.1401-4.88281.72781.7167-2.1117-5.69640.39330.89390.1314-2.73353.195-4.9521-4.9449QC'd by SIGMAInactive0
Inactive00042.7107-2.18841.39851.45820.7693-2.47871.522.89860.9702-0.02532.12932.77661.5392.7107QC'd by EnamineInactive0
Inactive0004-2.1522-2.3143-3.894-2.36983.0635-2.9724-0.6981.807-0.3874-2.23870.0851-4.19653.0171-2.1522QC'd by SIGMAInactive0
Inactive0-4.34892.25260.8543-15.2749-1.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-14.3957-1.8486-1.8251-1.3415-0.2999-5.8043-1.46250.1520.0394-2.6869-2.4228-2.2664-9.6519-14.3957QC'd by SIGMAInactive0-4.09892.18760.881
Inactive0-4.39891.34430.8661-18.2112-140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-16.0093-2.34660.81450.3878-0.5249-2.2045-0.0596-0.3675-2.1137-2.5302-0.6582-8.8446-8.7305-16.0093QC'd by AcrosInactive0-4.19891.62660.9372
Inactive0-4.37131.3310.7782-33.4439-3.50340 0 0 0 0 0 0 0 0 0 0 0 0 0 0-29.5366-4.0189-0.7745-2.4487-0.7353-13.4714-1.9963-2.0808-1.5803-2.9931-5.0804-13.0346-7.2628-16.8143-29.5366QC'd by LightBiologicalsInactive0-4.37131.22210.9463
Inactive0-4.14891.62660.9461-28.1716-140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-20.143-1.7608-0.23880.22480.5264-2.4986-0.1313-2.2365-0.2423-3.4362-3.0971-3.2181-11.2156-20.143QC'd by EnamineInhibitor79.640731.491610Partial curve; partial efficacy; poor fit-4.09892.58840.988
Inhibitor79.640737.878410Partial curve; partial efficacy; poor fit-4.09892.33320.6037-41.3784-3.5-2.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0-31.14860.0477-0.2424-0.1109-17.1482-2.60430.09871.3021-8.8121-0.6811-2.6079-6.0005-11.8578-31.1486QC'd by LightBiologicalsInhibitor70.979933.811310Partial curve; partial efficacy; poor fit-4.14891.47870.9532
Inactive0-4.14891.3310.6595-35.6335-140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-26.36121.8269-1.26512.0528-1.3342-1.1508-1.3078-0.329-8.12350.9213-0.3901-8.3475-13.4823-26.3612QC'd by LightBiologicalsInhibitor63.260940.716221Partial curve; partial efficacy-4.19891.55790.9889
Inhibitor31.7055100.219240Partial curve; high efficacy-4.49891.41630.9793-102.2947-2.0755-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-88.79751.59931.9578-0.4182-5.9156-12.3257-6.81250.6301-0.9357-7.8675-21.9718-39.1747-68.2733-88.7975QC'd by SIGMAInhibitor28.2576108.402740Partial curve; high efficacy-4.54891.24750.9984
Inactive0-4.44891.53860.9285-23.7863140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-21.48852.58192.144-0.92281.57780.3813-0.7273-0.01780.48032.4385-0.728-9.9293-11.8247-21.4885QC'd by SIGMAInactive0-4.39891.62590.9598
Inhibitor9.333739.896721Complete curve; partial efficacy-5.02992.04370.9899-39.89670-1.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-36.3129-0.2423-0.4463-0.29990.64780.36361.006-0.49871.2825-1.1546-7.8589-17.895-35.8398-36.3129QC'd by LightBiologicalsInhibitor11.750456.388421Partial curve; partial efficacy-4.92991.1110.9845
Inhibitor31.7055101.457340Partial curve; high efficacy-4.49891.1110.9982-102.7597-1.3024-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-82.349-1.7206-3.1014-1.0307-0.462-0.0614-0.5481-3.1286-4.6801-13.1432-23.5612-42.1146-67.192-82.349QC'd by SIGMAInhibitor25.184689.509140Partial curve; high efficacy-4.59891.37230.9943
Inactive0-4.39891.37230.9408-30.7143-1.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-27.2619-3.9038-4.25970.95220.2767-0.086-3.7725-0.0863-0.3476-4.4856-5.6587-11.4378-17.5999-27.2619QC'd by EnamineInactive0-4.39891.37230.9104
Inhibitor0.0291.537495Complete curve; high efficacy-7.69891.210.9985-95.5053-3.9679-1.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-96.9758-10.1145-26.2532-42.3865-67.4835-79.9456-90.8539-91.593-94.2489-95.4721-96.0956-96.1267-97.0582-96.9758QC'd by SIGMAInhibitor0.141694.840291Complete curve; high efficacy-6.84891.210.9987
Inhibitor70.979957.401421Partial curve; partial efficacy-4.14891.46410.9678-60.4859-3.0846-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-45.8227-1.5241-1.1304-2.119-3.4583-2.7138-4.9163-1.3699-5.0741-7.7268-8.2608-10.3758-24.1789-45.8227QC'd by TCIInhibitor63.260959.370621Partial curve; partial efficacy-4.19891.82650.9826
Inhibitor31.705588.458340Partial curve; high efficacy-4.49891.24750.9907-90.0614-1.6031-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-73.0646-2.1792-0.7242-0.9217-2.0267-1.1711-1.4022-1.5555-4.0648-12.1704-19.1709-32.2561-64.0802-73.0646QC'd by SIGMAInhibitor31.705586.838540Partial curve; high efficacy-4.49891.1110.9934
Inhibitor7.09899.944883Complete curve; high efficacy-5.14891.34430.9949-102.6257-2.681-1.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-98.8687-2.2636-1.9377-0.2674-0.3864-3.2139-8.5636-4.0834-14.5383-36.543-60.2337-91.3595-96.848-98.8687QC'd by TCIInhibitor5.638199.072784Complete curve; high efficacy-5.24891.62660.998
Inhibitor14.162399.52242Partial curve; high efficacy-4.84890.70.9894-100.6417-1.1197-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-88.2822-1.4919-2.9847-0.2649-1.6478-3.8502-2.8959-7.6423-18.6375-36.1235-44.1844-53.91-71.7844-88.2822QC'd by SIGMAInhibitor17.829395.774281Complete curve; high efficacy-4.74891.210.9995
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: TGF788
Protocol: Tox21 Assay Protocol Summary:

SBE-bla HEK 293T cells were dispensed at 4,000/well in 6 uL of assay medium into black wall/clear-bottom 1536-well plates using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. After the assay plates were incubated at 37 C and 5% CO2 for an overnight, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a Pintool station (Kalypsys, San Diego, CA). The assay plates were incubated at 37 C and 5% CO2 for 5 hr. One uL of LiveBLAzer B/G FRET substrate (Life Technologies) was added using a Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA) and the plates were incubated at room temperature for 2 hr. Fluorescence intensity (405 nm excitation, 460 nm and 530 nm emissions) was measured using an Envision plate reader (PerkinElmer, Shelton, CT). For cytotoxicity read, 4 uL of CellTiter-Glo reagent (Promega Corporation, Madison, WI) was added to each well of the assay plates using FRD. After 30min incubation at room temperature, the luminescence intensity was measured using ViewLux plate reader (PerkinElmer).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000049913 uM-Replicate_1Activity at 0.0000115944 uM-Replicate_1Activity at 0.0000453222 uM-Replicate_1Activity at 0.0001076943 uM-Replicate_1Activity at 0.0002499208 uM-Replicate_1Activity at 0.0005150359 uM-Replicate_1Activity at 0.00142 uM-Replicate_1Activity at 0.00434 uM-Replicate_1Activity at 0.011 uM-Replicate_1Activity at 0.025 uM-Replicate_1Activity at 0.057 uM-Replicate_1Activity at 0.127 uM-Replicate_1Activity at 0.290 uM-Replicate_1Activity at 0.877 uM-Replicate_1Activity at 2.716 uM-Replicate_1Activity at 6.973 uM-Replicate_1Activity at 15.76 uM-Replicate_1Activity at 35.30 uM-Replicate_1Activity at 76.83 uM-Replicate_1Activity at 199.8 uM-Replicate_1Activity at 725.3 uM-Replicate_1Activity at 1537.0 uM-Replicate_1Activity at 3438.0 uM-Replicate_1Activity at 7687.0 uM-Replicate_1Activity at 17190.0 uM-Replicate_1Activity at 38440.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive00042.1534-7.6354-9.5776-5.6143-1.012111.30590.3687-11.0158-1.1805-1.4643-13.2683-8.404711.77132.1534QC'd by ACCInactive0
Inactive00040.3853-2.34471.6915-3.8832-12.234-6.063910.4031-0.10763.0444-17.8434-9.0523-0.63646.16940.3853QC'd by ACCInactive0
Inactive0004-4.04217.28871.1321-1.0076-0.4257-17.815-1.9458-2.8324-0.26711.5412-6.3086-16.0498-1.234-4.0421QC'd by ACCInactive0
Inactive00042.2262-0.27841.1596-5.39745.13174.5477-1.56778.2001-2.3624-0.74210.3122-9.13862.05512.2262QC'd by ACCInactive0
Inactive0004-7.0334-9.58-0.28810.49541.5448-2.6274-5.451-10.57076.8461-12.23223.36080.0777-10.594-7.0334QC'd by RTIInactive0
Inactive00040.5577-6.92164.08684.81427.0784-12.4576-9.757-0.17037.57714.0781-2.79689.74059.81750.5577QC'd by RTIInactive0
Inactive0004-9.59890.1876-3.80886.11587.2443-9.1093-0.73231.2719-1.27595.66738.78383.38780.0903-9.5989QC'd by RTIInactive0
Inactive00044.351-5.72861.4678-2.1564-14.60168.34676.6356-0.760210.7032-11.9786-6.40967.79392.8074.351QC'd by RTIInactive0
Inactive00040.5045-3.7529-1.7626-8.850714.2694-9.98430.0505-9.8421-1.91.78692.24271.7842-8.44340.5045QC'd by RTIInactive0
Inactive0-5.65134.95490.5844-10.1340.540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-4.82153.5787-2.24930.3702-1.35587.5103-2.2408-2.10150.0327-5.0605-8.2738-14.2783-5.3299-4.8215QC'd by RTIInactive0
Inactive0-7.3254.95490.4788-2.754110.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-1.417614.9854-0.321512.242812.8638-7.8629-2.609614.4642-7.0084-3.0391-3.4978-8.9617-4.4531-1.4176QC'd by RTIInactive0
Inactive00040.26-0.762716.0941-0.699314.358614.84582.28110.1025-0.21150.6563-1.03243.6094-4.03590.26QC'd by RTIInactive0-5.23974.95490.3552
Inactive0-6.75654.95490.3325-3.11255.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-11.722210.09291.46324.36381.165514.80424.4674-8.09957.7835-8.22510.42724.0697-1.7864-11.7222QC'd by RTIInactive0-4.15654.95490.5825
Inactive0-8.48820.40.4872-11.87911840 0 0 0 0 0 0 0 0 0 0 0 0 0 12.539612.5472-0.71070.8605-10.70591.0837-11.80228.1488-10.492-13.9866-11.0593-10.6589-8.91962.5396QC'd by RTIInactive0
Inactive0004-16.4655-1.01182.37924.2934-13.9101-0.655-0.0372-12.7646-1.3391-4.99346.1809-15.64490.1065-16.4655QC'd by RTIInactive0-4.19991.3310.6533
Inactive0004-15.12790.8718-5.70941.3373-4.1706-10.7425-0.4827-6.8534-4.311-5.94720.3002-4.3387-5.5218-15.1279QC'd by RTIInactive0-4.2071.10.6324
Inactive0-8.39894.95490.39841-15.510440 0 0 0 0 0 0 0 0 0 0 0 0 0 03.2263-11.0633-8.0336-1.45620.8124-6.810510.32120.1049-8.2487-6.59317.18083.677413.793.2263QC'd by RTIInactive0
Inactive00042.7249-5.44857.2482-0.56370.9545-5.3267-5.53923.12183.20911.32840.045-4.3055-6.82312.7249QC'd by RTIInactive0
Inactive0004-10.928-3.0077-3.118-2.9977-8.1818-4.913-2.4687-8.7243-4.03920.46591.2575-8.5593-9.3013-10.928QC'd by RTIInactive0-5.34144.95490.4847
Inactive0-8.36044.95490.59011-10.626540 0 0 0 0 0 0 0 0 0 0 0 0 0 01.1574-7.1662-7.371-0.1699-1.2819-2.6537-0.86892.15273.9489-0.44732.1474-0.889910.26721.1574QC'd by RTIInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: TGF602
Protocol: Tox21 Assay Protocol Summary:

SBE-bla HEK 293T cells were dispensed at 4,000/well in 5 uL of assay medium into black wall/clear-bottom 1536-well plates using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. After the assay plates were incubated at 37 C and 5% CO2 for an overnight, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a Pintool station (Kalypsys, San Diego, CA). Compound transfer was followed by the addition of 1 uL of 0.25 ng/mL TGF-beta1 or assay buffer using two separate tips of Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA). The assay plates were incubated at 37 C and 5% CO2 for 5 hr. One uL of LiveBLAzer B/G FRET substrate (Life Technologies) was added using a Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA) and the plates were incubated at room temperature for 2 hr. Fluorescence intensity (405 nm excitation, 460 nm and 530 nm emissions) was measured using an Envision plate reader (PerkinElmer, Shelton, CT). For cytotoxicity read, 4 uL of CellTiter-Glo reagent (Promega Corporation, Madison, WI) was added to each well of the assay plates using FRD. After 30 min incubation at room temperature, the luminescence intensity was measured using ViewLux plate reader (PerkinElmer).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000049913 uM-Replicate_1Activity at 0.0000114526 uM-Replicate_1Activity at 0.0000453222 uM-Replicate_1Activity at 0.0001077752 uM-Replicate_1Activity at 0.0002496487 uM-Replicate_1Activity at 0.0005152025 uM-Replicate_1Activity at 0.00141 uM-Replicate_1Activity at 0.00434 uM-Replicate_1Activity at 0.011 uM-Replicate_1Activity at 0.025 uM-Replicate_1Activity at 0.057 uM-Replicate_1Activity at 0.127 uM-Replicate_1Activity at 0.290 uM-Replicate_1Activity at 0.887 uM-Replicate_1Activity at 2.716 uM-Replicate_1Activity at 6.973 uM-Replicate_1Activity at 15.76 uM-Replicate_1Activity at 35.30 uM-Replicate_1Activity at 76.83 uM-Replicate_1Activity at 199.8 uM-Replicate_1Activity at 725.3 uM-Replicate_1Activity at 1537.0 uM-Replicate_1Activity at 3438.0 uM-Replicate_1Activity at 7687.0 uM-Replicate_1Activity at 17190.0 uM-Replicate_1Activity at 38440.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive00046.3658-2.60391.44354.05925.1651.5102-2.10565.56941.89612.346-4.64773.2753.08096.3658QC'd by VitasInactive0
Inactive0004-9.1232-2.0779-7.2059-6.51591.88635.3085-6.6134-1.7254-6.0177-3.3289-0.59720.0597-3.9679-9.1232QC'd by VitasInactive0
Inactive0004-14.6818-7.381320.16795.2078-9.80888.5495-2.93110.32990.2627-2.9852-0.46775.9958-7.8291-14.6818QC'd by VitasInactive0-7.97132.33320.3462
Inactive0-5.47133.92950.49668.5-1.252540 0 0 0 0 0 0 0 0 0 0 0 0 0 11.07970.0681-8.5437-0.30444.31163.9143-5.1188-3.4351.9874-2.03211.031410.54466.43281.0797QC'd by EnzoInactive0-7.07134.95490.5615
Inactive00042.2672-3.51267.52698.31222.744-0.57573.1093-0.029311.067916.0548.29036.47982.8462.2672QC'd by MicrosourceInactive0
Inactive00041.15580.33993.3299-0.092-7.5073-0.3577-8.3319-10.4863-2.41117.30391.4618-0.16762.62321.1558QC'd by VitasInactive0
Inactive00042.38522.9608-0.180512-1.30482.0019-0.0637-3.707-2.1689-0.0132-1.6392-0.1802-4.9692.385QC'd by MicrosourceInactive0-7.67134.95490.4055
Inactive0-5.72134.95490.542411-1.126140 0 0 0 0 0 0 0 0 0 0 0 0 0 1-2.80521.32884.0595-4.21330.09360.00891.8704-2.1286-8.02172.98916.6742.851417.2213-2.8052QC'd by MicrosourceInactive0
Inactive0004-6.9975-21.5549-1.7139-11.1167.3205-15.0277-9.9118-10.7417-5.8795.0736-0.6498-8.2048-18.5531-6.9975QC'd by MicrosourceInactive0
Inactive0004-2.6286-1.0414-9.22751.67330.72290.357-0.6243-0.7725-9.54890.1376-3.2384-0.9664-7.7543-2.6286QC'd by VitasInactive0
Inactive00041.48930.60671.47462.70132.3731-0.48691.4237-6.3250.2843-0.1355-6.63581.48270.1211.4893QC'd by Prestwick Chemical; Inc.Inactive0
Inactive00047.6340.08773.034612.5867-17.70837.34379.2840.28641.555113.69274.523118.55914.637.634QC'd by MicrosourceInactive0-8.07131.1110.4375
Inactive0-4.97133.990.6591-16.2645.540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-4.52787.61125.25697.85098.909813.50341.78571.81494.4803-1.71623.85622.872-16.8866-4.5278QC'd by SIGMAInactive0-4.77133.1320.3667
Inactive00040.171-1.53623.69791.224901.11573.99470.113-6.284-4.8884-3.60180.32042.90880.171QC'd by Prestwick Chemical; Inc.Inactive0
Inactive0-6.42133.06540.79-18.2130.540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-1.1261-5.52083.18081.589-0.9417-0.8591.82581.0372-3.0226-22.6775-19.6966-22.219-6.7412-1.1261QC'd by SelleckInactive0-7.42132.72020.7639
Inactive00042.8502-9.313811.4561-6.908611.19517.78194.2316-1.51561.28360.275812.5861-1.362612.53392.8502QC'd by PrestwickInactive0
Cytotoxic26.832591.942820Single point of activity-4.57134.95490.9639-92.6815-0.7388-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-81.29966.0879-4.98851.72915.5077-2.3-2.0889-9.03090.0586-0.3597-1.6828-0.3346-8.2933-81.2996QC'd by MicrosourceCytotoxic26.8325100.309820Single point of activity-4.57134.95490.9433
Inactive00043.80165.117611.05366.35-1.95917.95854.8337-3.903414.1856.9862-10.64953.9475-3.363.8016QC'd by PrestwickInactive0
Inactive0-6.67130.80.5283-10.3174340 0 0 0 0 0 0 0 0 0 0 0 0 0 0-13.44116.27583.00181.25774.3703-4.0792-0.63050.1011-6.0601-0.5984-15.2828-8.51721.0014-13.4411QC'd by PrestwickInactive0-5.87131.10.7925
Inactive0-5.47134.95490.5805100.049640 0 0 0 0 0 0 0 0 0 0 0 0 0 10.12882.1046-1.20021.64694.3816-2.8696.1445-2.4997-3.1762-3.70871.929712.16337.81960.1288QC'd by MicrosourceInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: P53600
Protocol: Tox21 Assay Protocol Summary:

The p53RE-bla cells were dispensed at 4,000 cells/5 ul/well in 1536-well black wall/clear bottom plates using a Multidrop dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 5 hours, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pin tool. The plates were incubated at 37 C for 16 hours. After 1 uL of LiveBLAzerTM B/G FRET substrate was added using a Flying Reagent Dispenser, the plates were incubated at room temperature for 2 hours, and fluorescence intensity was measured by an Envision plate reader. For cell viability readout that measures cytotoxicity, 4 ul/well of CellTiter-Glo reagent was added into the assay plates using a Flying Reagent Dispenser. After 30 min incubation at room temperature, the luminescence intensity in the plates was measured using a ViewLux plate reader.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).
Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000043054 uM-Replicate_1Activity at 0.0000099513 uM-Replicate_1Activity at 0.0000394398 uM-Replicate_1Activity at 0.0000922287 uM-Replicate_1Activity at 0.0002147056 uM-Replicate_1Activity at 0.0004452702 uM-Replicate_1Activity at 0.00122 uM-Replicate_1Activity at 0.00376 uM-Replicate_1Activity at 0.00955 uM-Replicate_1Activity at 0.022 uM-Replicate_1Activity at 0.049 uM-Replicate_1Activity at 0.109 uM-Replicate_1Activity at 0.249 uM-Replicate_1Activity at 0.761 uM-Replicate_1Activity at 2.332 uM-Replicate_1Activity at 5.986 uM-Replicate_1Activity at 13.53 uM-Replicate_1Activity at 30.31 uM-Replicate_1Activity at 65.96 uM-Replicate_1Activity at 171.5 uM-Replicate_1Activity at 622.7 uM-Replicate_1Activity at 1320.0 uM-Replicate_1Activity at 2952.0 uM-Replicate_1Activity at 6600.0 uM-Replicate_1Activity at 14760.0 uM-Replicate_1Activity at 33000.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive000411.68960.1156-13.79419.96613.16310.7283-0.13048.42250.8152-0.10070.800321.2177-5.098911.6896QC'd by GVKInconclusive22.349231.210810Partial curve; partial efficacy; poor fit-4.65074.95490.8311
Inactive00044.1278-1.2132-0.531.1724-13.6008-15.8488-1.6086-19.5261-1.84034.6782.76125.28040.28044.1278QC'd by SequoiaInactive0
Inactive0004-9.80083.31944.9321-4.8812-12.78760.30429.0414-8.94990.223314.08858.8057-15.4411-4.9694-9.8008QC'd by TocrisInactive0
Inactive0004-1.97565.0865-1.7855-7.44442.244-1.822215.634118.165121.11031.735-10.98693.971310.803-1.9756QC'd by MicrosourceInactive0
Inactive00046.85951.21214.5834-1.147427.33062.48186.32539.01910.214520.70491.9499-9.1091-8.70446.8595QC'd by SIGMAInactive0
Inactive0-4.80072.09370.639333.4297-12.96840 0 0 0 0 0 0 0 0 0 0 1 0 0 025.4284-14.8066-9.0853-13.581-7.588-35.7992-8.9477-21.4634-0.5226-3.92488.5216-5.58437.506325.4284QC'd by MicrosourceInactive0
Inactive0004-15.007-3.1282-9.3591-0.59167.66516.92395.64735.12210.15582.5991-1.3526-6.47-0.785-15.007QC'd by MicrosourceInactive0
Inactive000424.0896-0.8446-9.61-6.08550.45112.491311.00488.98224.16252.593115.94870.8545-5.437324.0896QC'd by VitasInactive0
Inactive0004-17.67891.269819.24249.9274-7.42686.6741.6608-11.9547-6.5433-0.12947.7321-0.9298-3.0587-17.6789QC'd by SequoiaInactive0
Inactive0004-14.1816-14.82752.70742.3606-2.2355-4.2683-14.785-4.9866-14.55780.587-5.4301-8.78443.5884-14.1816QC'd by MicrosourceInactive0-9.20073.19250.6375
Inactive0004-1.2316-19.54044.6965-1.2942-1.67070.2407-15.5972-0.1313-8.4723-7.3738-1.20892.41540.8864-1.2316QC'd by SequoiaInactive0
Inactive00041.5567-5.753613.963810.2956-0.5580-1.68249.770620.988-2.01438.1577-7.9909-2.67841.5567QC'd by VitasInactive0
Inactive0-5.00071.96730.395926.0362-2.459340 0 0 0 0 0 0 0 0 1 0 0 0 0 10.23290.7504-0.0238-13.01490.91413.2757.6-0.817-14.514333.15894.5704-6.010126.66430.2329QC'd by VitasInactive0-7.85074.95490.3764
Inactive00040.4996-11.00798.4449-5.51661.0437-5.31884.2154-11.5318-0.68280.560410.3541-10.0764-3.39490.4996QC'd by SequoiaInactive0
Inactive0004-11.29821.6112-9.15080.0988-19.993-7.174916.2891-28.8965-0.2185-13.4455-15.182-7.4087.9797-11.2982QC'd by SIGMAInactive0
Cytotoxic0.001329.371420Complete curve; partial efficacy; poor fit-8.90074.95490.6762-1.930827.4406-1.40 0 0 0 0 0 0 0 0 0 0 0 0 0 02.084327.380322.2956-1.7991-14.5009-13.0557-1.27961.8292-4.68462.1858-2.80191.152812.67842.0843QC'd by MicrosourceInactive0
Cytotoxic22.349237.143520Single point of activity-4.65074.95490.6826-37.6249-0.4814-30 0 0 0 0 0 1 0 0 0 0 0 0 0 0-35.0886-10.0183-3.78480.92698.32995.971651.8329-7.9197-7.10119.7258-3.0119-1.82540.4137-35.0886QC'd by MicrosourceCytotoxic19.918841.056720Single point of activity-4.70074.50450.7845
Inactive0004-8.20534.878-0.8843.033-7.545116.823-9.3197.52683.3384-2.1505-2.9445-18.3014-0.1048-8.2053QC'd by SpecsInconclusive25.076243.037610Single point of activity-4.60074.95490.5622
Inactive000420.76650.814812.61279.9828-12.22150.44040.7956-15.56271.1625-6.82596.0669-0.0505-1.196720.7665QC'd by Prestwick Chemical; Inc.Inconclusive22.349234.562510Single point of activity-4.65074.0950.9286
Inconclusive8.897437.738210Single point of activity-5.05073.1320.718338.15130.413130 0 0 0 0 0 0 0 0 0 0 0 0 0 1-5.95941.40094.89037.6788-4.8095-4.8507-6.912-0.4163-7.58221.59434.88844.768442.6535-5.9594QC'd by MicrosourceInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: P53MS958
Protocol: Tox21 Assay Protocol Summary:

The p53RE-bla cells were dispensed at 4,000cells/3ul/well in 1536-well black-clear bottom plates. After the assay plates were incubated at 37 C, 5% CO2 incubator for 5 hours, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate. Following compound addition, 3 uL of rat liver microsomes (Molecular Toxicology, Boone, NC) at final concentration of 0.5 mg/mL and 1uL of B-Nicotinamide adenine dinucleotide 2'-phosphate (NADPH) at final concentration of 0.5 mg/mL were transferred to the assay plate. The plates were incubated at 37 C for 16 hours. 1 uL of LiveBLAzer detection mixture was added to each well and the plates were incubated at room temperature in the dark for 2 h. Fluorescence intensity at 460 and 530 nm emission and 405 nm excitation were measured by an Envision plate reader. For cell viability readout that measures cytotoxicity, 4 ul/well of CellTiter-Glo reagent was added into the assay plates using a Flying Reagent Dispenser. After 30 min incubation at room temperature, the luminescence intensity in the plates was measured using a ViewLux plate reader.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000043235 uM-Replicate_1Activity at 0.0000098296 uM-Replicate_1Activity at 0.0000380988 uM-Replicate_1Activity at 0.0000933477 uM-Replicate_1Activity at 0.0002146311 uM-Replicate_1Activity at 0.0004426192 uM-Replicate_1Activity at 0.00122 uM-Replicate_1Activity at 0.00372 uM-Replicate_1Activity at 0.00957 uM-Replicate_1Activity at 0.022 uM-Replicate_1Activity at 0.049 uM-Replicate_1Activity at 0.109 uM-Replicate_1Activity at 0.249 uM-Replicate_1Activity at 0.768 uM-Replicate_1Activity at 2.332 uM-Replicate_1Activity at 5.986 uM-Replicate_1Activity at 13.53 uM-Replicate_1Activity at 30.31 uM-Replicate_1Activity at 65.96 uM-Replicate_1Activity at 171.5 uM-Replicate_1Activity at 622.7 uM-Replicate_1Activity at 1320.0 uM-Replicate_1Activity at 2952.0 uM-Replicate_1Activity at 6600.0 uM-Replicate_1Activity at 14760.0 uM-Replicate_1Activity at 33000.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive000415.4129-0.3878-0.18645.37348.8557-0.29272.5035-10.205-0.2227.988-2.2891.52765.497915.4129QC'd by ACCInactive0
Inactive0-9.30074.95490.81131-17.707840 0 0 0 0 0 0 0 0 0 0 0 0 0 01.0149-13.08993.2756-1.32141.18321.8535-0.3978-0.4282.5506-0.24571.49181.68870.55861.0149QC'd by ACCInactive0
Inactive00040.0279-7.8342-1.89942.16960.5638-6.7392.6266-0.50970.73195.3764-7.7238-0.06747.02780.0279QC'd by ACCInactive0
Inactive00041.38786.287211.3346-1.35856.9465-2.58585.0519-2.5689.0021.6411-1.72927.00831.07741.3878QC'd by ACCInactive0-5.45072.40640.4602
Inactive0004-6.0549-14.8117-16.0755-3.9155-14.9771-10.937-32.5334-11.9531.4447-12.5843-18.1191-11.5121-10.2319-6.0549QC'd by RTIInactive0
Inactive0004-22.5649-3.3758-16.2168-4.5428-4.51510.1292-2.6754-23.201-8.3262-3.0518-1.1305-3.6383-2.6115-22.5649QC'd by RTIInactive0-8.59910.80.691
Inactive0004-0.2302-3.0733-11.95531.9394-0.062-0.7676-9.0695-1.09531.199-3.6509-10.3544-18.6262-9.6473-0.2302QC'd by RTIInactive0-4.20294.95490.345
Inactive0004-31.97-9.3562-1.8629-4.3936-8.3595-10.443-39.3827-2.50720.54372.3156-5.5145-4.9746-4.5578-31.97QC'd by RTIInactive0
Cytotoxic48.936540.016120Single point of activity-4.31044.95490.9076-41.0161-1-30 0 0 0 0 0 0 0 0 0 0 0 0 0 10.8752-0.1555-0.1471-0.86110.5088-1.62211.8567-5.5667-4.26740.6449-1.1659-1.471-37.97790.8752QC'd by RTIInactive0
Inactive0-4.4812.25260.6231-17.4881-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-14.1568-8.0428-0.62356.2346-0.9991-1.44871.2877-1.82882.3924-2.4336-0.4068-0.0819-10.8685-14.1568QC'd by RTIInactive0
Inactive0-4.15464.95490.3365-27.53820.41540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-21.24640.0979-1.09382.89261.68642.0417-11.5049-1.00074.87532.0771-10.214919.6036-0.4282-21.2464QC'd by RTIInactive0-4.35463.92950.4572
Cytotoxic1.909462.99420Single point of activity-5.71914.95490.8427-65.284-2.29-30 0 0 0 0 0 0 0 0 0 0 1 1 1 121.2448-4.4527-11.9693-0.7569-1.67770.0603-12.88981.4183.8556-64.004-3.125819.149730.660221.2448QC'd by RTIInconclusive26.970339.101610Partial curve; partial efficacy-4.56912.40640.8048
Inactive0-5.73594.95490.4398-11.70950.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-18.5079-13.1487-1.13453.01137.6647-1.76074.95091.42740.7821-7.5706-10.5531-11.2568-1.1121-18.5079QC'd by RTIInactive0-5.13593.990.4729
Inactive0-4.91744.95490.4007150.513840 0 0 0 0 0 0 0 0 0 0 0 0 0 1-8.2124-6.4957-1.34376.24526.8209-1.5109-0.187612.48363.7645-4.0819-5.983812.929113.901-8.2124QC'd by RTIInactive0
Inactive0004-4.309910.7843-0.2327-5.32226.8375-6.64633.82231.011417.173-2.68034.8346-1.5527-1.3315-4.3099QC'd by RTIInactive0
Inactive0-4.78644.95490.4643-0.5-6.943640 0 0 0 0 0 0 0 0 0 0 0 0 0 0-2.3412-9.0513-3.5748-2.3634-8.2237-8.0106-6.3527-9.1377-10.7863-6.9009-9.556-4.63561.3663-2.3412QC'd by RTIInactive0
Inactive00043.8948-9.18-4.528-7.8262-5.28180.1213-2.8514-5.27810.14171.4481-10.28080.21445.40843.8948QC'd by RTIInactive0-4.27824.0450.5133
Inactive00040.9309-0.3627-0.7959-0.29194.6133-6.45136.07670.37295.22822.4365-0.3736-6.44071.19840.9309QC'd by RTIInactive0
Inactive00044.6175-2.446-2.97794.96498.591-3.7225-1.29327.6265.56985.46650.618212.56510.39614.6175QC'd by RTIInactive0
Inactive00041.16141.11370.8635-2.0253-1.3109-1.0103-7.7297-0.07730.3904-0.9231-0.2649-8.99091.4551.1614QC'd by RTIInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: P53MS482
Protocol: Please refer to other AIDs 1963578, 1963580, 720687, 720685, 720678 and 720681 for detailed assay protocols.
Comment: This summary is written for the purposes of summarizing the compound activities from the project combining the results from both the p53 with rat microsomes agonist mode assay (AID 1963578), cell viability counter screen (AID 1963580), and auto fluorescence counter screens (AID 720687, 720685, 720678, and 720681). For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Potency and efficacy were used for determining relative score. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 5 and 30 determined by phenotype.

Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).
Activity SummaryRatio ActivityRatio Potency (uM)Ratio Efficacy (%)530 nm Activity530 nm Potency (uM)530 nm Efficacy (%)460 nm Activity460 nm Potency (uM)460 nm Efficacy (%)Viability ActivityViability Potency (uM)Viability Efficacy (%)Blue (460 nm) auto fluorescence outcomeSample Source
inactiveinactive0inactive0inactive0active antagonist37.95478669-56.89862383inactiveRohm and Haas
inactiveinactive0inactive0inactive0inactive0inactiveSIGMA
inactiveinactive0inactive0inactive0inactive0inactiveSIGMA
inactiveinactive0inactive0inactive0inactive0inactiveSIGMA
inactiveinactive0inactive0inactive0inactive0inactivePfaltz-Bauer
inactiveinactive0inactive0inactive0inactive0inactiveRadian International
inactiveinactive0inactive0inactive0inconclusive antagonistinactiveSpectrum Chemical
inactiveinactive0inconclusive agonistinactive0inactive0inactiveSIGMA
inactiveinactive0inactive0inactive0inactive0inactiveSigmaAldrich
inactiveinactive0inactive0inactive0inactive0inactiveBattelle Northwest
inactiveinactive0inactive0inactive0inactive0inactiveSIGMA
inactiveinactive0inactive0inconclusive agonistinactive0inactiveSIGMA
inactiveinactive0inactive0inactive0active antagonist11.47389904-137.559426inactiveTCI
inactiveinactive0inactive0inactive0inactive0inactiveSIGMA
inactiveinactive0inactive0inactive0inconclusiveinactiveSigmaAldrich
inactiveinactive0inactive0inactive0inactive0inactiveSIGMA
inactiveinactive0inactive0inactive0inactive0inactiveSIGMA
inactiveinactive0inactive0inactive0inactive0inactiveSIGMA
inactiveinactive0inactive0inactive0inactive0inactiveShanghai Xingling
inactiveinactive0inactive0inactive0inactive0inactiveSIGMA
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: P53344
Protocol: Tox21 Assay Protocol Summary:

The p53RE-bla cells were dispensed at 4,000 cells/5 ul/well in 1536-well black wall/clear bottom plates using a Multidrop dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 5 hours, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pin tool. The plates were incubated at 37 C for 16 hours. After 1 uL of LiveBLAzerTM B/G FRET substrate was added using a Flying Reagent Dispenser, the plates were incubated at room temperature for 2 hours, and fluorescence intensity was measured by an Envision plate reader.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000043054 uM-Replicate_1W530-Activity at 0.0000099513 uM-Replicate_1W530-Activity at 0.0000394398 uM-Replicate_1W530-Activity at 0.0000922287 uM-Replicate_1W530-Activity at 0.0002147056 uM-Replicate_1W530-Activity at 0.0004452702 uM-Replicate_1W530-Activity at 0.00122 uM-Replicate_1W530-Activity at 0.00376 uM-Replicate_1W530-Activity at 0.00955 uM-Replicate_1W530-Activity at 0.022 uM-Replicate_1W530-Activity at 0.049 uM-Replicate_1W530-Activity at 0.109 uM-Replicate_1W530-Activity at 0.249 uM-Replicate_1W530-Activity at 0.761 uM-Replicate_1W530-Activity at 2.332 uM-Replicate_1W530-Activity at 5.986 uM-Replicate_1W530-Activity at 13.53 uM-Replicate_1W530-Activity at 30.31 uM-Replicate_1W530-Activity at 65.96 uM-Replicate_1W530-Activity at 171.5 uM-Replicate_1W530-Activity at 622.7 uM-Replicate_1W530-Activity at 1320.0 uM-Replicate_1W530-Activity at 2952.0 uM-Replicate_1W530-Activity at 6600.0 uM-Replicate_1W530-Activity at 14760.0 uM-Replicate_1W530-Activity at 33000.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inactive10004-2.7054-0.742917.6324-5.7098-2.4442-8.8689-8.44923.85664.8951.316-4.2342-2.2173-1.3067-2.705410004-0.008
Inactive10004-9.2163-14.98060.5352-3.1889-1.87493.657-6.40320.83436.099515.97381.8503-6.6623-7.3549-9.2163100040.5551
Inconclusive15.82281.873510Partial curve; high efficacy-4.80071.46410.942883.86851.9952.11 0 0 0 0 0 0 0 0 0 0 0 0 0 063.7671-25.2350.72594.9823.8964-6.011-7.50423.0243-0.36318.58029.552814.338143.879163.767110-5.15071.41630.6697-11.5276040 0 0 0 0 0 0 0 0 0 0 0 0 0 0-9.41
Inactive10004-7.60360.157-0.8011-9.9636-13.0521-10.3016-8.2965-19.3101-11.1767-1.8658-10.3506-0.2558-4.7484-7.6036100040.7786
Inactive10004-1.25980.187213.2885.11046.52950.1337-12.0409-9.16955.1910.756-5.7729-4.064311.1384-1.2598100040.0274
Inactive10-4.79910.60.5308-18.20022.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-12.66682.13790.73361.997911.88191.0068-5.4624-1.91134.135-9.1428-3.5388-7.7512-8.3149-12.6668100042.1474
Inactive100040.120.6216.73751.29862.96138.4418-20.9196-8.36372.5119-0.9643-3.05170.98720.45280.12100040.1505
Inactive10004-3.34154.8601-0.05933.13132.492711.5913-1.4902-13.7451.9094-3.61140.17755.8982-1.925-3.3415100040.1916
Inactive100044.68764.03720.43261.7117-5.36330.01244.09393.29011.8675-5.35829.301-3.3996-6.65394.687610004-0.8649
Inactive1000414.45021.1662-13.4728-0.06892.7591-5.585-15.2304-11.60378.2866-5.55088.036-4.6022-4.845814.450210004-3.7942
Inactive10-4.60461.1110.576731.0459-6.10640 0 0 0 0 0 0 0 0 0 0 0 0 0 026.6548-7.6451-2.6127-0.4371-10.6818-11.93260.5693-21.22510.609-17.09791.011613.89869.803426.654810004-1.0538
Inconclusive15.166545.683610Partial curve; partial efficacy-4.81910.60.775941.0698-4.61382.20 0 0 0 0 0 0 0 0 0 0 0 0 0 032.1055-2.8274-2.73911.8943-2.4675-16.4634-3.3416-2.31647.09830.338415.525617.156218.43332.1055100040.1046
Inactive10-4.68594.50450.56518-4.235840 0 0 0 0 0 0 0 0 0 0 0 0 0 15.1259-0.5226-4.0178-6.8476-0.1323-11.918-14.7798-1.343-0.6951-0.0477-3.8234-0.157915.36455.125910004-0.8015
Inactive10004-2.57192.1271-15.6379-9.9458-0.0566-1.3009-10.3345-4.73090.7930.4322-6.21176.0155-0.1149-2.571910004-0.2737
Inactive10-4.429110.3508160.584740 0 0 0 0 0 0 0 0 0 0 0 0 0 014.03072.8758-1.4333-4.09618.1324-0.1788-1.8365-3.40460.96875.33925.74960.63436.788614.030710004-0.3011
Inactive10-5.88644.95490.460410-0.303340 0 0 0 0 0 0 0 0 0 0 0 0 0 014.81111.65651.78890.1435-7.595-1.069210.26810.1065-11.50277.37014.69215.95186.487814.811110004-6.6938
Inactive1000412.70575.94743.12190.9114-1.934610.27262.0269-12.6992-5.01885.3788-5.1369-2.868815.767612.705710004-1.5792
Inactive100048.0685-3.4653-4.85211.49384.676215.0539-6.5066-14.57680.9838-2.93245.02795.50265.54988.068510004-2.3647
Inactive100040.21273.5618-0.86484.668510.12697.869-0.11867.88796.91763.71724.3769.7145-1.76850.212710004-0.1916
Inactive1000415.68179.5665-3.95061.963.0139-1.30215.9929-15.24591.98272.56765.42287.37042.786215.681710004-3.34
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:tumor suppressor p53 [Homo sapiens]
External ID: P53MS233
Protocol: Tox21 Assay Protocol Summary:

The p53RE-bla cells were dispensed at 4,000cells/3ul/well in 1536-well black-clear bottom plates. After the assay plates were incubated at 37 C, 5% CO2 incubator for 5 hours, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate. Following compound addition, 3 uL of human liver microsomes (XenoTech, Kansas City, KS) at final concentration of 0.5 mg/mL and 1uL of Beta-Nicotinamide adenine dinucleotide 2-phosphate (NADPH) at final concentration of 0.5 mg/mL were transferred to the assay plate. The plates were incubated at 37 C for 16 hours. 1 uL of LiveBLAzer detection mixture was added to each well and the plates were incubated at room temperature in the dark for 2 h. Fluorescence intensity at 460 and 530 nm emission and 405 nm excitation were measured by an Envision plate reader.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000042859 uM-Replicate_1W530-Activity at 0.0000098296 uM-Replicate_1W530-Activity at 0.0000389118 uM-Replicate_1W530-Activity at 0.0000921325 uM-Replicate_1W530-Activity at 0.0002143310 uM-Replicate_1W530-Activity at 0.0004423865 uM-Replicate_1W530-Activity at 0.00121 uM-Replicate_1W530-Activity at 0.00372 uM-Replicate_1W530-Activity at 0.00955 uM-Replicate_1W530-Activity at 0.022 uM-Replicate_1W530-Activity at 0.049 uM-Replicate_1W530-Activity at 0.109 uM-Replicate_1W530-Activity at 0.249 uM-Replicate_1W530-Activity at 0.761 uM-Replicate_1W530-Activity at 2.332 uM-Replicate_1W530-Activity at 5.986 uM-Replicate_1W530-Activity at 13.53 uM-Replicate_1W530-Activity at 30.31 uM-Replicate_1W530-Activity at 65.96 uM-Replicate_1W530-Activity at 171.5 uM-Replicate_1W530-Activity at 622.7 uM-Replicate_1W530-Activity at 1320.0 uM-Replicate_1W530-Activity at 2952.0 uM-Replicate_1W530-Activity at 6600.0 uM-Replicate_1W530-Activity at 14760.0 uM-Replicate_1W530-Activity at 33000.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inactive10-5.20073.990.3607-2.5677740 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.945810.030110.74434.3442-5.05659.97422.951914.24288.764610.73796.49832.3813-4.5519-0.945810004.0000-0.4661
Inactive10-5.65074.95490.5456-1.9439840 0 0 0 0 0 0 0 0 0 0 0 0 0 15.08469.49733.81968.4513-0.619110.36259.433713.778210.27034.69635.4408-1.6199-1.45995.084610004.00001.5918
Inactive10-5.55070.20.470118-0.201840 0 0 0 0 0 0 0 0 0 0 0 0 0 011.2543-1.00153.75646.89974.79742.8342.87626.5347.24690.758412.16298.90029.7511.254310004.0000-5.5377
Inactive100041.163-3.51611.707-1.8835-3.46991.9890.10351.2453-2.9592-3.6379-2.9446-1.8761-0.93791.16310004.00000.1358
Inconclusive1000416.859332.73635.020523.23553.332115.0249-2.90566.9949.49478.34391.2576-2.0333-2.290216.859310004.00009.1878
Inconclusive10004-2.1455-0.55639.41727.7352.03946.42493.62662.90958.6089-4.7033-4.009520.11873.2965-2.145510004.00007.8923
Inactive10004-3.66575.64289.1238-0.71545.00783.34610.6894.02219.965210.092117.6894-0.24811.5526-3.665710004.000014.7162
Inconclusive100044.2675-5.79323.71026.399110.69910.51886.8431-0.265818.58843.903414.16020.41198.98754.267510004.00006.5135
Inactive100049.866218.26245.804817.49314.15489.82548.16059.947216.279414.177417.85510.539517.09199.866210004.0000-5.4950
Inactive10004-5.329712.331.7312-5.499611.4558-3.72499.28072.31575.44163.66498.36633.099311.8517-5.329710004.0000-5.3240
Inconclusive70.04772.348410Partial curve; high efficacy; poor fit-4.15460.80.6385105.628933.28052.30 0 0 0 0 0 0 0 0 0 0 0 0 0 080.211934.473140.812939.568732.405624.682727.567430.391541.000332.340943.744858.28146.303280.211910004.0000-2.1350
Inconclusive19.093534.34910Partial curve; partial efficacy; poor fit-4.71914.95490.7411-28.10156.2475-2.40 0 0 0 0 0 0 0 0 0 0 0 0 0 11.53110.97148.54297.49310.6748-2.691-2.1743-2.26359.19559.26333.86910.8178-29.03671.53110-5.01914.95490.734118.5000-1.04734.00000 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7941
Inactive10-5.33594.95490.4604141.095140 0 0 0 0 0 0 0 0 0 0 0 0 0 024.7756-3.87228.9743-3.24331.4147-5.33746.5468-1.04071.0629-0.639615.012312.85582.944224.775610004.00004.5021
Inactive100047.41038.87323.5826-6.8276-3.40045.10857.125.99217.88590.76615.2069-2.5857-2.38937.410310004.0000-2.5566
Inactive10004-1.2866-1.8663.79256.244.97715.953813.60749.92898.28548.214414.36688.1213-0.9202-1.286610004.0000-3.9577
Inconclusive1000423.99170.9944-3.96381.687221.14372.265812.972312.03323.94191.4937-3.1913.4-3.920623.991710004.00006.2522
Inactive10004-4.56660.7965-6.9681-2.20180.034-1.99810.8299-0.3127-3.4977-3.3230.25471.8446-8.8778-4.566610004.00002.4663
Inactive10-7.02153.51170.347180.303440 0 0 0 0 0 0 0 0 0 0 0 0 0 010.5722-4.18564.19643.9575-4.3305-3.43177.7017.906311.39089.358710.9552-1.394.103110.572210004.00001.0750
Inactive10004-3.64221.972216.7669-4.364-3.7771-2.02811.2212-1.9042-4.0395-1.3596-5.395-2.4515-3.7855-3.642210004.00004.9536
Inactive1000416.4401-5.27783.8363-0.299718.8033-3.88715.63613.536316.4656.73621.28493.68095.811416.440110004.00004.3898
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: P53MS837
Protocol: Tox21 Assay Protocol Summary:

The p53RE-bla cells were dispensed at 4,000cells/3ul/well in 1536-well black-clear bottom plates. After the assay plates were incubated at 37 C, 5% CO2 incubator for 5 hours, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate. Following compound addition, 3 uL of human liver microsomes (XenoTech, Kansas City, KS) at final concentration of 0.5 mg/mL and 1uL of B-Nicotinamide adenine dinucleotide 2'-phosphate (NADPH) at final concentration of 0.5 mg/mL were transferred to the assay plate. The plates were incubated at 37 C for 16 hours. 1 uL of LiveBLAzer detection mixture was added to each well and the plates were incubated at room temperature in the dark for 2 h. Fluorescence intensity at 460 and 530 nm emission and 405 nm excitation were measured by an Envision plate reader. For cell viability readout that measures cytotoxicity, 4 ul/well of CellTiter-Glo reagent was added into the assay plates using a Flying Reagent Dispenser. After 30 min incubation at room temperature, the luminescence intensity in the plates was measured using a ViewLux plate reader.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).
Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000042859 uM-Replicate_1Activity at 0.0000098296 uM-Replicate_1Activity at 0.0000389118 uM-Replicate_1Activity at 0.0000921325 uM-Replicate_1Activity at 0.0002143310 uM-Replicate_1Activity at 0.0004423865 uM-Replicate_1Activity at 0.00121 uM-Replicate_1Activity at 0.00372 uM-Replicate_1Activity at 0.00955 uM-Replicate_1Activity at 0.022 uM-Replicate_1Activity at 0.049 uM-Replicate_1Activity at 0.109 uM-Replicate_1Activity at 0.249 uM-Replicate_1Activity at 0.761 uM-Replicate_1Activity at 2.332 uM-Replicate_1Activity at 5.986 uM-Replicate_1Activity at 13.53 uM-Replicate_1Activity at 30.31 uM-Replicate_1Activity at 65.96 uM-Replicate_1Activity at 171.5 uM-Replicate_1Activity at 622.7 uM-Replicate_1Activity at 1320.0 uM-Replicate_1Activity at 2952.0 uM-Replicate_1Activity at 6600.0 uM-Replicate_1Activity at 14760.0 uM-Replicate_1Activity at 33000.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive0004-0.81153.24171.7036-3.88633.70051.90923.46112.62383.42171.96184.5532-2.1817-2.0587-0.8115QC'd by SIGMAInactive0
Inactive00042.02641.27780.40633.132-0.96178.39740.80260.38625.08541.03870.96490.31392.19092.0264QC'd by Sigma DiscoveryCPRInactive0-6.03963.990.6227
Inactive0004-0.07830.8602-0.43130.77533.3389-7.07430.1475-4.9244-5.6061.28811.431-5.9165-1.58613.3747-0.0783QC'd by SIGMAInactive0-4.85182.12110.4048
Inactive0-8.53960.90.4382.5-17.2540 0 0 0 0 0 0 0 0 0 0 0 0 0 00.4242-11.5665-3.6679-0.6129-7.17834.78830.4184-0.157710.703511.6402-3.9345-0.5512-6.24530.4242QC'd by SIGMAInactive0-7.93964.95490.4551
Inactive0004-5.3318-1.94410.4522-8.3321.0107-0.1156-10.7826-10.8532-4.24710.20287.2076-6.6671-8.3789-5.3318QC'd by SIGMAInactive0
Inactive00040.6118-3.3835-2.5203-9.6183-0.5168-7.3565-1.9351-3.59144.7435-5.2628-2.1247-4.3417-14.53680.6118QC'd by SIGMAInactive0
Inactive0004-5.3821-1.5125-3.5484-1.106-5.2777-3.6383-5.511-10.9006-6.9604-1.92230.6192-4.5677-4.7296-8.0223QC'd by SIGMAInactive0-8.2680.30.4015
Inactive00040.87320.4702-0.8794-0.6340.6861-1.04133.7723-12.8167-6.05652.7542-1.535-7.9041-5.49780.8732QC'd by SIGMAInactive0
Inactive0-6.83964.95490.55124-4.470340 0 0 0 0 0 0 0 0 0 0 0 0 0 01.0676-1.3224-9.1419-1.1865-3.6159-5.2485-8.195310.19175.79951.09081.49983.96712.02971.0676QC'd by SIGMAInactive0-6.78964.95490.3599
Inactive0004-1.0220.210.2513-2.37471.3717-0.50383.9894-1.7888-6.79872.53691.01664.19945.5844-1.022QC'd by SIGMAInactive0-6.38964.95490.3471
Inactive0004-1.4059-3.132-7.66070.7238-4.33320.32411.33020.24797.5234-14.4771-13.01446.36361.2275-1.4059QC'd by RocheInactive0
Inactive0-4.33964.95490.3429-10.88620.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-9.07183.4287-0.5118-4.4669-2.302-2.17713.30782.8439-1.01244.2267-6.21353.9872-0.6916-9.0718QC'd by TCIInactive0
Inactive0004-0.68310.0297-0.9593-0.7386-2.2052-1.3291-4.3626-5.62091.9907011.30340.7086-3.1047-0.6831QC'd by SIGMAInactive0-5.48964.95490.3751
Inactive0-5.93961.78850.35820-3.229640 0 0 0 0 0 0 0 0 0 0 0 0 0 00.3463-2.7679-2.538-3.6541-2.975-8.1080.403-4.8358-1.7099-1.45512.2456-0.5792-0.4960.3463QC'd by SIGMAInactive0
Inactive0004-11.95511.4361-7.8259-8.6263-1.52171.5909-12.8729-11.017-6.8916-3.5531-4.5898-4.7446-6.1302-11.9551QC'd by LightBiologicalsInactive0
Inactive0004-9.9242-1.6531-3.70011.0424-7.9893.6152-5.8328-1.3701-2.0464-3.8438-5.7091-2.1285-5.1644-9.9242QC'd by SIGMAInactive0-4.33963.67720.3682
Cytotoxic40.77972.441840Partial curve; high efficacy-4.38963.92950.8982-74.5596-2.1178-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-64.8179-2.60644.2761-5.9881-1.3877-6.5057-2.59266.3601-8.70221.2883-0.5997-1.9403-18.4593-64.8179QC'd by TCICytotoxic51.337734.492820Single point of activity-4.28964.95490.8014
Inactive0004-14.5026-3.1743.642-4.3769-9.3023-7.6508-8.2832-19.8532-7.861711.7122-6.9451-14.94643.8797-14.5026QC'd by SIGMAInactive0
Inactive0004-2.2222-0.98421.4931-1.41171.1017-10.6336-4.34-12.0027-8.0387-2.805-8.872512.3039-3.6772-2.2222QC'd by SIGMAInactive0
Inactive0-7.33964.95490.52824.5-2.771840 0 0 0 0 0 0 0 0 0 0 0 0 0 01.0674-3.5855-4.2141.2009-4.39320.913.422214.0382.72535.26962.21886.31271.41211.0674QC'd by RocheInactive0-4.73964.0950.6096
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:tumor suppressor p53 [Homo sapiens]
External ID: P53MS898
Protocol: Tox21 Assay Protocol Summary:

The p53RE-bla cells were dispensed at 4,000cells/3ul/well in 1536-well black-clear bottom plates. After the assay plates were incubated at 37 C, 5% CO2 incubator for 5 hours, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate. Following compound addition, 3 uL of rat liver microsomes (Molecular Toxicology, Boone, NC) at final concentration of 0.5 mg/mL and 1uL of Beta-Nicotinamide adenine dinucleotide 2-phosphate (NADPH) at final concentration of 0.5 mg/mL were transferred to the assay plate. The plates were incubated at 37 C for 16 hours. 1 uL of LiveBLAzer detection mixture was added to each well and the plates were incubated at room temperature in the dark for 2 h. Fluorescence intensity at 460 and 530 nm emission and 405 nm excitation were measured by an Envision plate reader.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000043397 uM-Replicate_1W530-Activity at 0.0000099416 uM-Replicate_1W530-Activity at 0.0000388206 uM-Replicate_1W530-Activity at 0.0000933245 uM-Replicate_1W530-Activity at 0.0002146562 uM-Replicate_1W530-Activity at 0.0004427766 uM-Replicate_1W530-Activity at 0.00122 uM-Replicate_1W530-Activity at 0.00372 uM-Replicate_1W530-Activity at 0.00957 uM-Replicate_1W530-Activity at 0.022 uM-Replicate_1W530-Activity at 0.049 uM-Replicate_1W530-Activity at 0.109 uM-Replicate_1W530-Activity at 0.249 uM-Replicate_1W530-Activity at 0.768 uM-Replicate_1W530-Activity at 2.332 uM-Replicate_1W530-Activity at 5.987 uM-Replicate_1W530-Activity at 13.55 uM-Replicate_1W530-Activity at 30.33 uM-Replicate_1W530-Activity at 65.98 uM-Replicate_1W530-Activity at 172.8 uM-Replicate_1W530-Activity at 616.1 uM-Replicate_1W530-Activity at 1320.0 uM-Replicate_1W530-Activity at 2952.0 uM-Replicate_1W530-Activity at 6600.0 uM-Replicate_1W530-Activity at 14760.0 uM-Replicate_1W530-Activity at 33000.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inactive10004-0.0766-0.0658-2.15293.9062-0.3999-1.37385.63961.2637-2.85641.76041.55167.3112-1.1534-0.076610004.0000-0.5396
Inactive10004-9.26574.0277-6.0118-0.0071-1.8112.0788-0.1063-9.81183.02231.6158-3.4131-0.3905-0.1348-9.265710004.0000-0.7395
Inconclusive17.752636.150110Partial curve; partial efficacy-4.75072.40640.95137.51.34992.20 0 0 0 0 0 0 0 0 0 0 0 0 0 030.754-1.3751.59181.76342.18881.4238-0.72522.56751.81642.88342.28283.111216.001330.75410-4.70072.40640.9040-16.0184-1.00004.00000 0 0 0 0 0 0 0 0 0 0 0 0 0 0-12.5153
Inactive10004-0.8668-1.48543.1589-1.5267-0.3498-0.9828-1.6965-4.30540.34461.0195-3.8892-0.0431-3.4971-0.866810004.00002.1550
Inactive100040.4687-0.3692-2.2383-2.0699-1.1088-1.1038-1.892-3.7217-0.3761-2.9675-7.199-1.25980.5490.468710004.0000-4.3810
Inactive100040.4126-1.2865-0.5387-2.298-1.8546-1.5264-1.5856-1.7954-2.1107-10.0252-3.0851-2.8249-1.38430.412610004.00000.0966
Inactive10-8.75291.53860.542-3.90151040 0 0 0 0 0 0 0 0 0 0 0 0 0 10.10826.8455-0.6219-1.9403-3.2657-2.4784-1.636-6.3641-2.7947-6.0758-3.8759-3.1216-2.63750.108210004.0000-1.7240
Inactive10004-2.64841.2797-2.7761-6.4353-4.779-1.4021-0.3446-1.6237-1.1309-5.3966-0.90140-0.5502-2.648410004.00004.8834
Inactive10004-0.1792-0.474-1.4694-0.8953-0.4709-0.74150.1743-4.2804-1.4515-8.5725-1.40966.8573-0.4899-0.179210004.00000.3507
Inactive10-5.2314.95490.63782.5-6.309340 0 0 0 0 0 0 0 0 0 0 0 0 0 03.5172-6.7601-8.0367-0.7524-8.9539-6.7515-6.0875-9.8411-8.2478-4.204-0.20621.74341.04493.517210004.00007.8280
Inactive10-5.25464.95490.73888-2.536240 0 0 0 0 0 0 0 0 0 0 0 0 0 011.2916-1.1337-0.9738-3.7502-3.5438-3.92812.0571-0.3539-3.0856-2.45181.10275.54624.50711.291610004.00000.2257
Inactive10-4.71910.80.3767-22.1814-240 0 0 0 0 0 0 0 0 0 0 0 0 0 1-7.9565-2.4609-4.7653-0.7909-4.3968-2.1758-2.0522-3.5012-2.3448-13.94742.318-16.8178-12.5058-7.956510004.0000-0.5576
Inactive10-5.38594.95490.609313-3.112140 0 0 0 0 0 0 0 0 0 0 0 0 0 1-0.9382-2.1013-5.1202-0.9168-6.4291-0.2473-7.5114-1.6150.7413-1.600515.74921.42750.7564-0.938210004.00003.5229
Inactive10004-2.5193-0.5943-0.7208-2.3194-2.31182.0984-4.0928-2.1388-3.1827-4.05230.0794-0.2907-0.4065-2.519310004.00002.1690
Inactive10-4.97912.72020.55856-4.095340 0 0 0 0 0 0 0 0 0 0 0 0 0 08.8855-0.6587-4.6588-0.4651-5.4882-3.2508-2.652-4.0762-6.6845-6.0914-4.67266.54320.29268.885510004.00008.4566
Inactive100040.3919-1.19260.06151.2782-3.2151-0.8299-0.6638-3.5934-2.2676-3.964912.1718-12.289-2.3960.391910-4.28643.13200.766711.50000.55584.00000 0 0 0 0 0 0 0 0 0 0 0 0 0 08.8922
Inactive100041.3115-1.013-0.5151-0.4031-1.1603-0.0285-0.1807-1.90091.5472-3.20528.574-14.1104-2.36981.311510004.00000.7374
Inactive100041.2453-0.1374-0.3605-3.4935-1.2563-2.4487-0.2616-0.72990.0304-4.47-0.75345.7775-0.09731.245310004.00001.2743
Inactive100040.0274-0.9052-3.7849-3.6459-0.6677-0.01462.1795-6.8978-0.8919-5.2845-0.8362-13.15210.1420.027410004.0000-2.5213
Inactive10004-2.4878-3.5001-2.6738-5.3379-5.5521-3.88740.4423-5.0105-3.9092-8.9672-0.5005-7.892-0.4544-2.487810004.00000.0360
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: TRHR611
Protocol: Tox21 Assay Protocol Summary:

The TRHR-Hek293 cells were dispensed at 1500cells/4uL/well in 1536-well black-clear bottom plates using a Multidrop dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 18 hours, 4 uL of Dye-Loading Solution was added to each well. The plates were incubated at 37 C for 2 hours. For agonist mode, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pin tool. The fluorescence intensity in the plates was measured using FDSS 7000EX kinetic plate reader for 3 min at 1 sec intervals. For antagonist mode, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pin tool. After 5 min incubation at room temperature, 1 uL of TRH was added on the top of the cell/compound mixtures to achieve a final agonist concentration of 1 nM. The fluorescence intensity in the plates was measured using FDSS 7000EX kinetic plate reader for 3 min at 1 sec intervals. Each test compound was measured at 15 concentrations and in triplicates.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000033322 uM-Replicate_1Activity at 0.0000076425 uM-Replicate_1Activity at 0.0000302545 uM-Replicate_1Activity at 0.0000719386 uM-Replicate_1Activity at 0.0001666559 uM-Replicate_1Activity at 0.0003439494 uM-Replicate_1Activity at 0.0009432137 uM-Replicate_1Activity at 0.00290 uM-Replicate_1Activity at 0.00744 uM-Replicate_1Activity at 0.017 uM-Replicate_1Activity at 0.038 uM-Replicate_1Activity at 0.085 uM-Replicate_1Activity at 0.194 uM-Replicate_1Activity at 0.597 uM-Replicate_1Activity at 1.813 uM-Replicate_1Activity at 4.654 uM-Replicate_1Activity at 10.52 uM-Replicate_1Activity at 23.57 uM-Replicate_1Activity at 51.28 uM-Replicate_1Activity at 133.3 uM-Replicate_1Activity at 484.2 uM-Replicate_1Activity at 1026.0 uM-Replicate_1Activity at 2295.0 uM-Replicate_1Activity at 5131.0 uM-Replicate_1Activity at 11470.0 uM-Replicate_1Activity at 25660.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive0004-0.7744-2.9676-3.5336-2.0879-1.19781.1881.14731.4749-2.1654-0.5693-0.3565-2.7155-2.1355-0.7744QC'd by SIGMAInactive0
Inactive0004-3.8248-3.8007-4.0065-1.0553-3.3562-0.39150.1642.0983-2.5376-0.4451-4.23-3.1441-0.0179-3.8248QC'd by SIGMAInactive0
Inactive0004-2.816-0.58230.961-4.2135-2.8784-1.3211-0.4465-1.7796-0.60655.8623-0.4085-2.09140.44-2.816QC'd by EnamineInactive0
Inactive0-4.82071.17050.5128-9.36493.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-7.80412.31667.02673.7969-3.38579.2767-0.27464.97642.59914.28-0.6299-1.2303-3.5953-7.8041QC'd by Astellas PharmaInactive0-4.42074.95490.8279
Inactive0004-0.52874.09797.20243.2011-0.81582.48942.94894.2283-1.09431.6134-0.62470.379-2.51710.0409-0.5287QC'd by SIGMAInactive0
Inactive0-4.92071.53860.8342-27.6782040 0 0 0 0 0 0 0 0 0 0 0 0 0 0-23.89855.1868-1.0467-0.352-7.51551.63921.1963-3.0718-1.9286-1.6973-5.6079-9.8676-22.5753-23.8985QC'd by LightBiologicalsInhibitor15.109550.817921Partial curve; partial efficacy-4.82071.50950.9098
Inactive00042.98924.72094.31383.7992-3.1974.55073.17640.49431.0409-0.69416.4130.69623.67912.9892QC'd by SIGMAInactive0
Inactive0004-3.6304-0.80541.76713.27213.2046-2.9585-0.9728-2.38430.2278-4.6072-0.0977-1.82750.2011-3.6304QC'd by SIGMAInactive0
Inactive0004-4.23550.00631.01451.17612.8799-0.22811.3028-1.0820.2702-0.3033-1.016-0.2938-0.1436-4.2355QC'd by SIGMAInactive0
Inactive0-4.65471.3310.6709-16.0615-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-11.71790.9207-1.56980.4890.1513-1.0708-0.16710.5122-1.9389-0.5306-1.1892-4.1206-2.1676-11.7179QC'd by SIGMAInactive0
Inactive0004-5.0893-0.6163-0.4494-3.01832.2944-2.1401-2.1537-3.8439-1.0556-0.789-8.1267-2.9119-2.3372-5.0893QC'd by FLUKAInactive0-7.92074.95490.4397
Inactive0004-0.6018-4.4247-2.5009-1.17-5.8691-0.6116-3.8612-3.0508-2.99750.0497-1.1142-1.4293-2.3401-0.6018QC'd by SIGMAInactive0-4.62070.40.3945
Inactive0004-3.4471-7.1239-3.8104-9.2894-6.7658-6.2027-4.0978-6.4890.1913-2.5663-4.1436-7.4351-5.2613-3.4471QC'd by SIGMAInactive0-4.47073.62720.6482
Inactive0004-4.0530.4267-0.6302-4.11610.9771.3099-3.8626-4.4544-2.4911-2.6511.1843-2.3234-8.7644-4.053QC'd by SIGMAInactive0
Inactive0004-9.1702-1.0714-3.8813-3.6742-2.9292-2.42871.7722-6.9647-0.875-6.1442-0.004-2.08110.9883-9.1702QC'd by SIGMAInactive0
Inactive0004-2.38590.93520.66930.78463.2569-0.3728-4.5542-3.6-0.27051.5551-1.0698-4.444-3.1433-2.3859QC'd by Sigma DiscoveryCPRInactive0
Inactive00042.2162.06790.73634.7092.69724.29754.33757.8846-1.82772.28743.6777-0.67839.62350.45812.216QC'd by SIGMAInactive0-4.9334.0950.4028
Inactive0004-0.1149-2.2956-0.2967-0.6614-0.7834-1.0672-1.86790.16950.2001-0.1104-0.75150.022-2.3663-0.1149QC'd by SIGMAInactive0
Inactive0004-7.8583-4.0761-1.69240.16735.0127-1.50412.3766-5.3461.0702-3.8043-2.525-0.383-3.9348-7.8583QC'd by SIGMAInactive0
Inactive00040.99981.2942-0.02581.57658.44621.6462.6384-0.5997-0.64140.57591.40520.37520.76210.9998QC'd by SIGMAInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External ID: CHRM1326
Protocol: Please refer to other AIDs, 1963589, 720680, 720682, 720675, 720686, for detailed assay protocols.
Comment: This summary is written for the purposes of summarizing the compound activities from the project combining the results from both the CHRM1 agonist mode assay (AID 1963589) and auto fluorescence counter screens (AID 720680, AID 720682, AID 720675, AID 720686). For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Potency and efficacy were used for determining relative score. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 5 and 30 determined by phenotype.
Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).
Activity SummaryAgonist ActivityAgonist Potency (uM)Agonist Efficacy (%)Green auto fluorescence outcomeSample Source
inactiveinactive0inactiveLightBiologicals
inactiveinactive0inactiveSIGMA
inactiveinactive0inactiveLightBiologicals
inactiveinactive0inactiveAcros
inactiveinactive0inactiveLightBiologicals
inactiveinactive0inactiveLightBiologicals
inactiveinactive0inactiveAcros
inactiveinactive0inactiveSIGMA
inactiveinactive0inactiveAcros
inactiveinactive0inactiveLightBiologicals
inactiveinactive0inactivePfaltz-Bauer
inactiveinactive0inactiveSIGMA
inactiveinactive0inactiveSIGMA
inactiveinactive0inactiveSIGMA
inactiveinactive0inactiveEQ Laboratories
inactiveinactive0inactiveAK Scientific
inactiveinactive0inactiveSigma DiscoveryCPR
inactiveinactive0inactiveLightBiologicals
inactiveinactive0inactiveSigma DiscoveryCPR
inactiveinactive0inactiveLightBiologicals
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: TGF255
Protocol: Tox21 Assay Protocol Summary:

SBE-bla HEK 293T cells were dispensed at 4,000/well in 6 uL of assay medium into black wall/clear-bottom 1536-well plates using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. After the assay plates were incubated at 37 C and 5% CO2 for an overnight, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a Pintool station (Kalypsys, San Diego, CA). The assay plates were incubated at 37 C and 5% CO2 for 5 hr. One uL of LiveBLAzer B/G FRET substrate (Life Technologies) was added using a Flying Reagent Dispenser (Aurora Discovery, San Diego, CA) and the plates were incubated at room temperature for 2 hr. Fluorescence intensity (405 nm excitation, 460 nm and 530 nm emissions) was measured using an Envision plate reader (PerkinElmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000049913 uM-Replicate_1W530-Activity at 0.0000115944 uM-Replicate_1W530-Activity at 0.0000453222 uM-Replicate_1W530-Activity at 0.0001076943 uM-Replicate_1W530-Activity at 0.0002499208 uM-Replicate_1W530-Activity at 0.0005150359 uM-Replicate_1W530-Activity at 0.00142 uM-Replicate_1W530-Activity at 0.00434 uM-Replicate_1W530-Activity at 0.011 uM-Replicate_1W530-Activity at 0.025 uM-Replicate_1W530-Activity at 0.057 uM-Replicate_1W530-Activity at 0.127 uM-Replicate_1W530-Activity at 0.290 uM-Replicate_1W530-Activity at 0.887 uM-Replicate_1W530-Activity at 2.716 uM-Replicate_1W530-Activity at 6.973 uM-Replicate_1W530-Activity at 15.76 uM-Replicate_1W530-Activity at 35.30 uM-Replicate_1W530-Activity at 76.83 uM-Replicate_1W530-Activity at 199.8 uM-Replicate_1W530-Activity at 725.3 uM-Replicate_1W530-Activity at 1537.0 uM-Replicate_1W530-Activity at 3438.0 uM-Replicate_1W530-Activity at 7687.0 uM-Replicate_1W530-Activity at 17190.0 uM-Replicate_1W530-Activity at 38440.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inactive100047.5075-0.85036.5859-1.0635-1.6023-0.3086-3.4622-1.35334.67687.26923.31746.2497-5.65217.507510004-2.7438
Inactive10004-1.28870.8753-6.2501-1.3857-1.4798-0.8404-0.236-3.1797-0.9103-4.2604-1.36420.6331-5.8425-1.2887100040.0676
Inconclusive18.9959145.361410Partial curve; high efficacy-4.72130.90.9188144.5041-0.85732.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0109.9727-2.0766-1.7253-4.6916-7.58760.08260.32240.573611.295315.955920.996444.907445.1038109.97270Partial curve; partial efficacy; poor fit-4.92130.50.8862-28.4592-2.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0-22.0491
Inactive10004-6.4338-1.0341-8.39771.934-1.7661-1.5079-2.4935-3.7532-1.6719-7.2189-0.7574-3.1297-0.0318-6.4338100041.3315
Inactive100049.85963.01998.2155-6.8884-0.0179.05278.537710.12172.00917.64318.4564.97095.20899.859610004-3.1319
Inactive1000410.31864.02425.8987-3.27783.691512.55185.52654.79640.45891.70539.28419.67945.384710.318610004-7.9666
Inactive10004-5.82564.01543.328411.3993-2.8532-3.14291.66583.1389-3.5164-3.7932-0.7781-6.034915.8059-5.825610004-0.1547
Inactive100041.42223.33975.3037-13.82891.017510.80678.90837.21042.06962.23865.87032.68043.06021.422210004-0.8644
Inactive10-7.33094.95490.4101-0.5861940 0 0 0 0 0 0 0 0 0 0 0 0 0 00.01295.189310.898714.8076-2.4549-2.4984-5.0717-3.433-1.947.7856-2.8644-0.75919.85430.0129100040.6149
Inactive100047.0581-1.63851.7037-6.0631.19361.22060.71740.3153.12120.55781.34552.40110.05917.058110004-2.0669
Inactive10-7.1254.95490.47383.5-2.978840 0 0 0 0 0 0 0 0 0 0 0 0 0 06.67130.5898-0.0173-3.0625-8.73240.64983.42651.3135.39496.05361.7549-0.26116.32586.671310004-2.6844
Inconclusive8.134342.018910Partial curve; partial efficacy-5.08971.41630.969941.9989-0.022.20 0 0 0 0 0 0 0 0 0 0 0 0 0 122.566-2.476-2.27040.35060.05390.00634.6469-2.24293.14719.858418.493328.64841.665322.56610-5.43971.10.9656-9.5994140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-9.2495
Inactive10-4.75651.46410.84927.51.750840 0 0 0 0 0 0 0 0 0 0 0 0 0 16.2621-3.95772.84074.3063-0.21850.22192.68385.07820.7383.75254.360116.576320.72476.262110004-2.4015
Inactive100044.46320.9961.0612-4.481815.44753.86030.6225.61672.13720.7845.34077.8319-0.49114.463210004-2.3472
Inactive10-5.04990.40.788724-5.628940 0 0 0 0 0 0 0 0 0 0 0 0 0 017.0836-11.7741-5.90074.36231.3645-3.50143.00160.3886-0.53832.88298.639210.751315.58817.083610-6.34990.20.7235-8.2096640 0 0 0 0 0 0 0 0 0 0 0 0 0 0-6.008
Inactive10-4.8570.80.620325.50.594740 0 0 0 0 0 0 0 0 0 0 0 0 0 022.8122.17973.2852-14.92112.35344.13817.72352.69921.40883.245214.992713.588414.224322.81210-5.1070.70.5375-7.786-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-7.7384
Inconclusive31.702366.609710Partial curve; partial efficacy; poor fit-4.49890.30.571271.73475.12512.40 0 0 0 0 0 0 0 0 0 0 0 0 0 054.84716.429520.56591.097517.76932.581224.098517.437722.220723.724628.199738.441926.932154.84710-4.49890.40.4983-11.38140.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-8.6511
Inactive10-8.84194.95490.62224-10.992540 0 0 0 0 0 0 0 0 0 0 0 0 0 03.6297-8.32713.39360.54518.87982.38882.5354.72694.08194.9942.97562.09288.90943.629710004-0.0914
Inactive10-8.84144.95490.3999-0.5-12.181740 0 0 0 0 0 0 0 0 0 0 0 0 0 04.9391-10.15140.5543-6.67930.5862-0.22940.56961.5006-0.1114-3.71070.4490.51320.35334.939110004-1.894
Inactive100042.2454-0.16621.56738.952-13.1994-0.1453-0.0030.4507-10.37920.5678-0.496-4.590817.04082.245410004-0.4072
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: ADRB2293
Protocol: Tox21 Assay Protocol Summary:

CHO-ADRB2 cells were dispensed at 1,000/well in 4uL assay medium into white/solid 1536-well plates (Greiner Bio-One North America Inc., Monroe, NC) using a Multidrop Combi dispenser (ThermoFisher Scientific, Waltham, MA). The assay plates were incubated at 37C and 5% CO2 for an overnight (18-20hr). Then positive control and test compounds dissolved in DMSO were transferred to the assay plates at 23nL using a Pintool station (Wako, San Diego, CA). Following the compound and positive control transfer, 1uL stimulation mix containing 100uM IBMX and 25uM Ro-20-1724 was added to each well of the assay plates using BioRAPTR Flying Reagent Dispenser (FRD, Beckman Coulter, Brea, CA). The assay plates were incubated at room temperature for 0.5hr. Then 2.5ul each d2-labled cAMP and anti-cAMP-cryptate solutions were added separately to each well of the assay plates using an FRD and the assay plates were incubated at room temperature for 1hr. The fluorescence signal was measured at two different wavelengths (665nm and 615nm) using an Envision plate reader (Perkin Elmer, Shelton, CT). Data were expressed as the ratio of 665 nm/615 nm.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000060039 uM-Replicate_1W530-Activity at 0.0000138057 uM-Replicate_1W530-Activity at 0.0000545120 uM-Replicate_1W530-Activity at 0.0001296300 uM-Replicate_1W530-Activity at 0.0003003888 uM-Replicate_1W530-Activity at 0.0006194162 uM-Replicate_1W530-Activity at 0.00172 uM-Replicate_1W530-Activity at 0.00522 uM-Replicate_1W530-Activity at 0.013 uM-Replicate_1W530-Activity at 0.030 uM-Replicate_1W530-Activity at 0.068 uM-Replicate_1W530-Activity at 0.153 uM-Replicate_1W530-Activity at 0.349 uM-Replicate_1W530-Activity at 1.067 uM-Replicate_1W530-Activity at 3.267 uM-Replicate_1W530-Activity at 8.386 uM-Replicate_1W530-Activity at 18.95 uM-Replicate_1W530-Activity at 42.46 uM-Replicate_1W530-Activity at 92.41 uM-Replicate_1W530-Activity at 240.3 uM-Replicate_1W530-Activity at 872.4 uM-Replicate_1W530-Activity at 1849.0 uM-Replicate_1W530-Activity at 4135.0 uM-Replicate_1W530-Activity at 9246.0 uM-Replicate_1W530-Activity at 20670.0 uM-Replicate_1W530-Activity at 46230.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inconclusive10004-1.9035-1.1923-2.0332-1.0619-12.6616-0.78820.0664-11.7887-6.4513-11.6244-1.9076-2.0225-3.2172-1.90350Single point of activity-5.61024.95490.9089-45.54365-30 0 0 0 0 0 0 0 0 0 0 1 1 1 126.2694
Inactive10004-1.20222.7609-0.01530.9955-0.41571.63592.32520.5928-0.99092.84790.1279-0.03861.8432-1.202210004-31.8285
Inhibitor0.994556.503510004-2.90612.33111.736-3.60126.00595.10040.6447-1.71252.76160.832-1.74680.48220.191-2.90610Single point of activity-6.00242.25260.6374-44.503512-31 0 0 0 0 0 0 0 0 0 1 1 1 1 18.1326
Inconclusive10004-1.3710.9506-2.91191.52635.1535.55271.52731.54971.7024.269902.5531-6.3366-1.37110004-25.7768
Inactive10004-4.2769-0.95591.72782.6067.9793-4.5417-5.96084.89575.48863.60130.2343-3.1649-0.1676-4.276910004-8.7462
Inhibitor8.758121.9554100041.30884.730914.16229.43255.624-1.95912.73144.32472.41837.8238-5.8845-5.16396.60721.30880Single point of activity-5.05761.10.6955-89.934132.0212-30 0 0 0 0 0 0 0 1 0 0 0 0 1 1-23.4699
Inconclusive0.002425.78310Complete curve; partial efficacy; poor fit-8.61330.80.8235-3.7909-29.57391.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0-2.4664-19.6302-7.473-8.9859-9.0898-8.3146-0.2424-6.5275-6.0557-3.3866-1.82-2.8939-4.0012-2.466410004-30.4385
Inactive10004-7.3264-1.5887-10.9052-0.9831-6.53-5.410.9435-5.6079-0.699-2.0867-3.2569-4.2536-2.16180.5621-7.326410-7.92771.80790.6047-24.965740 0 0 0 0 0 0 0 0 0 0 0 0 0 1-31.1667
Inconclusive10004-0.76813.03751.73091.12096.2561-0.0974-8.24190.864-0.54561.50994.4639-1.16054.7076-0.76810Single point of activity-4.95763.1320.706-69.1601-0.5-30 0 0 0 0 0 1 0 0 0 1 1 0 1 1-35.5326
Inconclusive10-5.8521.69240.3729-0.5701440 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.18373.34480.978.50642.5766.04151.76024.88511.9267-0.2988-0.0183-1.0279-1.3405-0.183710-8.8024.95490.41826-43.08340 0 0 1 0 0 0 0 0 0 0 0 0 0 022.5365
Inconclusive10-9.12574.44950.3776-1-17.747540 0 0 0 0 0 0 0 0 0 0 0 0 0 02.0705-13.4218-2.2278-1.534-1.45313.8095-2.4909-1.0374-13.5396-0.16050.0263-0.09952.04422.0705100046.6627
Inconclusive10Partial curve; partial efficacy; poor fit-4.15594.95490.9512-25.9952-1-2.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0-21.246-1.2286-0.8428-1.2278-0.5805-1.8719-0.06640.8961-0.8452-1.9038-2.1419-3.3814-0.974-21.24610-5.25594.95490.5517-28.362-240 0 0 0 0 0 0 0 0 1 1 0 0 0 1-3.0491
Inconclusive10004-2.6403-1.5203-3.2668-0.3318-5.31293.2585-4.0841-4.30851.19516.0144-4.8227-2.25281.5709-2.64030Partial curve; high efficacy; poor fit-5.16334.95490.4313-80.8838-1.5-2.30 0 0 0 0 0 0 0 0 0 0 0 1 1 1-1.3949
Inactive10004-0.26721.230113.62434.24763.99616.594517.55362.17369.11160.1969-3.48061.5252-2.0777-0.267210-5.31244.95490.3735-19.39133.540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-1.3739
Inactive10004-5.77735.11124.0288-1.9434-1.021412.92192.34717.4846-2.0121.291-2.74985.90195.369-5.777310004-4.4961
Inconclusive10004-15.4564-4.51941.21191.7588-11.93060.5255-1.2623.2933-2.6412-3.3809-1.071-2.7851-1.8097-15.456410-4.66420.70.437326.1319-6.859441 0 0 0 1 0 0 0 0 0 0 0 0 0 10.7866
Inactive100045.20961.56415.30634.99462.482-1.21514.35076.00556.2785-0.47860.86696.1344.32315.209610004-35.4391
Inactive100042.47121.4625-2.9807-1.69247.24483.0542-12.2145-8.3996-2.4864.052-1.4266-1.5593-0.16762.4712100043.4572
Inactive10-4.91021.46410.523614.5-0.475640 0 0 0 0 0 0 0 0 0 0 0 0 0 013.887.5564-7.4796-3.3029-4.4182-3.7928-2.6927-0.11982.6654-1.01760.301216.57859.432213.88100043.7428
Inactive100040.5160.0357.1699-4.87981.4861-5.9734-8.5349-6.6743-1.7256-1.1817-1.1379-5.50792.8730.51610004-5.7554
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: ADRB2713
Protocol: Tox21 Assay Protocol Summary:

CHO-ADRB2 cells were dispensed at 1,000/well in 4uL assay medium into white/solid 1536-well plates (Greiner Bio-One North America Inc., Monroe, NC) using a Multidrop Combi dispenser (ThermoFisher Scientific, Waltham, MA). The assay plates were incubated at 37C and 5% CO2 for an overnight (18-20hr). Then positive control and test compounds dissolved in DMSO were transferred to the assay plates at 23nL using a Pintool station (Wako, San Diego, CA). Following the compound and positive control transfer, 1uL agonist-stimulation mix containing 1nM Isoproterenol HCl, 100uM IBMX and 25uM Ro-20-1724 was added to each well of the assay plates using BioRAPTR Flying Reagent Dispenser (FRD, Beckman Coulter, Brea, CA). The assay plates were incubated at room temperature for 0.5hr. Then 2.5ul each d2-labled cAMP and anti-cAMP-cryptate solutions were added separately to each well of the assay plates using an FRD and the assay plates were incubated at room temperature for 1hr. The fluorescence signal was measured at two different wavelengths (665nm and 615nm) using an Envision plate reader (Perkin Elmer, Shelton, CT). Data were expressed as the ratio of 665 nm/615 nm.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000060039 uM-Replicate_1W530-Activity at 0.0000137707 uM-Replicate_1W530-Activity at 0.0000545120 uM-Replicate_1W530-Activity at 0.0001296300 uM-Replicate_1W530-Activity at 0.0003002588 uM-Replicate_1W530-Activity at 0.0006197232 uM-Replicate_1W530-Activity at 0.00170 uM-Replicate_1W530-Activity at 0.00522 uM-Replicate_1W530-Activity at 0.013 uM-Replicate_1W530-Activity at 0.030 uM-Replicate_1W530-Activity at 0.068 uM-Replicate_1W530-Activity at 0.153 uM-Replicate_1W530-Activity at 0.349 uM-Replicate_1W530-Activity at 1.067 uM-Replicate_1W530-Activity at 3.267 uM-Replicate_1W530-Activity at 8.386 uM-Replicate_1W530-Activity at 18.95 uM-Replicate_1W530-Activity at 42.46 uM-Replicate_1W530-Activity at 92.41 uM-Replicate_1W530-Activity at 240.3 uM-Replicate_1W530-Activity at 872.4 uM-Replicate_1W530-Activity at 1849.0 uM-Replicate_1W530-Activity at 4135.0 uM-Replicate_1W530-Activity at 9246.0 uM-Replicate_1W530-Activity at 20670.0 uM-Replicate_1W530-Activity at 46230.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inhibitor26.603267.916510004-6.3959-9.65890.68632.7866-13.8272-6.7622-5.1896-0.7481-5.27594.03470.82940.1619-7.9826-6.39590Partial curve; partial efficacy-4.57512.04790.7981-71.9165-4-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-55.9973
Inactive10-4.62514.44950.3528-7.16493.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-6.38749.90032.8880.83753.8232-0.0972-3.85071.63986.05136.86712.68588.8472-0.8502-6.3874100041.575
Inactive10-6.97511.47810.3563-3.5961240 0 0 0 0 0 0 0 0 0 0 0 0 0 10.93160.12450.04624.37542.76350.5086-0.9132-2.76892.6163-8.8301-3.1415-5.9818-0.09820.9316100041.7546
Inactive10004-0.2652-5.20890.1059-0.2104-5.15230.33386.5915-0.1964-2.77990.7841-0.7171-11.48410.0954-0.265210004-13.1319
Inactive100042.5869-2.9649-3.11563.2094-2.83759.1891-4.0873-2.306-3.35572.25610.25920.4568-2.76022.586910004-1.7942
Inactive10-8.42514.95490.42-1.5675840 0 0 0 0 0 0 0 0 0 0 0 0 0 13.10992.05513.45141.5277-1.18820.19451.17012.6784-0.2053-6.4479-0.458-3.6987-4.65953.109910-6.57510.50.3897-7.94783.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-8.9647
Inactive100041.98244.9364-3.0777-2.52245.8788-4.393-2.1514-6.5660.2639-2.3165-0.97250.1618.67231.9824100046.8262
Inactive100043.1910.64224.5969-8.3735-6.2557-10.06561.9483-0.0245-0.5998-6.34343.4655-0.97126.44013.19110-6.42514.95490.47171-6.555840 0 0 0 0 0 0 0 0 0 0 0 0 0 01.4044
Inactive100043.06910.94732.7335-0.3539-2.50762.6313-2.14111.34421.3076-1.59431.5055-0.4395-0.98173.0691100041.074
Inactive100040.03460.7513-5.05642.3416-3.78150.6279-8.57720.96422.5971-5.43511.94880.0125-4.35290.0346100041.8201
Inactive100040.6895-3.70214.9864-1.54015.41435.0376-4.7424-5.3192-0.37944.4337-3.11858.58982.10140.6895100040.0062
Inactive100041.35410.6932-6.5104-4.10014.12961.40140.1852-2.5615-2.9103-6.16262.11950.64771.75491.354110004-0.079
Inactive10004-0.9612-2.32050.75015.3012-0.3654-0.41856.8872-1.988210.93541.3283-3.35076.4187-0.5006-0.961210-8.87513.06540.39511.5-6.166340 0 0 0 0 0 0 0 0 0 0 0 0 0 05.4117
Inactive10-4.97510.70.3315-10.872-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-7.76180.98150.1-0.85683.8492-10.310.16961.4622-0.195-5.3525-2.1777-5.7002-7.2375-7.761810-7.52514.95490.3969-2.9301540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-3.0376
Inactive10-5.12514.95490.8156-9.2611-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-8.12810.0145-0.6779-1.47220.3898-1.23510.5729-4.44590.86280.7235-0.3998-7.3742-9.8009-8.128110004-2.0593
Inactive100046.04370.32725.2199-1.386516.5133-4.78731.16280.41731.29560.90511.13123.78936.19046.0437100040.8526
Inactive10004-5.2833-3.6332-8.5443-7.987-8.28162.6995-7.1202-2.40580.91532.5108-1.3669-7.4886-7.4328-5.2833100046.8517
Inhibitor29.8493106.094510-5.47512.84730.42146.5-2.542840 0 0 0 0 0 0 0 0 0 0 0 0 0 1-3.2442-0.53315.2895-5.86780.6544-0.4618-5.09910.1718-8.184-9.20241.59976.35576.1854-3.24420Partial curve; high efficacy-4.52512.12110.9077-108.0945-2-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-81.8897
Inactive10-6.02514.95490.40980-4.031340 0 0 0 0 0 0 0 0 0 0 0 0 0 02.6436-7.1138-4.8994-1.2953-3.42690.0695-5.181-8.7761-5.8014-2.75760.2413-0.1351-2.45232.643610004-7.8883
Inactive10004-5.3863-7.35993.98542.9754-2.40971.18239.4234-0.41260.864-0.3003-2.479-0.03810.1317-5.386310004-9.0143
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: DRD2945
Protocol: Tox21 Assay Protocol Summary:

DRD2-Hek293 cells were dispensed at 600 cells/3uL/well in 1536-well white plates using a Multidrop Dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 24 h, 1 uL of Ro20-1724 at final concentration of 0.1 mM was transferred to the assay plate by a Flying Reagent Dispenser. Following Ro20-1724 addition, 23 nL of compound dissolved in DMSO, positive controls or DMSO only was added to the assay plates via Wako pintool station. The assay plates were incubated at room temperature for 10 min. Next, 1 uL of mixture of NKH477 (final concentration at 200 nM) and quinpirole (final concentration at 12 nM) was added into the plates. After the assay plates were incubated at room temperature for an additional 30 min, 2.5 ul/well of cAMP-d2 and 2.5 ul/well of anti-cAMP-cryptate were added respectively into the assay plates using a Flying Reagent Dispenser. The plates were incubated at room temperature for 1 h. The fluorescence intensity in the plates was measured at 340 nm excitation and 665 & 620 nm emission by an Envision plate reader.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000060292 uM-Replicate_1W530-Activity at 0.0000139277 uM-Replicate_1W530-Activity at 0.0000552087 uM-Replicate_1W530-Activity at 0.0001297661 uM-Replicate_1W530-Activity at 0.0003003480 uM-Replicate_1W530-Activity at 0.0006206701 uM-Replicate_1W530-Activity at 0.00170 uM-Replicate_1W530-Activity at 0.00522 uM-Replicate_1W530-Activity at 0.013 uM-Replicate_1W530-Activity at 0.030 uM-Replicate_1W530-Activity at 0.068 uM-Replicate_1W530-Activity at 0.153 uM-Replicate_1W530-Activity at 0.348 uM-Replicate_1W530-Activity at 1.074 uM-Replicate_1W530-Activity at 3.280 uM-Replicate_1W530-Activity at 8.379 uM-Replicate_1W530-Activity at 18.94 uM-Replicate_1W530-Activity at 42.46 uM-Replicate_1W530-Activity at 92.41 uM-Replicate_1W530-Activity at 242.9 uM-Replicate_1W530-Activity at 865.8 uM-Replicate_1W530-Activity at 1849.0 uM-Replicate_1W530-Activity at 4135.0 uM-Replicate_1W530-Activity at 9246.0 uM-Replicate_1W530-Activity at 20670.0 uM-Replicate_1W530-Activity at 46230.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inactive100043.78813.72091.98610.20610.59235.59482.53080.60822.30311.88620.3033-2.23441.87823.788110004-12.0188
Inactive100040.30120.52940.6626-2.6038-0.5572-0.6631-4.33661.0325-2.759-0.3338-0.3287-1.63422.49720.3012100042.5444
Inactive10004-6.3367-0.20894.28190.94444.1311-1.1259-2.3025-0.8518-3.0168-0.69982.3696-1.04735.4453-6.336710-4.87513.51170.6776-24.2714-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 12.914
Inactive10004-1.1765-2.02963.5024-1.9703-0.15791.9613-0.75732.76970.8721.72771.1044-0.05681.933-1.176510-6.12514.95490.4361-5.3789240 0 0 0 0 0 0 0 0 0 0 0 0 0 116.187
Inactive10-4.44014.95490.7066-19.0899240 0 0 0 0 0 0 0 0 0 0 0 0 0 1-0.90474.8233-2.51545.04834.70586.1601-0.2063-0.8092-0.6546-4.17011.85590.3717-17.5749-0.904710-4.49014.95490.471515.5-4.348640 0 0 0 0 0 0 0 0 0 0 0 0 0 1-2.0917
Inconclusive10-6.62354.95490.7986-0.6511040 0 0 0 0 0 0 0 0 0 0 0 0 0 0-3.63988.774811.18327.61489.427810.847712.24230.7218-1.8373-2.18071.01625.3861-1.696-3.639810004-1.5758
Inactive100041.33252.41660.0324-1.17531.0360.22312.63193.94840.94140.00221.27583.2279-2.80021.332510004-3.3592
Inactive10-6.37992.72020.319-1.29553.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-3.3155.53032.4743-0.4098-0.05774.777410.7719-2.01031.7767-1.0637-1.2042.5912-3.5795-3.31510-6.32994.95490.42623.5-6.413140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.295
Inactive100041.11512.34553.30752.55170.31210.86413.3572-5.8070.82230.74510.4398-3.3457-5.97791.115110-7.08462.04790.54874-12.505140 0 0 0 0 0 0 0 0 0 0 0 0 0 1-9.5005
Inactive100041.63771.2371-1.25830.3296-1.6140.7175-1.114-0.0071-2.3580.54470.1386-1.0325-0.62621.637710004-2.264
Inactive100041.1729-5.37470.0618-1.16140.2075-0.5657-2.68830.98772.79770.48074.20440.5734-4.58271.172910-7.72874.95490.3377-4.06432.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-5.4636
Inhibitor50.887851.364110004-0.0970.4130.80160.55140.49890.17153.02080.70020.7634-4.9454-3.23730.4082-4.1558-0.0970Partial curve; partial efficacy-4.29343.06540.7755-53.8641-2.5-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-47.2455
Inactive100047.09728.61190.86441.2866-1.15580.06177.65980.00716.608-1.8979-2.1702-0.918410.71347.097210-4.66014.44950.5285-18.6347-340 0 0 0 0 0 0 0 0 0 0 0 0 0 0-16.5019
Inactive100040.4698-1.0082-3.0359-1.3764-2.8847-2.1219-1.72584.0502-6.0703-2.72140.76450.6902-0.23090.469810004-4.9773
Inactive100045.8424.59930.09510.5509-0.07364.4281-2.8904-1.95170.0719-0.5266-2.90590.46610.03965.84210-4.15331.210.5077-31.931240 0 0 0 0 0 0 0 0 0 0 0 0 0 0-23.2758
Inconclusive100042.20030.65450.18076.1358-0.38062.10074.9512-0.01961.9422-1.56120.41822.5985-2.1292.200310-6.56052.72020.4244-1.5-9.440940 0 0 0 0 0 0 0 0 0 0 0 0 0 1-12.2578
Inhibitor31.4373115.3525100049.71694.21783.58235.13815.09542.57424.22143.54180.04322.4418-1.71227.3565-0.25439.71690Partial curve; high efficacy-4.50261.24750.9516-117.8525-2.5-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-103.3794
Inactive100041.7529-5.7942-2.1210.23431.62890.87140.2124-5.88470.01861.5276-1.9768-1.2986-3.43591.752910-8.09594.95490.48860.5917840 0 0 0 0 0 0 0 0 0 0 0 0 0 00.6765
Inactive100043.39870.6520.80240.3115-3.13092.1040.4118-2.7174-3.73120.0892-0.14594.0124-0.74333.398710-8.74514.95490.45570.928714.540 0 0 0 0 0 0 0 0 0 0 0 0 0 00.1127
Inactive100045.282.1409-0.18040.24510.4128-3.92832.74470.34230.07910.359-0.25380.8178-2.33135.2810004-1.3082
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: DRD2180
Protocol: Tox21 Assay Protocol Summary:

DRD2-Hek293 cells were dispensed at 600 cells/3uL/well in 1536-well white plates using a Multidrop Dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 24 h, 1 uL of Ro20-1724 at final concentration of 0.1 mM was transferred to the assay plate by a Flying Reagent Dispenser. Following Ro20-1724 addition, 23 nL of compound dissolved in DMSO, positive controls or DMSO only was added to the assay plates via Wako pintool station. The assay plates were incubated at room temperature for 10 min. Next, 1 uL of NKH477 at 200nM was added into the plates. After the assay plates were incubated at room temperature for an additional 30 min, 2.5 ul/well of cAMP-d2 and 2.5 ul/well of anti-cAMP-cryptate were added respectively into the assay plates using a Flying Reagent Dispenser. The plates were incubated at room temperature for 1 h. The fluorescence intensity in the plates was measured at 340 nm excitation and 665 & 620 nm emission by an Envision plate reader.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000060039 uM-Replicate_1W530-Activity at 0.0000137707 uM-Replicate_1W530-Activity at 0.0000545120 uM-Replicate_1W530-Activity at 0.0001296300 uM-Replicate_1W530-Activity at 0.0003002588 uM-Replicate_1W530-Activity at 0.0006189798 uM-Replicate_1W530-Activity at 0.00171 uM-Replicate_1W530-Activity at 0.00522 uM-Replicate_1W530-Activity at 0.013 uM-Replicate_1W530-Activity at 0.030 uM-Replicate_1W530-Activity at 0.068 uM-Replicate_1W530-Activity at 0.153 uM-Replicate_1W530-Activity at 0.349 uM-Replicate_1W530-Activity at 1.067 uM-Replicate_1W530-Activity at 3.267 uM-Replicate_1W530-Activity at 8.386 uM-Replicate_1W530-Activity at 18.95 uM-Replicate_1W530-Activity at 42.46 uM-Replicate_1W530-Activity at 92.41 uM-Replicate_1W530-Activity at 240.3 uM-Replicate_1W530-Activity at 872.4 uM-Replicate_1W530-Activity at 1849.0 uM-Replicate_1W530-Activity at 4135.0 uM-Replicate_1W530-Activity at 9246.0 uM-Replicate_1W530-Activity at 20670.0 uM-Replicate_1W530-Activity at 46230.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inactive10-9.17434.95490.4482-3.18846.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-1.07816.0843-0.8272-3.4248-7.0165-0.7165-1.5939-6.0807-6.8337-3.16772.3771-1.0033-5.7858-1.5510004-2.7583
Inactive10-4.56371.86170.317890.084640 0 0 0 0 0 0 0 0 0 0 0 0 0 10.0842-0.0855-0.2953-0.78052.34661.2131-0.54523.1167-3.3842-0.91893.75641.40566.4780.084210004-4.2236
Inactive100042.61982.3466-0.37735.5914.99152.11680.87533.1726-0.17420.9304-1.192-0.56531.70682.619810004-6.2418
Inactive100046.3560.92680.5680.6444-3.3685.672.3853-0.05552.7361-3.48357.347-3.04965.74596.356100043.4789
Inactive100041.38231.31710.97261.5261-8.2713-38.61011.4699-0.6371-5.1128-8.1546-1.1688-0.5786-0.66451.3823100048.8154
Inactive10004-2.5144-2.361-1.80391.85040.1129-6.2676-1.336-3.9127-3.9292-2.7130.026-2.79-2.1424-2.514410004-9.9999
Inactive100048.63938.07697.9985-2.61410.32086.27480.56646.16683.97512.40730.27918.65336.08258.6393100040.6824
Inactive10004-4.5511-0.5715-12.6079-5.3348-1.7778-1.64430.7428-13.8301-1.3699-2.6117-9.8602-7.4651-3.7149-4.5511100044.8975
Inactive10004-8.9924-2.5393-12.2689-12.3285-8.4096-5.3726-7.3661-8.2488-6.5273-10.2917-10.0818-0.9401-19.8028-8.992410-4.56374.95490.6441100.364840 0 0 0 0 0 0 0 0 0 0 0 0 0 08.3824
Inactive100040.5065-4.7724-1.7416-5.05921.11050.443-0.1512-1.416-1.4307-0.5117-7.58251.11541.19672.93930.5065100042.402
Inactive100040.07942.87210.18864.94540.2886-2.1392-1.7328-1.01662.15434.9444.9611.73843.84360.079410-5.06374.95490.4347-3.07543.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.2874
Inactive10-4.61644.0950.4209-7.778140 0 0 0 0 0 0 0 0 0 0 0 0 0 12.11662.02-0.42232.25972.48460.06621.20842.5829-1.68581.7929-0.6289-1.1-6.89832.116610-4.11644.95490.5915-20.3885-1.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-15.3238
Inactive10004-7.0632-0.8623-1.7916-4.2652-5.9669-19.4504-1.91220.824-2.2999-5.5153-0.4675-5.37812.0763-7.063210-8.81374.95490.73241-15.784740 0 0 0 0 0 0 0 0 0 0 0 0 0 03.2717
Inactive100045.45724.7104-1.6933-3.19594.97480.59361.7222-0.1931.27552.5585-4.68520.39195.48635.457210-9.04334.95490.6699-0.51411.540 0 0 0 0 0 0 0 0 0 0 0 0 0 01.4299
Inactive10004-5.15337.6944-0.2819-6.74360.13834.2317-8.8165.28882.3311.64635.25816.3561-1.5635-5.153310-8.71374.44950.67941.5-14.151240 0 0 0 0 0 0 0 0 0 0 0 0 0 01.5537
Inactive100047.48515.0097.9161-5.82395.4781-0.20210.73765.95164.1964-6.02863.1953-2.5872.51947.4851100042.0117
Inactive100047.63123.15953.60054.23419.422-0.7563.62193.93153.42863.89981.27179.0227-0.49517.631210004-6.9865
Inactive10-5.36374.95490.3650.132640 0 0 0 0 0 0 0 0 0 0 0 0 0 111.41172.26859.495711.56072.32788.75936.01856.48955.66755.3341-2.80674.5233-1.542111.411710004-1.6128
Inactive100042.8507-1.44118.21990.12610.2712-2.1386-1.41324.99742.20190.50950.32360.58160.98078.83382.8507100040.3148
Inactive10004-3.5331.7914-3.9103-4.2814-4.8026-0.23944.0174-2.4595-1.52260.851.611-2.87492.3635-3.53310004-4.1257
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: CHRM1834
Protocol: Assay Protocol Summary:

CHRM1-CHO cells were dispensed at 1000 cells/3uL/well in 1536-well black-clear bottom plates using a Multidrop Dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 18 h, 3 uL of Dye Loading Buffer was transferred to the assay plate by a Flying Reagent Dispenser. The assay plates were incubated at 37 C for 1h. For agonist mode, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pin tool. The fluorescence intensity in the plates was measured using FDSS 7000EX kinetic plate reader for 2 min at 1 sec intervals. The fluorescence intensity in the plates was measured using FDSS 7000EX kinetic plate reader for 3 min at 1 sec intervals. Each test compound was measured at 15 concentrations in three independent runs.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000049913 uM-Replicate_1Activity at 0.0000114526 uM-Replicate_1Activity at 0.0000453222 uM-Replicate_1Activity at 0.0001077752 uM-Replicate_1Activity at 0.0002496487 uM-Replicate_1Activity at 0.0005152025 uM-Replicate_1Activity at 0.00141 uM-Replicate_1Activity at 0.00434 uM-Replicate_1Activity at 0.011 uM-Replicate_1Activity at 0.025 uM-Replicate_1Activity at 0.057 uM-Replicate_1Activity at 0.127 uM-Replicate_1Activity at 0.290 uM-Replicate_1Activity at 0.887 uM-Replicate_1Activity at 2.716 uM-Replicate_1Activity at 6.973 uM-Replicate_1Activity at 15.76 uM-Replicate_1Activity at 35.30 uM-Replicate_1Activity at 76.83 uM-Replicate_1Activity at 199.8 uM-Replicate_1Activity at 725.3 uM-Replicate_1Activity at 1537.0 uM-Replicate_1Activity at 3438.0 uM-Replicate_1Activity at 7687.0 uM-Replicate_1Activity at 17190.0 uM-Replicate_1Activity at 38440.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive00040.27-0.01710.2452-0.00120.080.07230.2279-0.64050.02840.0796-0.0665-0.0639-0.02560.27QC'd by SigmaAldrichInactive0
Inactive00040.3979-0.06510.78140.003-0.08590.1712-0.03250.09370.0666-0.442-0.6501-0.7181-1.19180.3979QC'd by Toronto ResearchInactive0
Inactive00040.50960.13750.02540.15070.01870.023-0.0882-0.04940.26750.23570.15260.0353-0.51360.5096QC'd by SigmaAldrichInactive0
Inactive00042.53080.77180.56770.1541-0.18960.0586-0.0992-0.19140.07380.69750.14260.09660.34082.5308QC'd by SIGMAInactive0
Inactive0004-1.14720.10470.25460.15670.13560.05240.35320.1530.0574-0.6714-0.19020.1471-1.2293-1.1472QC'd by SIGMAInactive0
Inactive00040.14630.0224-0.33040.05520.09030.0693-0.08240.1615-0.03260.09990.3798-0.07420.35760.1463QC'd by SIGMAInactive0
Inactive0004-0.0699-0.94060.80630.77990.03390.7610.03490.21810.49060.0890.2004-0.0501-0.0028-0.0699QC'd by SIGMAInactive0
Inactive00041.83420.1116-0.00320.11720.23360.2218-0.15310.0723-0.0177-0.04750.0390.36720.25951.8342QC'd by SigmaAldrichInactive0
Inactive00041.2961-0.0487-0.113-0.27430.0322-0.18530.2616-0.01810.4137-0.05260.35890.45560.61241.2961QC'd by SigmaAldrichInactive0
Inactive0004-0.17021.55020.53860.099-0.1571-0.2841-0.4676-0.23710.2585-0.29890.42120.2244-0.329-0.1702QC'd by SIGMAInactive0-4.24844.95490.9849
Inactive00040.617-0.0348-0.0116-0.15060.12690.09220.04280.13080.67190.54110.05040.04340.07380.617QC'd by SigmaAldrichInactive0
Inactive00040.08250.10830.13780.04780.2340.03580.0664-0.12370.0503-0.01640.11520.24270.00820.0825QC'd by SIGMAInactive0
Inactive00040.29450.04740.51170.20190.25530.09380.3703-0.06840.1512-0.01270.2949-0.07560.07070.2945QC'd by SigmaAldrichInactive0
Inactive0004-0.47420.19480.86240.64810.36120.4680.4992-0.19240.7415-0.0520.3014-0.4759-0.7733-0.4742QC'd by SIGMAActivator4.888238.3142Complete curve; partial efficacy-5.31084.95490.9876
Inactive0004-0.10730.05280.15780.0556-0.06520.094-0.0707-0.09840.15540.01480.06-0.683-0.0854-0.1073QC'd by SIGMAInactive0
Inactive0004-0.38280.7081.10930.27520.50230.35130.5920.2070.31280.31150.00490.15090.0186-0.3828QC'd by SIGMAInactive0
Inactive00043.19140.05370.0627-0.0199-0.91560.34450.1644-0.0051-0.06990.12160.44840.16630.14663.1914QC'd by Spectrum ChemicalInactive0
Inactive0-8.86033.990.97980.24231740 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.08198.09170.91440.3470.2061.69190.27670.2627-0.1985-0.0993-0.2147-0.0596-0.0858-0.0819QC'd by SIGMAInactive0
Inactive00040.11330.20950.15290.2804-0.00250.29590.57160.22840.33210.03070.11970.07720.34590.1133QC'd by SigmaAldrichInactive0
Inactive00040.53410.02420.21240.18710.04730.10960.04040.0920.12340.01120.1629-0.07080.20290.5341QC'd by SigmaAldrichInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: CHRM1997
Protocol: Tox21 Assay Protocol Summary:

CHRM1-CHO cells were dispensed at 1000 cells/3uL/well in 1536-well black-clear bottom plates using a Multidrop Dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 18 h, 3 uL of Dye Loading Buffer was transferred to the assay plate by a Flying Reagent Dispenser. The assay plates were incubated at 37 C for 1h. For antagonist mode, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pin tool. After 5 min incubation at room temperature, 1.5 uL of acetylcholine at 50nM was added to each well. The fluorescence intensity in the plates was measured using FDSS 7000EX kinetic plate reader for 3 min at 1 sec intervals. Each test compound was measured at 15 concentrations in three independent runs.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000039960 uM-Replicate_1Activity at 0.0000091663 uM-Replicate_1Activity at 0.0000362847 uM-Replicate_1Activity at 0.0000862850 uM-Replicate_1Activity at 0.0001998674 uM-Replicate_1Activity at 0.0004124603 uM-Replicate_1Activity at 0.00113 uM-Replicate_1Activity at 0.00347 uM-Replicate_1Activity at 0.00893 uM-Replicate_1Activity at 0.020 uM-Replicate_1Activity at 0.045 uM-Replicate_1Activity at 0.102 uM-Replicate_1Activity at 0.232 uM-Replicate_1Activity at 0.710 uM-Replicate_1Activity at 2.174 uM-Replicate_1Activity at 5.582 uM-Replicate_1Activity at 12.62 uM-Replicate_1Activity at 28.26 uM-Replicate_1Activity at 61.51 uM-Replicate_1Activity at 159.9 uM-Replicate_1Activity at 580.7 uM-Replicate_1Activity at 1231.0 uM-Replicate_1Activity at 2752.0 uM-Replicate_1Activity at 6155.0 uM-Replicate_1Activity at 13760.0 uM-Replicate_1Activity at 30770.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive0004-2.1781-14.6077-15.74035.874-6.19418.893-5.649710.7344-0.67673.7136-6.5739-2.1499-21.2783-2.1781QC'd by SIGMAInactive0
Inactive0-6.1260.30.4906-11.7304-33.739340 0 0 0 0 0 0 0 0 0 0 0 0 0 0-16.5369-31.6558-25.1796-28.7381-31.0798-26.2723-27.0785-30.5027-26.1541-8.1086-12.2914-19.9415-24.8788-16.5369QC'd by SIGMAInactive0
Inactive000415.11824.3534-3.1877-2.3826-5.7413-2.494211.75430.97083.76215.91024.486711.0592-5.946515.1182QC'd by SIGMAInactive0
Inactive0-8.52620.80.37567.5-8.95740 0 0 0 0 0 0 0 0 0 0 0 0 0 1-7.0338-3.64071.60920.62293.187712.91231.74593.92468.020910.518311.639515.6309-5.7975-7.0338QC'd by SIGMAInactive0
Inactive0-6.0263.990.37841.5-16.326140 0 0 0 0 0 0 0 0 0 0 0 0 0 07.701-23.9593-2.61690.34194.1756-23.8273-28.1884-27.1927-13.1416-3.4634-3.930911.7786-7.39137.701QC'd by SIGMAInactive0-7.4761.3310.4129
Inactive0-8.87624.95490.4467-2.89869.540 0 0 0 0 0 0 0 0 0 0 0 0 0 11.2264.0632-6.2638-6.4961-4.2253-3.5816-3.9002-1.843-3.68491.19333.89413.4558-6.99891.226QC'd by SIGMAInactive0
Inactive000417.853-4.4191-4.34458.438221.648-5.45146.6976-11.093111.255112.5287-7.84059.850416.079317.853QC'd by SIGMAInactive0
Inhibitor14.929466.177610Single point of activity-4.8264.44950.89-59.67766.5-30 0 0 0 0 0 0 0 0 0 0 0 0 0 1-15.344512.41639.71031.67098.92985.04529.81652.21698.6338-9.05192.0403-8.8885-59.3874-15.3445QC'd by CrescentInhibitor14.929443.584610Partial curve; partial efficacy; poor fit-4.8261.24750.7244
Inactive0004-12.3393-5.4707-7.76841.2125-0.9372-2.8638-4.8159-2.7306-8.3906-9.8909-5.1158-7.2832-3.7752-12.3393QC'd by CrescentInactive0
Inactive0004-12.39951.73690.337212.25698.1175-3.8979-0.5168-2.9245-1.5012-11.34040.83976.57380.9346-12.3995QC'd by CrescentInactive0
Inactive0-7.4764.95490.44240.4896-18.399340 0 0 0 0 0 0 0 0 0 0 0 0 0 0-4.4979-11.8174-3.4832-35.6655-28.5631-0.27183.2831-4.3744-4.3198.29879.438-3.47050.9414-4.4979QC'd by SIGMAInactive0
Inactive000411.53510.193311.9123-7.312714.60326.2774-3.41324.3898-1.954310.42329.88493.05612.716611.5351QC'd by SIGMAInactive0
Inhibitor0.594430.146810Partial curve; partial efficacy; poor fit-6.2263.92950.7596-31.1468-1-2.40 0 0 0 0 0 0 0 0 0 1 1 1 1 19.5925-8.13272.24441.75489.3564-5.7864-0.27772.5376-21.72486.41512.81351.15442.42899.5925QC'd by SIGMAInactive0
Inactive0-5.2763.990.4615-5.34586.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-2.30194.76232.487611.73962.3257-6.645112.017214.48989.03815.5870.4265-6.2237-6.9549-2.3019QC'd by SIGMAInactive0-4.3764.95490.5619
Inactive00042.05448.146913.882312.5534-5.61650.912412.01381.37735.791415.21471.24863.25714.80342.0544QC'd by SIGMAInactive0
Inhibitor8.395486.565182Complete curve; high efficacy-5.0762.25260.9515-80.06516.5-1.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-75.405-0.47175.053514.06375.580411.760223.03491.4555-1.71019.2627-17.022-54.0908-79.057-75.405QC'd by SIGMAInactive0-4.3764.95490.4538
Inactive00041.3209-3.56471.30272.7209-12.34330.54250.6416-2.4475-9.1264-0.7083-1.51823.5135-1.75421.3209QC'd by SIGMAInactive0
Inactive00040.14032.2597-2.059213.664116.96353.773113.14130.69514.996-1.62290.30745.6118.65320.1403QC'd by SIGMAInactive0
Inactive0-5.58383.990.6268-0.5-10.788840 0 0 0 0 0 0 0 0 0 0 0 0 0 0-1.6985-10.3141-12.3897-15.0539-7.0521-6.4389-18.9907-5.2846-10.0691-6.4352-0.26281.1904-1.6416-1.6985QC'd by SIGMAInactive0
Inactive000410.66146.5582-3.2554-3.2146-2.04712.598611.13443.1739-1.526-0.57044.82454.971210.532110.6614QC'd by SIGMAInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: CRE506
Protocol: Tox21 Assay Protocol Summary:
CRE-bla Hek 293T cells were suspended in assay medium (DMEM containing 10% dialyzed FBS, 0.1 mM NEAA, 1 mM sodium pyruvate and 25 mM HEPES) and dispensed at 2,000 cells/4 uL /well into 1536-well black wall/clear bottom plates using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. After the assay plates were incubated at 37 C/5% CO2 for 18 hrs, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pintool workstation (Kalypsys, San Diego, CA), followed by addition of 1 only was transferred to the assay plate by a Pintool station (Kalypsys, San Diego, CA), followed by addition of 1 uL of 1.25uM NKH477 (0.25 uM as final concentration) in assay medium using a Flying Reagent Dispenser (Aurora Discovery, San Diego, CA). The plates were incubated at 37 C and 5% CO2 for 3 hrs. Then 1 uL of LiveBLAzer B/G FRET substrate (Invitrogen, Carlsbad, CA) was added to each well using Bioraptr Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA). The plates were incubated at room temperature for 2 h.
Comment: Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).
Compound Ranking:
1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000060039 uM-Replicate_1W530-Activity at 0.0000137707 uM-Replicate_1W530-Activity at 0.0000545120 uM-Replicate_1W530-Activity at 0.0001296798 uM-Replicate_1W530-Activity at 0.0003000028 uM-Replicate_1W530-Activity at 0.0006177381 uM-Replicate_1W530-Activity at 0.00171 uM-Replicate_1W530-Activity at 0.00519 uM-Replicate_1W530-Activity at 0.013 uM-Replicate_1W530-Activity at 0.030 uM-Replicate_1W530-Activity at 0.068 uM-Replicate_1W530-Activity at 0.153 uM-Replicate_1W530-Activity at 0.349 uM-Replicate_1W530-Activity at 1.067 uM-Replicate_1W530-Activity at 3.267 uM-Replicate_1W530-Activity at 8.391 uM-Replicate_1W530-Activity at 18.95 uM-Replicate_1W530-Activity at 42.44 uM-Replicate_1W530-Activity at 92.40 uM-Replicate_1W530-Activity at 240.3 uM-Replicate_1W530-Activity at 872.4 uM-Replicate_1W530-Activity at 1849.0 uM-Replicate_1W530-Activity at 4135.0 uM-Replicate_1W530-Activity at 9246.0 uM-Replicate_1W530-Activity at 20670.0 uM-Replicate_1W530-Activity at 46230.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inactive10004-7.0159-0.28761.01321.44170.0888-9.1268-1.0522-7.4421-2.13092.3-0.6113-7.015910004-3.4056
Inactive10004-3.011-1.145-2.4844-1.55333.485-0.204-2.4902-1.54362.3767-6.3498-2.685-3.011100040.7393
Inactive10004-0.47-2.8951-3.2523-3.7349-2.26785.50733.05993.31041.24725.2625-0.1696-0.4710004-1.555
Inactive10004-0.09036.7111-0.5976-0.3144-0.47654.1544-6.4709-0.4438-7.8642.2606-1.579-0.0903100040.228
Inconclusive10004-0.2489-6.5215-0.8591-0.5168-7.3815-0.3741.3251-4.3898-1.81870-5.0418-0.24890Single point of activity-4.94454.95490.8866-44.0901-1.7908-30 0 0 0 0 0 0 0 0 0 1 12.9202
Inactive10004-5.6294-14.3173-2.7201-11.2343-4.43723.4425-5.249628.2483-6.79752.1333-6.1463-5.629410-8.24452.33320.5422-2-14.519340 0 0 0 0 0 0 0 0 0 0 1-7.0593
Inactive10004-4.8656-4.3458-5.475-4.89231.908812.6287-0.6734-6.886-6.7235-12.2506-0.9244-4.865610004-0.1056
Inactive100042.05360.3109-7.7771-4.05191.735913.82374.1529-1.641-6.3339-7.8549-1.84152.053610-8.54450.20.35041.5-15.408240 0 0 0 0 0 0 0 0 0 0 01.5023
Inactive100041.8357-3.8712-4.59684.9056-2.4421-0.4821-0.70024.091-5.05424.7764-0.18731.835710-6.84454.95490.3731-1.2664840 0 0 0 0 0 0 0 0 0 0 0-6.472
Inconclusive10-8.44454.95490.4825-0.97971140 0 0 0 0 0 0 0 0 0 0 0-2.985812.2192-7.4831-2.76110.9594.608-1.19161.5553-4.61891.86440.8695-2.98580Complete curve; partial efficacy; poor fit-8.44454.95490.854-2.188620-1.40 0 0 0 0 0 0 0 0 0 0 0-3.7347
Inactive10-7.69454.95490.30740-6.674740 0 0 0 0 0 0 0 0 0 0 16.9665-0.2746-13.4789-0.7541.4976-6.63441.89750.04562.39343.2814-4.07626.966510004-1.252
Inactive10004-0.47391.766-10.94371.36752.373-9.08121.0872-1.62221.10851.03521.2078-0.473910004-1.5827
Inactive10-4.44452.40640.9192-16.0230.540 0 0 0 0 0 0 0 0 0 0 0-13.76922.63221.58520.43591.6531-1.4042-0.73890.9511-0.33230.0369-10.5155-13.769210-4.19454.95490.57139-3.14940 0 0 0 0 0 0 0 0 0 0 07.2634
Inactive100048.62161.66121.39551.5105-8.28851.1474-1.52842.0426-0.73990.4137-1.85788.621610004-2.0298
Inactive10004-4.4756-0.29490.23863.43141.14790.7678-0.0067-0.6507-5.9741-0.2067-0.9416-4.475610004-3.061
Inactive100045.8601-2.39410.0423-2.0754.7846.2997-0.85951.393-3.01113.55965.32115.860110004-9.2067
Inconclusive10-4.24454.95490.427210.5-2.309340 0 0 0 0 0 0 0 0 0 0 09.5331-2.85560-1.2063-0.52341.9291-1.3959-2.6682-0.0439-13.5911-0.2019.533110-4.19454.95490.4089-3.448340 0 0 0 0 0 0 0 0 0 0 07.6869
Inactive10-4.28664.95490.72825.5-1.172640 0 0 0 0 0 0 0 0 0 0 023.3828-8.06053.02756.3622-3.8991.2563-5.1797-5.777-0.78790.19013.771823.382810-4.18664.95490.6532-22.1907-340 0 0 0 0 0 0 0 0 0 0 0-18.4923
Inconclusive100045.4646-3.9154-3.2006-6.41313.52925.1932-1.12710.5761-20.3247-0.5782-7.18015.464610004-5.264
Activator45.240774.820710-7.89454.95490.36863-7.172940 0 0 0 0 0 0 0 0 0 0 1-4.09-4.1888-10.14418.5838-1.725112.80163.66663.2286-2.06960.7385-1.1706-4.090Partial curve; high efficacy-4.34453.06540.983172.728-2.09272.10 0 0 0 0 0 0 0 0 0 0 064.1
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: CRE623
Protocol: Tox21 Assay Protocol Summary:
CRE-bla Hek 293T cells were suspended in assay medium (DMEM containing 10% dialyzed FBS, 0.1 mM NEAA, 1 mM sodium pyruvate and 25 mM HEPES) and dispensed at 2,000 cells/5 uL /well into 1536-well black wall/clear bottom plates using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. After the assay plates were incubated at 37 C/5% CO2 for 18 hrs, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pintool workstation (Kalypsys, San Diego, CA). After the plates were incubated at 37 C/5% CO2 for 3 hrs, 1 uL of LiveBLAzer B/G FRET substrate (Invitrogen, Carlsbad, CA) was added to each well using Bioraptr Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA). The plates were incubated at room temperature for 2 h.
Comment: Disclaimer:
Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).
Compound Ranking:
1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000060039 uM-Replicate_1W530-Activity at 0.0000137707 uM-Replicate_1W530-Activity at 0.0000545120 uM-Replicate_1W530-Activity at 0.0001296300 uM-Replicate_1W530-Activity at 0.0003002588 uM-Replicate_1W530-Activity at 0.0006197232 uM-Replicate_1W530-Activity at 0.00170 uM-Replicate_1W530-Activity at 0.00522 uM-Replicate_1W530-Activity at 0.013 uM-Replicate_1W530-Activity at 0.030 uM-Replicate_1W530-Activity at 0.068 uM-Replicate_1W530-Activity at 0.153 uM-Replicate_1W530-Activity at 0.349 uM-Replicate_1W530-Activity at 1.067 uM-Replicate_1W530-Activity at 3.267 uM-Replicate_1W530-Activity at 8.386 uM-Replicate_1W530-Activity at 18.95 uM-Replicate_1W530-Activity at 42.46 uM-Replicate_1W530-Activity at 92.41 uM-Replicate_1W530-Activity at 240.3 uM-Replicate_1W530-Activity at 872.4 uM-Replicate_1W530-Activity at 1849.0 uM-Replicate_1W530-Activity at 4135.0 uM-Replicate_1W530-Activity at 9246.0 uM-Replicate_1W530-Activity at 20670.0 uM-Replicate_1W530-Activity at 46230.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inactive10004-0.9548-0.4195-0.08090.01770.7848-1.9753-7.8495-0.2201-5.8525-0.1843-6.667-6.1435-0.8948-0.9548100040.4943
Inconclusive33.491535.467210Single point of activity-4.47514.95490.843234-1.467230 0 0 0 0 0 0 0 0 0 0 0 0 0 031.5847-0.2053.1711-0.15032.02621.8413-4.6774-6.6393-0.2496-0.3165-2.4959-5.1038-6.43831.5847100040.7055
Fluorescent21.1317233.52310Partial curve; high efficacy-4.67511.66040.9916233.382-0.14082.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0187.9080.2599-1.6287-1.3781-0.2984-4.561-5.7662-0.1876-0.89793.775318.200944.8649106.298187.90810004-7.3866
Inactive10-9.12514.95490.3604-3.3986940 0 0 0 0 0 0 0 0 0 0 0 0 0 0-3.97486.1565-4.2866-4.2034-1.1608-2.7993-8.2488-3.77590.147-6.6878-0.72651.7247-4.6409-3.9748100040.7006
Inactive10004-2.523-0.126-0.55750.26870.577-0.4465-1.82971.4459-0.8687-0.2229-1.2617-1.1583-2.804-2.523100040.1481
Inactive10004-3.3158-2.46060.8744-2.4805-1.96530.2783-2.1155-3.1759-0.73280.0273-2.7411-1.1742-2.5861-3.3158100040.3542
Inactive10004-6.3298-3.0655-0.5983-3.9559-3.2297-0.1472-0.9072-0.8472-0.4548-2.3342-4.8197-0.9701-5.2874-6.3298100040.0515
Inactive10004-1.6718-2.7534-3.0434-3.2368-0.5266-0.94970.8324-0.4991-0.1271-2.3961-5.9765-2.88891.3265-1.671810004-0.8308
Inactive100040.2704-0.01130.2093-0.13591.8534-1.9442-1.318-1.36660.26060.3476-0.5964-4.328-0.650.2704100040.2962
Inactive100046.1074-1.09610.1205-0.9377-0.83138.31174.16744.893111.21568.51340.08540.32950.12876.107410004-1.6275
Inconclusive66.265742.352310Partial curve; partial efficacy; poor fit-4.17872.18760.744138.0307-4.32152.40 0 0 0 0 0 0 0 0 0 0 0 0 0 029.2246-1.7761-13.0089-0.6771-0.1398-0.17050.3188-8.468-7.9781-16.97650.4529-0.721710.880929.224610004-3.7076
Fluorescent28.616390.842810Partial curve; high efficacy-4.54341.10.981890.3256-0.51722.10 0 0 0 0 0 0 0 0 0 0 0 0 0 071.8878-4.4616-0.0053-3.23970.62975.4330.79530.3464.285511.413917.470133.335455.296271.8878100044.8243
Inconclusive34.66854.985810Partial curve; partial efficacy-4.46011.10.947255.96930.98352.20 0 0 0 0 0 0 0 0 0 0 0 0 0 046.8430.3409-1.0852-0.7636-0.33174.23040.81593.05980.71718.24410.756619.145128.547346.84310004-3.0992
Inactive100040.2088-0.50992.4533-1.9209-0.41840.4617-1.05255.94946.28828.7636-0.5450.9216-2.79590.208810004-1.4861
Inconclusive49.734642.262210Partial curve; partial efficacy-4.303310.807245.23142.96912.20 0 0 0 0 0 0 0 0 0 0 0 0 0 039.7015-0.61882.84480.88810.00942.76685.875211.958.22448.9497.06849.448122.15539.701510004-4.3489
Inconclusive30.869639.274510Partial curve; partial efficacy-4.51052.63840.979938.9369-0.33752.20 0 0 0 0 0 0 0 0 0 0 0 0 0 038.3807-0.22181.8163-0.7660.9433-1.62850.7273-1.86440.5114-1.39731.36159.830428.899138.380710004-3.1002
Inconclusive62.725631.99510Partial curve; partial efficacy; poor fit-4.20263.24750.808229-2.9952.40 0 0 0 0 0 0 0 0 0 0 0 0 0 023.8094-4.1625-1.3901-1.5226-0.3825-8.32920.3951-6.4986-0.4749-5.7267-0.3547-1.45245.496723.809410004-4.0375
Inactive10-4.39591.69240.5803-7.38343.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-7.8195-0.15651.02455.34581.68774.78684.9925.87394.32077.04250.0148-0.2167-0.2419-7.8195100040.8078
Inactive10-5.99513.92950.3374-3.0208240 0 0 0 0 0 0 0 0 0 0 0 0 0 0-6.7098-0.61051.9344.08050.45173.65393.7594-0.97033.256-6.2855-0.62940.2278-0.9853-6.7098100040.5022
Inactive10-4.06410.80.6276240.821840 0 0 0 0 0 0 0 0 0 0 0 0 0 017.14390.83390.9785-2.37282.60513.2312-0.1354-1.67722.75114.08237.28953.67335.072317.143910004-1.6432
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: P53MS574
Protocol: Please refer to other AIDs 1963577 and 1963579 for detailed assay protocols.
Comment: This summary is written for the purposes of summarizing the compound activities from the project combining the results from both the p53 with human microsomes agonist mode assay (AID 1963577), cell viability counter screen (AID 1963579), and auto fluorescence counter screens (AID 720687, 720685, 720678, and 720681). For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Potency and efficacy were used for determining relative score. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 5 and 30 determined by phenotype.

Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).
Activity SummaryRatio ActivityRatio Potency (uM)Ratio Efficacy (%)530 nm Activity530 nm Potency (uM)530 nm Efficacy (%)460 nm Activity460 nm Potency (uM)460 nm Efficacy (%)Viability ActivityViability Potency (uM)Viability Efficacy (%)Blue (460 nm) auto fluorescence outcomeSample Source
active agonistactive agonist1.217408778.37631949inconclusive agonistactive agonist0.64630334178.39811596inactive0inactiveLightBiologicals
active agonistactive agonist0.43195290759.28553099active agonist0.91292773444.30993466active agonist0.55433172482.63203296inactive0inactiveLightBiologicals
active agonistactive agonist1.92946276175.72635936inconclusive agonistactive agonist1.39241833793.4523553inactive0inactiveLightBiologicals
active agonistactive agonist0.90676599358.50333518active agonist0.30731181552.96240355active agonist0.50725702284.98953543inactive0inactiveLightBiologicals
active agonistactive agonist0.46322605451.84457808active agonist0.58316704959.08400159active agonist0.56121117687.34471148inactive0inconclusiveCrescent
active agonistactive agonist3.97431503881.35179825inconclusive antagonist6.298864848-55.06041593inconclusive agonistactive antagonist8.897383087-112.1712623inactiveMicrosource
active agonistactive agonist2.57297994471.82694939inconclusive agonistactive agonist1.5623190775.01686917inactive0inactiveLightBiologicals
active agonistactive agonist0.96702210456.88216128inconclusive agonistactive agonist0.813647772.2886186inactive0inactiveLightBiologicals
active agonistactive agonist2.16489282570.10936057inconclusive agonist0.16234405951.55911786active agonist0.78301437374.08029793inactive0inactiveSIGMA
active agonistactive agonist1.18648510457.37963601active agonist2.1099020365.82498706active agonist1.30595723699.20329811inactive0inactiveSequoia
active agonistactive agonist0.94245861853.83876935inactive0active agonist1.12011416783.34522444inactive0inactivePharmaron
active agonistactive agonist1.13670862258.22057975active agonist0.38813471546.97356994active agonist0.69021197284.87369086inactive0inactiveSigmaAldrich
active agonistactive agonist1.37140703260.17931711inconclusive agonist8.16895252360.48218607active agonist3.94003160970.47314257inactive0inactiveFisher
active agonistactive agonist1.30131434158.4681202inconclusive agonistactive agonist0.88657513973.04049532inactive0inconclusiveSIGMA
active agonistactive agonist0.43195290746.46415354active agonist1.02432176549.29568673active agonist0.57601845974.36852288inactive0Sigma Chemical Company
active agonistactive agonist2.1099020362.60069161inconclusive agonistactive agonist1.20947145569.12030947inactive0inactiveSIGMA
active agonistactive agonist3.97431503876.85083297inconclusive agonist0.0792980148.75406392active agonist1.844713627108.3175397inactive0inactiveChemos
active agonistactive agonist4.07789839875.41728704inconclusive agonistactive agonist5.54331724488.76279206inactive0inactiveLightBiologicals
active agonistactive agonist3.23918983670.70756618inconclusive agonistactive agonist4.40321340175.21515029inactive0inactiveLightBiologicals
active agonistactive agonist3.84978433576.47198713inconclusive agonistactive agonist2.29317078985.70280133inactive0inactiveSIGMA
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: P53654
Protocol: Please refer to other AIDs 1963582 and 1963581 for detailed assay protocols.
Comment: This summary is written for the purposes of summarizing the compound activities from the project combining the results from both the p53 agonist mode assay (AID 1963582), cell viability counter screen (AID 1963581), and auto fluorescence counter screens (AID 720687, 720685, 720678, and 720681). For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Potency and efficacy were used for determining relative score. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 5 and 30 determined by phenotype.

Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).
Activity SummaryRatio ActivityRatio Potency (uM)Ratio Efficacy (%)530 nm Activity530 nm Potency (uM)530 nm Efficacy (%)460 nm Activity460 nm Potency (uM)460 nm Efficacy (%)Viability ActivityViability Potency (uM)Viability Efficacy (%)Blue (460 nm) auto fluorescence outcomeSample Source
active agonistactive agonist0.047234823152.29472inactive0active agonist0.037519953136.8633354inactive0GVK
active agonistactive agonist0.844238379220.2162354inconclusive antagonistactive agonist0.512623398104.6191287inactive0inactiveToronto Research
active agonistactive agonist0.012094715104.4361664inconclusive agonistactive agonist0.011201142144.4467864active antagonist0.397431504-70.21237763inactiveSelleck
active agonistactive agonist1.209471455180.1226065inactive0active agonist0.606171653113.571674inconclusive agonistinactiveSequoia
active agonistactive agonist2.778239835211.6412216inconclusive agonist48.4659132967.35167123active agonist5.13376992205.3954222inactive0inconclusiveSigmaAldrich
active agonistactive agonist13.57817889353.547094active antagonist13.06696898-36.85413308active agonist12.57500577253.5649028active agonist2.9828481548.90133363inactiveMicrosource
active agonistactive agonist0.13570492993.31141224inconclusive antagonist0.188045216-22.20736842active agonist0.14101401985.04743995inactive0inactiveSequoia
active agonistactive agonist0.16450339394.32096258inconclusive antagonistactive agonist0.36827722384.98769167inconclusive agonistinactivePrestwick
active agonistactive agonist9.486435714254.9932329active antagonist5.985536287-48.49725447active agonist8.136476998139.346131inactive0inactivePharma
active agonistactive agonist8.399671273237.8402483active antagonist1.410140188-48.09733887active agonist7.071445409180.865123inconclusiveinactiveMicrosource
active agonistactive agonist0.09129277384.95609526inactive0active agonist0.05437964977.70981018inactive0inconclusiveAcros
active agonistactive agonist4.38376925182.3000923active antagonist5.111099704-51.21597367active agonist3.48215169122.7336497inactive0inactiveSigmaAldrich
active agonistactive agonist1.993004104142.3810228inconclusive antagonistactive agonist5.202054047130.3026231inactive0inconclusiveSIGMA
active agonistactive agonist0.500619997103.8418341inactive0active agonist0.856725169155.0303204inconclusive antagonist0.562341325-43.25974821inactiveVitas
active agonistactive agonist0.12094714681.97009147inconclusive agonistactive agonist0.103735871123.2085258active antagonist0.70674426-72.37265734inactiveSequoia
active agonistactive agonist2.815193123137.0716961active antagonist3.159593015-33.41462647active agonist2.15199632892.29790016inactive0inactiveMicrosource
active agonistactive agonist0.61789561391.22925261inactive0active agonist1.809596631101.0029829inactive0inconclusiveSIGMA
active agonistactive agonist0.55433172483.79635801inactive0active agonist1.39241833788.81361331inactive0inactiveSIGMA
active agonistactive agonist0.43195290778.01689897inconclusive agonistactive agonist0.37766180899.59298459active agonist0.51337699277.40150829inactiveRoche
active agonistactive agonist2.605727258108.4007283inconclusive agonistactive agonist1.916883076121.5082983active antagonist2.507623262-38.90785093inactiveMicrosource
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: HTR2A603
Protocol: Assay Protocol Summary:

HTR2A-CHO cells were dispensed at 2000 cells/3uL/well in 1536-well black-clear bottom plates using a Multidrop Dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 18 h, 3 uL of Dye Loading Buffer was transferred to the assay plate by a Flying Reagent Dispenser. The assay plates were incubated at 37 C for 1h. For agonist mode, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pin tool. The fluorescence intensity in the plates was measured using FDSS 7000EX kinetic plate reader for 2 min at 1 sec intervals.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (https://www.epa.gov/comptox-tools/comptox-chemicals-dashboard) and NTP (https://cebs.niehs.nih.gov/cebs/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000049636 uM-Replicate_1Activity at 0.0000112894 uM-Replicate_1Activity at 0.0000451294 uM-Replicate_1Activity at 0.0001083383 uM-Replicate_1Activity at 0.0002490219 uM-Replicate_1Activity at 0.0005090755 uM-Replicate_1Activity at 0.00139 uM-Replicate_1Activity at 0.00429 uM-Replicate_1Activity at 0.011 uM-Replicate_1Activity at 0.025 uM-Replicate_1Activity at 0.057 uM-Replicate_1Activity at 0.128 uM-Replicate_1Activity at 0.292 uM-Replicate_1Activity at 0.874 uM-Replicate_1Activity at 2.651 uM-Replicate_1Activity at 7.023 uM-Replicate_1Activity at 15.88 uM-Replicate_1Activity at 35.56 uM-Replicate_1Activity at 76.84 uM-Replicate_1Activity at 198.7 uM-Replicate_1Activity at 725.3 uM-Replicate_1Activity at 1537.0 uM-Replicate_1Activity at 3438.0 uM-Replicate_1Activity at 7687.0 uM-Replicate_1Activity at 17190.0 uM-Replicate_1Activity at 38440.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive0-5.67131.10.547980.819540 0 0 0 0 0 0 0 0 0 0 0 0 0 08.7235-1.7246-0.79674.02471.9622-1.14673.4822-1.5146-1.8176.06554.31945.62146.74618.7235QC'd by ACCInactive0
Inactive00040.71362.84913.15472.62081.73272.79433.62882.21110.9461-1.0072-0.4977-1.0290.49570.7136QC'd by ACCInactive0-6.67134.95490.4722
Activator23.9145533.488243Partial curve; high efficacy-4.62131.98870.987537.0293.54082.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0406.84010.49816.65853.85970.56377.39464.5987-3.71610.781112.19813.264681.5331158.4589406.8401QC'd by ACCActivator18.9959357.953744Partial curve; high efficacy-4.72131.34430.9586
Inactive0004-3.33330.3686-2.1838-0.97840.28920.0634-2.0419-0.18710.061-3.3304-2.6853-2.00990.2108-3.3333QC'd by ACCInactive0
Inactive00043.36520.94171.36941.3511-0.11411.40170.29941.14555.12170.75433.87762.18824.52673.3652QC'd by RTIInactive0
Inactive0-4.96951.88510.9211-14.6405140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-13.45042.42870.3370.34840.7070.60323.1373-1.09171.7571-3.2954-1.1568-10.861-12.9725-13.4504QC'd by RTIInactive0-4.41952.18760.6553
Activator0.075282.249290Complete curve; high efficacy-7.12350.80.98879.7492-2.51.10 0 0 0 0 0 0 0 0 0 0 0 0 0 080.83461.78786.13089.925819.761739.591652.77160.918266.105569.033480.327881.334383.594680.8346QC'd by RTIActivator0.474788.523888Complete curve; high efficacy-6.32350.90.9909
Activator0.265393.198289Complete curve; high efficacy-6.57630.80.995589.1185-4.07971.10 0 0 0 0 0 0 0 0 0 0 0 0 0 090.5676-0.8998-0.035-0.36238.222717.297432.011448.365862.041171.971786.9385.895983.583490.5676QC'd by RTIActivator0.026577.546693Complete curve; high efficacy-7.57630.90.987
Inactive0-4.13091.24750.8779-16.497-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-14.58080.1628-0.5762-1.1136-0.2048-0.368-0.8819-0.8283-2.0195-1.2058-1.9466-7.6162-7.0211-14.5808QC'd by RTIInactive0
Inactive0004-6.6585-1.8147-3.036-2.7414-2.9382-3.1098-0.24922.1427-2.6629-0.1939-2.7488-1.4566-8.5268-6.6585QC'd by RTIInactive0
Inactive0004-3.4757-0.43290.3326-0.84020.0544-2.7307-0.3172-1.3413-2.0597-1.0047-1.1604-1.2522-8.0139-3.4757QC'd by RTIInactive0-4.0751.10.6917
Activator57.586431.97110Partial curve; partial efficacy; poor fit-4.23974.95490.909830-1.9712.40 0 0 0 0 0 0 0 0 0 0 0 0 0 024.7904-1.4056-0.3633-0.0089-3.0195-0.599-0.5758-0.7948-0.4323-4.1986-5.0136-5.39250.354724.7904QC'd by RTIInactive0
Activator62.154948.383510Single point of activity-4.20654.95490.969648.1294-0.254130 0 0 0 0 0 0 0 0 0 0 0 0 0 039.8328-0.49521.4760.66241.9344-0.3395-0.7123-1.4037-1.73662.2992-2.7117-1.43311.585639.8328QC'd by RTIActivator55.395689.54741Partial curve; high efficacy-4.25652.58840.9752
Inactive0004-1.5545-1.6566-2.6838-1.6155-1.2771-2.8033-0.7992-2.2086-2.1165-1.43662.10792.0395-0.1964-1.5545QC'd by RTIInactive0
Inactive0-6.44991.96730.9648-15.489-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-11.8883-0.1006-0.005-1.1316-1.8411-1.5843-1.4803-6.9758-12.1972-15.4653-17.0742-15.8774-16.437-11.8883QC'd by RTIInactive0-7.24990.90.9292
Inactive0-6.7574.95490.7181-12.0035140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-11.7465-0.46011.86560.11251.6950.44190.0198-17.5030.0822-10.7704-15.9134-13.7319-15.7608-11.7465QC'd by RTIInactive0-6.6074.95490.7096
Inactive0-5.39891.62660.717541440 0 0 0 0 0 0 0 0 0 0 0 0 0 02.18889.749913.244215.360917.054711.082914.114214.655317.559610.40557.12343.60218.61112.1888QC'd by RTIInactive0
Activator0.00149.315210Complete curve; high efficacy; poor fit-8.99190.40.646890.475241.161.30 0 0 0 0 0 0 0 0 0 0 0 0 0 087.673963.476275.320673.937776.90881.009883.341778.7232103.994589.298187.72991.364785.620587.6739QC'd by RTIActivator5.0E-480.912699Complete curve; high efficacy-9.29190.60.7869
Activator1.440861.767884Complete curve; high efficacy-5.84141.47870.990864.30992.54211.10 0 0 0 0 0 0 0 0 0 0 0 0 0 062.09883.60835.35485.57370.9311-2.04832.24227.913418.225242.68557.609265.591966.455462.0988QC'd by RTIActivator1.616683.116985Complete curve; high efficacy-5.79140.80.9937
Inactive0-5.36041.96730.3672-14.2663-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-12.6859-5.5953-3.7533-2.9145-1.4897-2.1001-2.8826.1673-6.0115-4.3461-9.4884-15.1664-14.9205-12.6859QC'd by RTIInactive0-5.56044.0950.9954
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: TRHR846
Protocol: Assay Protocol Summary:

The TRHR-Hek293 cells were dispensed at 1500cells/4uL/well in 1536-well black-clear bottom plates using a Multidrop dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 18 hours, 4 uL of Dye-Loading Solution was added to each well. The plates were incubated at 37 C for 2 hours. For agonist mode, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pin tool. The fluorescence intensity in the plates was measured using FDSS 7000EX kinetic plate reader for 3 min at 1 sec intervals. The fluorescence intensity in the plates was measured using FDSS 7000EX kinetic plate reader for 3 min at 1 sec intervals. Each test compound was measured at 15 concentrations and in triplicates.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000037435 uM-Replicate_1Activity at 0.0000085869 uM-Replicate_1Activity at 0.0000339910 uM-Replicate_1Activity at 0.0000808278 uM-Replicate_1Activity at 0.0001872372 uM-Replicate_1Activity at 0.0003864015 uM-Replicate_1Activity at 0.00106 uM-Replicate_1Activity at 0.00325 uM-Replicate_1Activity at 0.00836 uM-Replicate_1Activity at 0.019 uM-Replicate_1Activity at 0.042 uM-Replicate_1Activity at 0.095 uM-Replicate_1Activity at 0.218 uM-Replicate_1Activity at 0.671 uM-Replicate_1Activity at 2.037 uM-Replicate_1Activity at 5.229 uM-Replicate_1Activity at 11.82 uM-Replicate_1Activity at 26.48 uM-Replicate_1Activity at 57.62 uM-Replicate_1Activity at 149.8 uM-Replicate_1Activity at 544.0 uM-Replicate_1Activity at 1153.0 uM-Replicate_1Activity at 2578.0 uM-Replicate_1Activity at 5766.0 uM-Replicate_1Activity at 12890.0 uM-Replicate_1Activity at 28830.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive00040.10930.2358-0.0556-0.00810.14040.15070.201-0.08330.18080.03640.10190.179-0.06570.1093QC'd by ACCInactive0
Inactive0004-0.08260.1165-0.12440.0910.08390.086-0.0570.1191-0.0237-0.00640.10510.13660.0977-0.0826QC'd by ACCInactive0
Activator13.4504185.063543Partial curve; high efficacy-4.87131.34430.979188.02522.96172.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0149.2264-0.01930.01480.04390.02130.19741.24791.70349.361310.686421.893643.350480.8391149.2264QC'd by ACCActivator6.7412159.225445Partial curve; high efficacy-5.17130.80.9938
Inactive0004-0.09190.04220.02470.2511-0.04750.09930.05120.07890.0431-0.09510.07050.15520.259-0.0919QC'd by ACCInactive0
Inactive00040.3570.0351.0769-0.04880.04280.01970.08090.0423-0.0558-0.16680.0617-0.02840.0230.357QC'd by RTIInactive0
Inactive00040.44640.09740.12760.0710.02670.36870.07490.06780.88090.20480.05290.0919-0.03970.4464QC'd by RTIInactive0
Inactive00040.1569-0.0551-0.13040.086-0.0327-0.2711-0.00250.07510.6977-0.1180.2279-0.00310.15580.1569QC'd by RTIInactive0
Inactive00040.03340.00710.0162-0.08070.34660.19270.03130.70270.20210.2010.0430.02050.23920.0334QC'd by RTIInactive0
Inactive00040.060.0913-0.2536-0.25570.0909-0.39150.14430.06150.3358-0.3039-0.0294-0.0157-0.34490.06QC'd by RTIInactive0
Inactive00040.7668-0.3864-0.5076-0.1205-0.3265-0.1851-0.05860.30320.2267-0.19860.13710.30490.31410.7668QC'd by RTIInactive0
Inactive0004-0.00790.39050.0082-0.04050.0092-0.00260.27720.25920.18390.2223-0.2255-0.1070.157-0.0079QC'd by RTIInactive0
Inactive00040.05118.0E-40.60860.01010.3030.15310.0339-0.05140.2490.12410.432-0.0564-0.09890.0511QC'd by RTIInactive0
Inactive00047.0696-0.0392-0.1419-0.0362-0.05270.00150.02530.12410.1120.03190.47470.56781.30247.0696QC'd by RTIInactive0-4.35644.0950.9848
Inactive00040.04250.00170.48421.49711.28681.13970.5285-0.7745-0.04341.0430.36880.53560.77070.0425QC'd by RTIInactive0
Inactive0004-0.17740.07410.48340.09530.04380.30330.3770.27950.98210.37220.69470.4124-0.137-0.1774QC'd by RTIInactive0
Inactive00041.11110.05290.04210.29180.41180.02040.16180.13380.35650.34060.24880.0523-0.01351.1111QC'd by RTIInactive0
Inactive0004-0.02220.1040.18030.06330.48630.11110.09290.31610.30650.08940.43310.28130.1391-0.0222QC'd by RTIInactive0
Inactive00040.17030.0685-0.0092-0.0578-0.0015-0.05980.1636-0.0389-0.01670.07350.18970.5480.12190.1703QC'd by RTIInactive0
Inactive00040.1420.053-0.0542-0.01230.15140.14380.149-0.01770.47540.41330.24180.32330.00540.142QC'd by RTIInactive0
Inactive00040.99650.19290.1588-0.1208-0.13780.05610.12690.23260.24240.242-0.4335-0.09120.23550.9965QC'd by RTIInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: HTR2A875
Protocol: Tox21 Assay Protocol Summary:

HTR2A-CHO cells were dispensed at 2000 cells/3uL/well in 1536-well black-clear bottom plates using a Multidrop Dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 18 h, 3 uL of Dye Loading Buffer was transferred to the assay plate by a Flying Reagent Dispenser. The assay plates were incubated at 37 C for 1h. For antagonist mode, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pin tool. After 5 min incubation at room temperature, 1.5 uL of 4-Iodo-2,5-dimethoxy-alpha-methylbenzeneethanamine hydrochloride (DOI) at 4nM was added to each well. The fluorescence intensity in the plates was measured using FDSS 7000EX kinetic plate reader for 3 min at 1 sec intervals.
Comment: Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000039737 uM-Replicate_1Activity at 0.0000090357 uM-Replicate_1Activity at 0.0000361304 uM-Replicate_1Activity at 0.0000867348 uM-Replicate_1Activity at 0.0001993648 uM-Replicate_1Activity at 0.0004075545 uM-Replicate_1Activity at 0.00112 uM-Replicate_1Activity at 0.00343 uM-Replicate_1Activity at 0.00899 uM-Replicate_1Activity at 0.020 uM-Replicate_1Activity at 0.046 uM-Replicate_1Activity at 0.103 uM-Replicate_1Activity at 0.233 uM-Replicate_1Activity at 0.700 uM-Replicate_1Activity at 2.122 uM-Replicate_1Activity at 5.622 uM-Replicate_1Activity at 12.72 uM-Replicate_1Activity at 28.47 uM-Replicate_1Activity at 61.52 uM-Replicate_1Activity at 159.1 uM-Replicate_1Activity at 580.7 uM-Replicate_1Activity at 1231.0 uM-Replicate_1Activity at 2752.0 uM-Replicate_1Activity at 6155.0 uM-Replicate_1Activity at 13760.0 uM-Replicate_1Activity at 30770.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive0004-7.2061-3.526-9.9489-2.97267.0388-5.0617-5.7675-3.6219-0.0251-2.7206-1.11990.8657-10.4359-7.2061QC'd by SIGMAInactive0
Inactive00046.13445.64138.53264.04038.44095.441410.92884.31674.82284.80260.47619.71629.14296.1344QC'd by WaterstoneInactive0-8.6263.06540.5917
Inactive00042.3205-1.4158-3.9188-1.2064-7.0528-5.2123-2.2684-6.0073-2.0124-4.3471-2.4408-5.7061-1.99452.3205QC'd by SIGMAInactive0
Inactive00040.29564.40161.67061.4091-1.97283.5850.63440.38270.4984-2.7333.67393.46242.37810.2956QC'd by LightBiologicalsInactive0
Inactive0004-6.96170.1347-10.9722-11.3789-0.9886-3.2185-2.6238-5.3048-2.66760.8444-8.24951.4346-0.1703-6.9617QC'd by LightBiologicalsInactive0
Inactive0-4.9264.95490.47717-3.149540 0 0 0 0 0 0 0 0 0 0 0 0 0 08.9844-4.3701-1.7004-8.87464.1299-5.48120.94572.1614-3.6786-2.2479-8.06382.37734.41318.9844QC'd by SIGMAInactive0
Inactive00042.7598-1.388-10.7501-2.243-7.1709-7.7234-0.86450.53450.11642.5902-8.76125.54313.50742.7598QC'd by LightBiologicalsInactive0
Inactive0-5.65821.46410.408-4.6092240 0 0 0 0 0 0 0 0 0 0 0 0 0 10.78232.28384.9364.2099-4.16470.83986.4512-0.0288-0.01385.2677-3.4901-4.5008-2.3051-5.0910.7823QC'd by SIGMAInactive0
Inactive00043.79320.7208-1.6962-3.28710.9942-4.8215.321-4.7996-0.71224.43679.43390.65277.89283.7932QC'd by SIGMAInactive0
Inactive00041.00171.7707-1.3919-0.9574.20364.12342.9095-0.1743.60228.54267.03274.49020.66171.0017QC'd by TCIInhibitor0.167523.871710Single point of activity-6.7764.95490.6462
Inactive00041.3141-0.92173.5166-2.30331.6783.27250.5745-9.0E-41.5868-0.40153.79654.99052.65621.3141QC'd by SIGMAInactive0
Inactive0-5.62610.41615-3.772340 0 0 0 0 0 0 0 0 0 0 0 0 0 06.036-2.1149-5.697-13.97690.09992.219-1.9463-2.9706-3.34883.16550.39146.03741.34256.036QC'd by SIGMAInactive0
Inhibitor9.419843.686410Single point of activity-5.0264.95490.8559-47.6864-4-30 0 0 0 0 0 0 0 0 0 0 0 0 1 1-4.2356-9.8138-9.423-4.05922.411-1.0589-7.4879-2.3574-4.7276-3.6806-4.4603-38.39886.5491-4.2356QC'd by LightBiologicalsInactive0-7.0260.20.4384
Inactive0004-0.06471.12492.86741.33545.11772.14-1.44271.18032.9089-1.5124-0.02495.72685.9847-0.0647QC'd by LightBiologicalsInhibitor47.210925.535310Partial curve; partial efficacy; poor fit-4.3264.95490.7127
Inactive0-6.42610.55530.5-8.527640 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.5555-7.8118-8.811-10.011-6.4119-10.1734-6.8978-2.0059-5.3563.4401-1.34733.18-0.9271-0.5555QC'd by LightBiologicalsInactive0
Inactive00041.97624.76444.171228.06640.678-1.83649.05051.55284.31155.40685.86384.23756.04841.9762QC'd by SIGMAInactive0
Inactive0004-2.38713.6232-0.273903.5491.08915.48920.99120.71813.3244-2.86665.65283.6147-2.3871QC'd by LightBiologicalsInactive0
Inactive000413.15252.6229-1.041215.1602-2.820813.804212.821710.52165.190911.06815.40983.05368.005213.1525QC'd by SIGMAInactive0
Inactive0-5.2761.10.6487-16.0176-1.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-15.848-6.15315.9102-2.0982-1.5437-3.338-2.63271.5609-0.7495-10.8518-7.7926-9.3193-14.5467-15.848QC'd by LightBiologicalsInactive0-4.6261.3310.6582
Inactive00040.0466-2.72680.2154-0.12984.7191-1.4011-1.10474.8769-0.64661.98962.8818-2.35198.50421.5602QC'd by AcrosInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: MDA114
Protocol: Tox21 Assay Protocol Summary:

MDA-kb2 cells (cells cultured without CO2) were dispensed at 3,000 cells/well in 4uL of culture medium into white wall/solid-bottom 1536-well plates (Corning Life Sciences, Corning, NY) using a Multidrop Combi (Thermo Fisher Scientific Inc., Waltham, MA) dispenser. The assay plates were incubated at 37C and 0% CO2 for 5hr. One uL of 3.0uM (final concentration) Nilutamide or assay buffer was added using two separate tips of Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA). Then 23nL of compounds dissolved in DMSO at 15 concentrations and positive controls were transferred to the assay plates using a Pintool station (Wako, San Diego, CA). The assay plates were incubated at 37C and 0% CO2 for 16 hr. After 15hr incubation at 37C, 1uL/well CellTiter-Fluor reagent (Promega Corporation) was added to each well of the assay plates using FRD. After 1hr incubation at 37C and 0% CO2, the fluorescence signal was measured using a ViewLux plate reader (PerkinElmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000060039 uM-Replicate_1Activity at 0.0000137707 uM-Replicate_1Activity at 0.0000545120 uM-Replicate_1Activity at 0.0001296300 uM-Replicate_1Activity at 0.0003002588 uM-Replicate_1Activity at 0.0006197232 uM-Replicate_1Activity at 0.00170 uM-Replicate_1Activity at 0.00522 uM-Replicate_1Activity at 0.013 uM-Replicate_1Activity at 0.030 uM-Replicate_1Activity at 0.068 uM-Replicate_1Activity at 0.153 uM-Replicate_1Activity at 0.350 uM-Replicate_1Activity at 1.067 uM-Replicate_1Activity at 3.267 uM-Replicate_1Activity at 8.386 uM-Replicate_1Activity at 18.95 uM-Replicate_1Activity at 42.46 uM-Replicate_1Activity at 92.41 uM-Replicate_1Activity at 240.3 uM-Replicate_1Activity at 872.4 uM-Replicate_1Activity at 1849.0 uM-Replicate_1Activity at 4135.0 uM-Replicate_1Activity at 9246.0 uM-Replicate_1Activity at 20670.0 uM-Replicate_1Activity at 46230.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive0004-0.55241.18310.47891.68463.5429-0.83441.41670.99730.79660.0472.6292-0.58680.007-0.5524QC'd by ACCInactive0
Inactive00044.1974.35290.04353.5575-5.29615.76050.1385-2.123-1.4138-1.515-1.05450.3120.06924.197QC'd by ACCInactive0
Inactive0-4.87510.70.5971111.540 0 0 0 0 0 0 0 0 0 0 0 0 0 10.87581.45032.7741.48094.94581.5350.70923.19170.71191.29092.83436.97848.08310.8758QC'd by ACCCytotoxic33.491515.311720Partial curve; partial efficacy; poor fit-4.47514.95490.8078
Inactive0004-1.12340.92030.038-1.3621-1.3579-14.8259-2.2889-1.3087-0.29160.4561-1.00561.83912.5206-1.1234QC'd by ACCInactive0
Inactive0-4.04011.27160.6373-19.22460.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-12.6872-0.4845-0.6807-1.46530.11838.04060.12860.19450.60930.7495-0.5162-4.8802-2.8328-12.6872QC'd by RTIInactive0
Inactive00042.1646-0.07711.599-0.12581.0659-3.028-1.1528-1.9751-3.3891-0.32920.5374-7.19232.77962.1646QC'd by RTIInactive0-5.07354.95490.3853
Inactive00042.07190.73842.04082.41195.35932.49712.28520.06692.20063.03194.2150.5972-0.35912.0719QC'd by RTIInactive0
Inactive0004-3.0924-0.2247-2.0954-2.71892.057311.193-1.7626-0.3141-2.7329-0.39760.624-11.5428-2.6273-3.0924QC'd by RTIInactive0
Inactive0004-0.0093-0.0114-4.6381-0.72144.6921-0.16043.4294-0.4990.4030.0189-0.53384.0192-0.37-0.0093QC'd by RTIInactive0
Inactive0-4.60534.95490.5671-7.0135-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-7.0946-6.5265-0.81961.53040.3455-1.92080.43271.0134-1.50880.19250.1622-2.5017-6.6855-7.0946QC'd by RTIInactive0
Inactive0-4.07872.53340.6097-12.9494-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-9.5411-5.38542.5477-0.02322.3324-0.6916-2.23470.4455-0.3938-0.718-1.3355-2.0098-2.9528-9.5411QC'd by RTIInactive0-6.42870.60.4764
Cytotoxic50.887815.677120Partial curve; partial efficacy; poor fit-4.29342.72020.8774-16.1771-0.5-2.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0-13.8976-1.0656-2.3787-1.4289-0.5890.23483.5769-1.6150.0596-0.5139-0.4172-0.179-7.0568-13.8976QC'd by RTICytotoxic50.887821.185120Partial curve; partial efficacy-4.29342.25260.9435
Cytotoxic48.969985.004941Partial curve; high efficacy-4.31012.40640.9883-84.39410.6108-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-71.88950.3027-1.81631.1126-0.45360.82041.0719-1.4994-1.02961.34980.3786-2.1508-39.9092-71.8895QC'd by RTICytotoxic54.945188.000841Partial curve; high efficacy-4.26013.1320.9919
Inactive0-8.69173.990.6964-1-12.630840 0 0 0 0 0 0 0 0 0 0 0 0 0 0-1.7017-10.5256-1.5538-1.7862-4.2249-2.93-1.8203-0.6597-1.7887-1.1579-0.83773.1023-0.0027-1.7017QC'd by RTIInactive0
Cytotoxic70.252142.048141Partial curve; high efficacy-4.15333.62720.9421-42.5481-0.5-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-34.12741.4098-1.5873-1.85563.87561.2709-3.02510.5635-2.51360.5544-3.2309-3.1802-7.7944-34.1274QC'd by RTICytotoxic70.252132.847821Partial curve; partial efficacy-4.15333.19250.7963
Cytotoxic61.592960.475941Partial curve; high efficacy-4.21053.990.9903-61.0337-0.5578-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-54.1922-1.72680.7304-2.3391-1.1311-0.5358-2.6706-1.82930.9651-0.91551.16151.0808-13.9193-54.1922QC'd by RTICytotoxic69.108468.72741Partial curve; high efficacy-4.16052.84730.9893
Inactive0004-1.70150.5203-1.9234-2.5821.5080.5336-0.5675-0.93981.0467-1.1776-0.18770.4126-1.3733-1.7015QC'd by RTIInactive0
Cytotoxic20.140922.058320Partial curve; partial efficacy-4.69591.50950.9728-22.05830-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-21.7153-0.67560.6652-0.47260.21090.35180.65980.0271-0.6199-1.1465-4.1114-14.0876-14.7751-21.7153QC'd by RTICytotoxic45.089920.252820Single point of activity-4.34591.10.7091
Inactive0-4.04514.95490.5914-11.560.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-7.96673.6147-0.0630.22425.69680.3207-0.4556-0.4392-1.5661-0.60340.1630.40550.1257-7.9667QC'd by RTIInactive0
Inactive0004-1.1708-4.37-2.30020.11330.83312.04781.60271.2839-1.4773-1.25011.42840.1595-1.0601-1.1708QC'd by RTIInactive0-5.31413.92950.3998
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: ERB669
Protocol: Tox21 Assay Protocol Summary:

ER-beta-UAS-bla HEK293T cells were dispensed at 2,000 cells/4 uL of assay medium containing 2% charcoal stripped FBS per well into black wall/clear-bottom 1536-well plates using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. After the assay plates were incubated at a 37C and 5% CO2 for 6 hr, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a Pintool station (Kalypsys, San Diego, CA), followed by addition of 1 uL (1nM as final concentration) of 17-beta-estradiol (E2) in assay medium using a BioRAPTR FRD (Flying Reagent Dispenser, Aurora Discovery, San Diego, CA). The plates were incubated at 37C and 5% CO2 for 16 hr. Then 1 uL of LiveBLAzerTM B/G FRET substrate was added using a Flying Reagent Dispenser, the plates were incubated at room temperature for 2 hours, and fluorescence intensity was measured by an Envision plate reader (PerkinElmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000060039 uM-Replicate_1W530-Activity at 0.0000137707 uM-Replicate_1W530-Activity at 0.0000545120 uM-Replicate_1W530-Activity at 0.0001296300 uM-Replicate_1W530-Activity at 0.0003002588 uM-Replicate_1W530-Activity at 0.0006197232 uM-Replicate_1W530-Activity at 0.00170 uM-Replicate_1W530-Activity at 0.00522 uM-Replicate_1W530-Activity at 0.013 uM-Replicate_1W530-Activity at 0.030 uM-Replicate_1W530-Activity at 0.068 uM-Replicate_1W530-Activity at 0.153 uM-Replicate_1W530-Activity at 0.349 uM-Replicate_1W530-Activity at 1.067 uM-Replicate_1W530-Activity at 3.267 uM-Replicate_1W530-Activity at 8.386 uM-Replicate_1W530-Activity at 18.95 uM-Replicate_1W530-Activity at 42.46 uM-Replicate_1W530-Activity at 92.41 uM-Replicate_1W530-Activity at 240.3 uM-Replicate_1W530-Activity at 872.4 uM-Replicate_1W530-Activity at 1849.0 uM-Replicate_1W530-Activity at 4135.0 uM-Replicate_1W530-Activity at 9246.0 uM-Replicate_1W530-Activity at 20670.0 uM-Replicate_1W530-Activity at 46230.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inactive10004-11.7022-6.2144-4.419-1.9771-5.58860.9305-1.0579-3.75235.8815-4.4111-3.6203-13.9831-6.9433-11.7022100047.0683
Inactive10-5.97513.24750.74021.5-5.898740 0 0 0 0 0 0 0 0 0 0 0 0 0 1-8.4503-9.9156-4.6061-6.3526-4.1483-6.3471-3.8808-6.3061-5.3587-3.6621.72474.0399-1.7558-8.450310-4.72513.06540.735912.5-0.893840 0 0 0 0 0 0 0 0 0 0 0 0 0 011.4853
Inconclusive33.491569.383810Single point of activity-4.47514.95490.972167.5308-1.85330 0 0 0 0 0 0 0 0 0 0 0 0 0 059.4787-1.7705-3.5156-2.2413-2.34281.1146-3.3724-1.2725-1.6752-0.40520.0613-1.7967-0.812759.47870Partial curve; high efficacy-4.62511.88510.969-110.6194-8.0744-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-88.2133
Inactive10-7.97514.95490.4339-9.97860.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-13.21254.06751.4909-1.9605-10.8912-10.418-13.3155-9.4918-11.5006-13.2085-12.92082.1512-4.0645-13.212510-4.47514.95490.8873311.893840 0 0 0 0 0 0 0 0 0 0 0 0 0 026.1674
Inconclusive10-4.24012.72020.5088-16.287-140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-13.9892-0.2795-4.6351-3.7259-0.77990.64852.7532-0.8624-5.54251.2289-2.59695.2815-9.8307-13.98920Complete curve; partial efficacy; poor fit-4.29010.80.516542101.40 0 0 0 0 0 0 0 0 0 0 0 0 0 033.0418
Inconclusive100045.34560.44720.0437-12.5631-2.17222.7513-0.26143.87982.0449-9.6214-14.80487.4717-6.69645.345610-4.373510.7676191.387540 0 0 0 0 0 0 0 0 0 0 0 0 0 015.7972
Activator41.950930.157510004-3.408-4.9312-3.4374-0.2102-1.80694.04810.024-3.5084-4.4016-0.1433-1.3609-11.4239-3.169-3.4080Partial curve; partial efficacy; poor fit-4.37731.210.8582321.84252.40 0 0 0 0 0 0 0 0 0 0 0 0 0 028.1262
Activator26.309737.9755100042.60172.2367-2.6955-9.5399-6.20113.07640.34051.6195-4.0199-4.3194-10.35272.8856-17.70092.60170Partial curve; partial efficacy; poor fit-4.57990.50.555840.64692.67142.40 0 0 0 0 0 0 0 0 0 0 0 0 0 034.0072
Inactive100041.0335-4.9094-4.07220.9376-4.3761-1.9326-2.8737-8.7614-4.4312-2.5598-1.17-6.10490.02791.03351000411.3333
Inactive10-4.10534.44950.695316.50.510640 0 0 0 0 0 0 0 0 0 0 0 0 0 012.93073.44361.6998-0.06993.1532-0.95292.20683.4816-1.6579-0.09362.95581.02671.568312.930710-4.30532.33320.8735-19.4838440 0 0 0 0 0 0 0 0 0 0 0 0 0 0-15.8198
Inactive100042.7172-3.2465.7714-1.0847-0.3022-3.04281.1444.77976.3488-2.55812.9983-0.702-3.00782.717210-4.42874.95490.828-16.59640 0 0 0 0 0 0 0 0 0 0 0 0 0 1-0.1836
Inhibitor57.09755.1068100042.091-0.25914.00281.80693.3561-0.68052.118-1.29894.6133.29181.23592.40487.55662.0910Single point of activity-4.24344.44950.8125-51.89163.2152-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-47.3516
Inconclusive61.649550.22310Partial curve; partial efficacy-4.21011.46410.885850.83640.61342.20 0 0 0 0 0 0 0 0 0 0 0 0 0 038.7374-1.9046-3.09063.49874.14940.33256.0652-2.9246-1.97022.93577.2956.339516.293638.73740Partial curve; high efficacy-4.46012.72020.9728-68.01970.4439-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-70.8538
Inconclusive10004-3.62-0.6225-1.0752-2.00988.2247-1.1614-2.323-3.2663-3.78911.5179-1.5835-2.9407-1.2256-3.620Partial curve; partial efficacy; poor fit-4.14171.210.8815321.75612.40 0 0 0 0 0 0 0 0 0 0 0 0 0 023.9897
Inactive10-5.35332.72020.702610.50.818540 0 0 0 0 0 0 0 0 0 0 0 0 0 09.53270.32650.734-1.79845.20812.3392.3849-1.3487-2.23462.883415.619310.68817.61929.5327100045.4187
Inactive10-5.31054.95490.4249-9.1860.540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-2.12442.47872.8774-13.0717-0.40211.89612.2838-0.4037-0.4671.9853-10.0377-11.9591-4.8223-2.124410004-0.987
Inactive10-5.05260.40.4982-12.22880.540 0 0 0 0 0 0 0 0 0 0 0 0 0 10.855-1.56510.7484-1.63563.1341-3.7061-1.7192-0.4121-4.0129-6.1814-0.6278-9.0619-8.96930.855100041.4648
Inactive100048.92551.59770.65371.44535.54373.00325.57165.6023-1.8532-0.53577.59812.86786.7368.925510-4.44591.98870.7278-20.2307240 0 0 0 0 0 0 0 0 0 0 0 0 0 0-18.5256
Inactive100044.57232.74022.77574.53231.31693.78052.50364.89590.13482.37920.08884.0227-2.04714.5723100042.0429
Inactive100043.4295-3.6228-4.5941-2.638-3.05452.9959-2.615-4.2947-2.9051-1.28664.7656-9.24424.49213.429510-4.11414.95490.743621.51.877840 0 0 0 0 0 0 0 0 0 0 0 0 0 017.7489
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: ERB626
Protocol: Tox21 Assay Protocol Summary:

ER-beta-UAS-bla HEK293T cells were dispensed at 2,000 cells/5 uL of assay medium containing 2% charcoal stripped FBS per well into black wall/clear-bottom 1536-well plates using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. After the assay plates were incubated at a 37C and 5% CO2 for 6 hr, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a Pintool station (Kalypsys, San Diego, CA). The plates were incubated at 37C and 5% CO2 for 16 hr. Then 1 uL of LiveBLAzerTM B/G FRET substrate was added using a BioRAPTR FRD (Flying Reagent Dispenser, Aurora Discovery, San Diego, CA). After the plates were incubated at room temperature for 2 hours, fluorescence intensity was measured by an Envision plate reader (PerkinElmer, Shelton, CT).
Comment: Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000060039 uM-Replicate_1W530-Activity at 0.0000137707 uM-Replicate_1W530-Activity at 0.0000545120 uM-Replicate_1W530-Activity at 0.0001296300 uM-Replicate_1W530-Activity at 0.0003002588 uM-Replicate_1W530-Activity at 0.0006197232 uM-Replicate_1W530-Activity at 0.00170 uM-Replicate_1W530-Activity at 0.00522 uM-Replicate_1W530-Activity at 0.013 uM-Replicate_1W530-Activity at 0.030 uM-Replicate_1W530-Activity at 0.068 uM-Replicate_1W530-Activity at 0.153 uM-Replicate_1W530-Activity at 0.348 uM-Replicate_1W530-Activity at 1.076 uM-Replicate_1W530-Activity at 3.319 uM-Replicate_1W530-Activity at 8.387 uM-Replicate_1W530-Activity at 18.95 uM-Replicate_1W530-Activity at 42.46 uM-Replicate_1W530-Activity at 92.41 uM-Replicate_1W530-Activity at 240.3 uM-Replicate_1W530-Activity at 872.4 uM-Replicate_1W530-Activity at 1849.0 uM-Replicate_1W530-Activity at 4135.0 uM-Replicate_1W530-Activity at 9246.0 uM-Replicate_1W530-Activity at 20670.0 uM-Replicate_1W530-Activity at 46230.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inactive10-4.57510.90.8134-31.2885-2.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-22.7404-0.17021.886-2.2289-3.7942-1.3889-8.8527-3.0876-5.8386-3.6208-6.0244-9.0429-12.9216-22.740410-5.07511.46410.9274100.688740 0 0 0 0 0 0 0 0 0 0 0 0 0 08.4945
Inconclusive10-5.125110.659-20.2035-340 0 0 0 0 0 0 0 0 0 0 0 0 0 0-18.9195-1.114-12.6474-0.9852-5.15581.7895-4.9431-5.8545-0.107-2.355-7.8412-15.338-12.5904-18.91950Partial curve; partial efficacy; poor fit-4.67511.82650.9727160.87142.40 0 0 0 0 0 0 0 0 0 0 0 0 0 012.9722
Inconclusive33.491579.152610Single point of activity-4.47514.95490.948976.8968-2.255830 0 0 0 0 0 0 0 0 0 0 0 0 0 067.66314.8767-3.3662-2.9864-0.33180.55531.3366-0.5155-4.9619-6.9008-1.8675-5.19571.086667.66310Single point of activity-4.52514.50450.9648-17.41441-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-15.3453
Inactive10004-2.18923.8936-1.92772.2218-5.2713-1.07621.692-6.56420.71672.66130.5957-1.54385.1404-2.189210004-0.0787
Inactive104-0.8525-3.7209-2.9429-9.8503-8.8929-14.1222-10.3975-0.7762-2.837-13.4109-9.7989-6.7408-32.4975-0.852510-4.19011.34430.5497-4.70841.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-3.0903
Inactive10004-3.8221-5.6659-11.09954.2204-11.5799-11.77051.11823.7818-7.4048-7.73794.64410.3625-29.7706-3.822110004-3.8621
Inactive10-4.47732.72020.7314-29.68-2.540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-0.6231-4.143-2.473-6.0892-1.91021.81641.44780.2759-6.2427-3.5906-3.6843-7.9324-23.0667-0.623110004-0.9133
Inactive104-4.779-7.9282-4.0791-0.7375-15.3499-12.6783-1.4428-2.8961-11.8252-10.2044-11.7796-5.7939-31.5379-4.779100041.6757
Inactive10-4.13464.0450.6012-18.4992-1.540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-5.4842-3.30012.91580.2048-2.06350.954-6.12693.3482-1.3157-2.1221-3.4441-3.7858-15.416-5.484210004-0.0573
Inactive10-4.50534.95490.8037-24.33272.540 0 0 0 0 0 0 0 0 0 0 0 0 0 11.214.31062.3690.53355.90594.9711-2.96381.0651-2.89614.66913.3467-0.6256-21.94391.2110004-2.0542
Inactive100049.6940.7452-0.2932-0.14240.5309-1.53695.6226-3.01775.64561.96036.54714.3639-6.07849.69410-4.57874.95490.8186-3.8554040 0 0 0 0 0 0 0 0 0 0 0 0 0 0-3.7339
Inactive10-4.44344.95490.684-417.540 0 0 0 0 0 0 0 0 0 0 0 0 0 117.550417.333916.347614.983322.52917.646917.593116.463614.756220.224813.300121.44231.16917.550410-4.29342.33320.8991-6.8402-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-5.7002
Inconclusive77.612149.794510Single point of activity-4.11014.95490.827351.81652.02230 0 0 0 0 0 0 0 0 0 0 0 0 0 042.46726.69440.3738-0.33035.29682.8122.8907-3.75692.62922.5742-4.148412.6437-2.221242.467210-4.21012.40640.9714-14.8713-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-11.5594
Inactive10-4.44174.95490.4318-6.0664440 0 0 0 0 0 0 0 0 0 0 0 0 0 13.24380.01173.71180.94942.149810.80863.3144.34543.87075.05732.87046.1437-5.88863.243810-4.59174.0950.5966-3.7492040 0 0 0 0 0 0 0 0 0 0 0 0 0 1-1.2778
Inactive10-4.50330.30.450221-0.800740 0 0 0 0 0 0 0 0 0 0 0 0 0 017.84023.2083-1.3433-0.90022.22422.13697.21034.09613.91365.79637.45615.4257-1.026317.840210004-0.375
Inactive10004-8.9214-10.81-9.9186-3.395-10.988-22.9648-5.2276-9.3673-13.7385-12.4058-8.3712-8.7967-25.008-8.921410-5.06054.95490.4129-1.4771.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.3867
Inactive10004-3.1123-9.89640.54651.8816-12.182-17.91570.34381.5826-9.8343-0.9876-16.61414.9253-22.7303-3.112310-4.55264.95490.4131-2.9612140 0 0 0 0 0 0 0 0 0 0 0 0 0 10.3744
Inactive100043.62351.58766.8983.84892.3842-0.54432.91911.26681.540.04726.39026.1778-3.06293.623510-4.49594.0950.5652-3.82240.540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-0.623
Inactive10-4.49514.0950.7824-21.2872.540 0 0 0 0 0 0 0 0 0 0 0 0 0 13.08311.28890.43554.53765.77411.6357.62343.16280.24464.2622-2.411-1.2508-17.73923.083110004-0.0907
Inactive10-4.71412.40640.8034-15.4295140 0 0 0 0 0 0 0 0 0 0 0 0 0 1-0.9527-5.21281.19860.80370.88462.13053.56980.5017-0.8732.3059-2.1882-7.5973-13.2746-0.952710004-0.179
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: ER849
Protocol: Assay Protocol Summary:

VM7Luc4E2 cells were cultured in phenol red free assay medium containing 10% charcoal stripped FBS for 5 days prior to the assay. The cells were dispensed at 4,000 cells in 4uL of assay medium per well into white wall/solid-bottom 1536-well plates (Corning Life Sciences, Corning, NY) using a Multidrop Combi (Thermo Fisher Scientific Inc., Waltham, MA) dispenser. After the assay plates were incubated at 37C and 5% CO2 for 24hr, 1uL of 10.0nM (final concentration) ICI-182,780 or assay buffer was added using two separate tips of Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA). Then 23nL of compounds dissolved in DMSO at 15 concentrations and positive controls or DMSO only was transferred to the assay plates by a Pintool station (Wako, San Diego, CA). The assay plates were incubated at 37C and 5% CO2 for 22hr. For luciferase read, 4uL/well ONE-Glo reagent (Promega Corporation, Madison, WI) was added to each well using FRD and after 30min incubation at room temperature, luminescence signal was measured on ViewLux plate reader (PerkinElmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000060039 uM-Replicate_1Activity at 0.0000137707 uM-Replicate_1Activity at 0.0000545120 uM-Replicate_1Activity at 0.0001296300 uM-Replicate_1Activity at 0.0003002588 uM-Replicate_1Activity at 0.0006197232 uM-Replicate_1Activity at 0.00170 uM-Replicate_1Activity at 0.00522 uM-Replicate_1Activity at 0.013 uM-Replicate_1Activity at 0.030 uM-Replicate_1Activity at 0.068 uM-Replicate_1Activity at 0.153 uM-Replicate_1Activity at 0.349 uM-Replicate_1Activity at 1.067 uM-Replicate_1Activity at 3.267 uM-Replicate_1Activity at 8.386 uM-Replicate_1Activity at 18.95 uM-Replicate_1Activity at 42.46 uM-Replicate_1Activity at 92.41 uM-Replicate_1Activity at 240.3 uM-Replicate_1Activity at 872.4 uM-Replicate_1Activity at 1849.0 uM-Replicate_1Activity at 4135.0 uM-Replicate_1Activity at 9246.0 uM-Replicate_1Activity at 20670.0 uM-Replicate_1Activity at 46230.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive00040.59120.08920.60490.23010.21961.5787-0.0112-0.04121.33531.36120.24380.63250.50730.5912QC'd by ACCInactive0
Inactive0004-0.3132-0.33860.001-0.7687-2.1437-1.5162-1.492-1.7398-1.44920.282-1.1279-0.4814-2.0441-0.3132QC'd by ACCInactive0
Inactive0-4.47514.95490.9257-10.4948040 0 0 0 0 0 0 0 0 0 0 0 0 0 0-8.74560.33491.0296-0.3177-1.2718-0.39320.6259-0.55970.95270.6377-0.3132-0.2648-0.7321-8.7456QC'd by ACCInactive0
Inactive00040.03840.40520.19270.55840.72642.4350.65530.85110.79790.5446-3.4030.93210.47080.0384QC'd by ACCInactive0
Inactive0004-0.03610.2292-1.42480.04750.5361.4848-0.9318-1.24451.64510.74551.32471.43220.0358-0.0361QC'd by RTIInactive0
Inactive00043.3072-0.6481-0.5297-1.5344-0.64283.0448-0.7464-1.0203-0.39340.13484.63320.06750.15763.3072QC'd by RTIInactive0
Inactive00040.79150.1294-0.28870.4392-0.0175-0.0588-0.7304-0.2904-0.17490.7250.02090.68410.81330.7915QC'd by RTIInactive0
Inactive0004-1.0594-0.6399-1.1778-1.76740.26960.6449-1.2084-1.8384-0.7619-0.25590.1861-0.8312-0.2106-1.0594QC'd by RTIInactive0
Inactive0004-1.4558-1.36180.1589-0.9035-1.071.7792-1.6997-0.8889-0.17790.07491.8195-0.1972-0.5907-1.4558QC'd by RTIInactive0
Inactive0004-0.0304-1.4787-1.1722-0.27120.44140.4917-1.71340.34570.14040.28480.80640.7581-0.1545-0.0304QC'd by RTIInactive0
Inactive0004-2.6825-1.0617-1.5476-1.3127-0.9478-1.6244-1.7871-1.17-0.13910.1048-0.27550.0134-0.206-2.6825QC'd by RTIInactive0
Inactive0004-1.9162-0.16650.36180.59680.2416-0.2629-0.14790.2580.52380.00220.42311.13820.496-1.9162QC'd by RTIInactive0
Inactive0004-4.4411-2.0964-1.3473-1.9925-0.2696-0.0526-1.7479-1.83010.0787-1.1435-0.2151-1.6448-1.9356-4.4411QC'd by RTIInactive0-4.01013.990.6896
Inactive00040.3147-0.9009-1.1297-1.0908-0.9658-1.0231-1.7115-0.09030.1826-0.6041-0.7798-0.43110.01530.3147QC'd by RTIInactive0
Inactive0004-0.2829-0.483-0.7136-1.3278-0.93860.4253-1.0756-1.0518-0.4337-0.278-0.85420.19240.3514-0.2829QC'd by RTIInactive0
Inactive0-4.06054.95490.7489-13.9075-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-10.7563-1.3008-1.9233-0.9557-0.132.7546-1.3459-1.31-0.4201-0.74070.175-0.64592.6134-10.7563QC'd by RTIInactive0-4.06054.95490.9589
Inactive0004-0.6428-0.0712-1.24-0.1331.26241.72280.49820.02222.27670.06571.8720.74850.262-0.6428QC'd by RTIInactive0
Inactive0004-1.3388-0.5541-0.6778-0.4791-0.3718-1.0111-0.075-0.98380.4258-0.07390.3868-0.69840.2797-1.3388QC'd by RTIInactive0
Inactive0004-0.54060.133-0.8047-1.08660.01250.1279-1.6969-1.53961.1130.84341.7650.29030.1113-0.5406QC'd by RTIInactive0
Inactive0004-0.2103-0.6235-0.2511-1.2402-1.2906-0.2324-1.053-1.10960.0717-0.1818-0.43150.1548-0.3601-0.2103QC'd by RTIInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: ERB865
Protocol: Tox21 Assay Protocol Summary:

ER-beta-UAS-bla HEK293T cells were dispensed at 2,000 cells/4 uL of assay medium containing 2% charcoal stripped FBS per well into black wall/clear-bottom 1536-well plates using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. After the assay plates were incubated at a 37C and 5% CO2 for 6 hr, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a Pintool station (Kalypsys, San Diego, CA), followed by addition of 1 uL (1nM as final concentration) of 17-beta-estradiol (E2) in assay medium using a Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA). The plates were incubated at 37C and 5% CO2 for 16 hr. Then 1 uL of LiveBLAzer B/G FRET substrate was added using a Flying Reagent Dispenser, the plates were incubated at room temperature for 2 hours, and fluorescence intensity was measured by an Envision plate reader (PerkinElmer, Shelton, CT). For cell viability readout that measures cytotoxicity, 4 uL/well of CellTiter-Glo reagent was added into the assay plates using a FRD. After 30 min incubation at room temperature, the luminescence intensity in the plates was measured using a ViewLux (PerkinElmer) plate reader.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000060039 uM-Replicate_1Activity at 0.0000137707 uM-Replicate_1Activity at 0.0000545120 uM-Replicate_1Activity at 0.0001296300 uM-Replicate_1Activity at 0.0003002588 uM-Replicate_1Activity at 0.0006197232 uM-Replicate_1Activity at 0.00170 uM-Replicate_1Activity at 0.00522 uM-Replicate_1Activity at 0.013 uM-Replicate_1Activity at 0.030 uM-Replicate_1Activity at 0.068 uM-Replicate_1Activity at 0.153 uM-Replicate_1Activity at 0.349 uM-Replicate_1Activity at 1.067 uM-Replicate_1Activity at 3.267 uM-Replicate_1Activity at 8.386 uM-Replicate_1Activity at 18.95 uM-Replicate_1Activity at 42.46 uM-Replicate_1Activity at 92.41 uM-Replicate_1Activity at 240.3 uM-Replicate_1Activity at 872.4 uM-Replicate_1Activity at 1849.0 uM-Replicate_1Activity at 4135.0 uM-Replicate_1Activity at 9246.0 uM-Replicate_1Activity at 20670.0 uM-Replicate_1Activity at 46230.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Cytotoxic54.482798.46741Partial curve; high efficacy-4.26370.90.8075-99.7664-1.2994-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-75.5806-1.57380.0757-4.3669-0.08580.8837-2.07050.5718-0.2879-13.9659-38.8135-17.3347-27.0497-75.5806QC'd by LightBiologicalsCytotoxic54.4827102.981641Partial curve; high efficacy-4.26371.96730.9367
Inactive00041.5141-1.9113-3.5463-5.39411.42361.0438-5.162-4.6512-2.509-1.0375-0.0136-6.3139-4.66881.5141QC'd by TCIInactive0
Inactive0004-5.2909-1.4189-0.0563-1.62264.2786-2.02490.1197-10.3519-2.07823.3448-10.1019-7.24683.4883-5.2909QC'd by LightBiologicalsInactive0-4.19854.0950.7223
Inactive0-4.16374.50450.4956-11.2303440 0 0 0 0 0 0 0 0 0 0 0 0 0 0-8.10865.99152.37146.423.98082.5771-0.53458.13273.7773-1.10996.96014.84492.4985-8.1086QC'd by EnamineInactive0
Cytotoxic21.689997.63681Complete curve; high efficacy-4.66372.24810.9841-96.89210.7439-1.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-91.23551.13373.1520.0671-0.77274.38336.3258-2.25132.4042-8.0363-14.4366-32.8612-82.9808-91.2355QC'd by SIGMACytotoxic19.331295.914181Complete curve; high efficacy-4.71372.84730.9728
Inactive0-4.11374.95490.3823-19.0357-140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-13.77980.8598-0.92551.10933.61860.0888-8.681-0.6038-1.11930.4414-3.3017-5.3111-0.9722-13.7798QC'd by LightBiologicalsInactive0
Inactive0-4.06370.90.6778-34.6902-5.873640 0 0 0 0 0 0 0 0 0 0 0 0 0 0-25.5751-2.9046-2.3947-7.3579-11.105-8.7555-8.9507-3.3355-8.0025-7.2273-8.9136-11.5781-10.154-25.5751QC'd by SIGMACytotoxic68.589642.785620Single point of activity-4.16373.57220.8066
Inactive00042.58760.6725-2.9359-7.2635-4.3052-0.7829-1.4404-1.7353-1.0399-0.6015-5.2793.275-1.59522.5876QC'd by SIGMAInactive0
Inactive0-4.61371.96730.9075-28.3787-340 0 0 0 0 0 0 0 0 0 0 0 0 0 0-26.5656-2.7419-0.9215-3.702-3.6215-1.8821-4.56-7.12970.5276-3.7477-7.4177-10.6868-22.5588-26.5656QC'd by SIGMAInactive0-4.36371.210.7615
Inactive00040.7134-7.2842-3.6101-3.2773-9.97390.4057-8.08171.5799-9.0162-0.34720.91731.4105-3.94320.7134QC'd by SIGMAInactive0
Inactive0004-5.3381-8.5857-0.821-1.3318-3.17443.6763-0.5969-2.0359-2.63362.2913-2.67683.23773.2113-5.3381QC'd by SIGMAInactive0-5.31374.95490.3819
Inactive0004-5.3985-1.3878-2.0917-0.3219-3.6756-3.0163-8.4907-1.7807-2.6644-6.85625.4651-4.14-2.4929-5.3985QC'd by EnamineInactive0
Inactive00047.8833-5.82396.0577-2.7756-0.05495.4543-8.3687-2.36592.9533-5.35790.14710.31556.19987.8833QC'd by LightBiologicalsInactive0
Cytotoxic8.634944.891621Partial curve; partial efficacy-5.06373.51170.9334-42.57952.3121-2.20 0 0 0 0 0 0 0 0 0 0 0 0 1 1-10.714.29080.32251.4851.95083.02571.8424-1.67863.24520.5293-14.6068-44.4426-0.5363-10.71QC'd by Alfa AesarInactive0-5.51372.40640.435
Inactive0-5.06374.95490.54335-3.50440 0 0 0 0 0 0 0 0 0 0 0 0 0 1-1.0133-2.1927-2.7516-3.8112-5.4481-3.3296-7.0867-1.6366-1.6868-5.3814-0.635410.7351-0.2666-1.0133QC'd by SIGMAInactive0
Inactive0004-1.8233-1.248-0.5108-1.0616-3.5969-1.91441.2786-1.7754-2.2569-4.0296-4.0835-3.09740.3316-1.8233QC'd by SIGMAInactive0
Inactive0004-5.6337-4.1968-3.1085-7.0605-0.9253-1.1325-2.47321.8848-4.6487-5.7518-0.2753-3.6516-4.811-5.6337QC'd by EnamineInactive0
Cytotoxic3.857133.972921Complete curve; partial efficacy-5.41372.40640.9322-30.88733.0856-1.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-26.7383.09854.3376-0.172712.6919-0.9024-0.5964.135-0.7183-13.4226-24.0456-35.5968-31.6577-26.738QC'd by EnamineCytotoxic3.063831.161120Complete curve; partial efficacy; poor fit-5.51372.25260.9017
Inactive0004-3.863-5.62041.357-0.611411.20944.2553.2050.53130.48081.4119-0.82314.4176-8.0091-3.863QC'd by EnamineInactive0
Inactive0004-6.2068-2.90462.1669-2.389-1.73452.42011.4122-0.7049-2.2362-2.5608-5.4307-7.2141.6501-6.2068QC'd by SIGMAInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: MDA353
Protocol: Assay Protocol Summary:

MDA-kb2 cells (cells cultured without CO2) were dispensed at 3,000 cells/well in 4uL of culture medium into white wall/solid-bottom 1536-well plates (Corning Life Sciences, Corning, NY) using a Multidrop Combi (Thermo Fisher Scientific Inc., Waltham, MA) dispenser. The assay plates were incubated at 37C and 0% CO2 for 5hr. One uL of 3.0uM (final concentration) Nilutamide or assay buffer was added using two separate tips of Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA). Then 23nL of compounds dissolved in DMSO at 15 concentrations and positive controls were transferred to the assay plates using a Pintool station (Wako, San Diego, CA). The assay plates were incubated at 37C and 0% CO2 for 16hr. For luciferase read, 4uL/well ONE-Glo reagent (Promega Corporation, Madison, WI) was added to each well of the assay plates using FRD. After 30min incubation at room temperature, the luminescence signal was measured using a ViewLux plate reader (PerkinElmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000060039 uM-Replicate_1Activity at 0.0000137707 uM-Replicate_1Activity at 0.0000545120 uM-Replicate_1Activity at 0.0001296300 uM-Replicate_1Activity at 0.0003002588 uM-Replicate_1Activity at 0.0006197232 uM-Replicate_1Activity at 0.00170 uM-Replicate_1Activity at 0.00522 uM-Replicate_1Activity at 0.013 uM-Replicate_1Activity at 0.030 uM-Replicate_1Activity at 0.068 uM-Replicate_1Activity at 0.153 uM-Replicate_1Activity at 0.349 uM-Replicate_1Activity at 1.067 uM-Replicate_1Activity at 3.267 uM-Replicate_1Activity at 8.386 uM-Replicate_1Activity at 18.95 uM-Replicate_1Activity at 42.46 uM-Replicate_1Activity at 92.41 uM-Replicate_1Activity at 240.3 uM-Replicate_1Activity at 872.4 uM-Replicate_1Activity at 1849.0 uM-Replicate_1Activity at 4135.0 uM-Replicate_1Activity at 9246.0 uM-Replicate_1Activity at 20670.0 uM-Replicate_1Activity at 46230.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive00040.54890.94311.21581.3802-0.6992-0.12650.4863-0.3361-0.04511.98510.9359-0.42840.05170.5489QC'd by Sigma DiscoveryCPRInactive0
Inactive00040.22720.54660.53610.019-0.0477-2.48180.43240.81670.24650.1297-0.07480.1230.7250.2272QC'd by SIGMAInactive0
Inactive00040.03020.36-0.0472-0.4002-1.46690.21751.1929-0.6658-0.1215-0.9227-1.3549-1.1639-0.50320.0302QC'd by Sigma DiscoveryCPRInactive0
Inactive0-8.86374.95490.3785-0.14464.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-2.62051.20220.89691.2252-0.47330.1289-0.3392-0.51480.7819-0.0391-0.67461.1141-0.554-2.6205QC'd by Sigma DiscoveryCPRInactive0-4.91371.88510.6543
Inactive0004-4.2506-0.2907-0.3058-1.2276-0.74350.5227-0.8355-0.6453-0.7287-0.7633-0.4184-1.4496-1.488-4.2506QC'd by Sigma DiscoveryCPRInactive0-5.01374.44950.3655
Inactive0004-0.9838-0.0259-0.41640.0209-1.3922-0.20740.0063-0.8086-0.3985-0.6379-0.1051-0.10581.8952-0.9838QC'd by Sigma DiscoveryCPRInactive0
Inactive0-5.46372.33320.49363.50.164340 0 0 0 0 0 0 0 0 0 0 0 0 0 10.50061.1162-0.0949-0.4648-1.1131-0.0498-0.01220.64650.74220.39286.6873.36141.18420.5006QC'd by Sigma DiscoveryCPRInactive0-5.71370.90.4927
Inactive0004-1.2699-0.17431.0209-0.8316-0.8931-0.8729-0.3447-1.06410.66130.0346-0.2705-0.2823-0.2655-1.2699QC'd by Sigma DiscoveryCPRInactive0
Inactive00041.63380.2632-0.1682-1.8681-0.15550.07330.9595-0.18930.1121-0.17530.27070.24330.08351.6338QC'd by Sigma DiscoveryCPRInactive0
Inactive0004-0.1022-0.0901-1.77630.3997-0.4370.0202-0.0794-0.1706-0.2473-0.1126-0.304-0.14080.1468-0.1022QC'd by Sigma DiscoveryCPRInactive0
Inactive00040.14390.1634-0.0081-0.29640.2279-1.40430.06961.44370.63270.24350.4155-0.0447-0.30080.1439QC'd by Sigma DiscoveryCPRInactive0
Inactive00040.91740.28160.42940.5116-0.2905-0.13380.9388-0.67860.2228-0.34740.43650.60821.07650.9174QC'd by Sigma DiscoveryCPRInactive0
Inactive00040.0811-0.74471.2464-0.1464-1.09160.2604-1.8599-1.2678-0.98380.5826-0.4458-0.41250.42630.0811QC'd by Sigma DiscoveryCPRInactive0
Inactive0004-0.5705-0.1686-0.1249-1.01131.3525-0.4945-0.7228-0.4784-0.55280.5530.17750.0797-0.3849-0.5705QC'd by Sigma DiscoveryCPRInactive0
Inactive00040.6427-0.304-1.4519-1.049-2.1818-1.23061.36350.0101-1.14820.573-2.5209-1.9114-1.24060.6427QC'd by Sigma DiscoveryCPRInactive0
Inactive0004-0.1740.25861.0471-0.32510.04440.02170.4962-0.11712.14790.2275-0.31460.56330.2942-0.174QC'd by Sigma DiscoveryCPRInactive0
Inactive0004-0.69580.0944-0.6743-1.0622-0.6998-1.51080.1198-0.16380.37030.0746-0.0508-0.68630.3826-0.6958QC'd by Sigma DiscoveryCPRInactive0
Inactive0004-0.82610.46050.59140.55141.73351.2233-0.6602-1.23950.002-0.63670.36011.8197-0.7372-0.8261QC'd by SIGMAInactive0
Inactive0004-0.49310.60180.00370.4461-0.07590.0021.783-1.0125-0.23881.66740.05520.8842-0.0783-0.4931QC'd by Sigma DiscoveryCPRInactive0
Inactive00043.00440.20360.0940.37190.4399-1.66030.1542-0.1420.25990.9742-0.0562-1.48281.46873.0044QC'd by Sigma DiscoveryCPRInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: ERB503
Protocol: Tox21 Assay Protocol Summary:

ER-beta-UAS-bla HEK293T cells were dispensed at 2,000 cells/5 uL of assay medium containing 2% charcoal stripped FBS per well into black wall/clear-bottom 1536-well plates using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. After the assay plates were incubated at a 37C and 5% CO2 for 6 hr, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a Pintool station (Kalypsys, San Diego, CA). The plates were incubated at 37C and 5% CO2 for 16 hr. Then 1 uL of LiveBLAzerTM B/G FRET substrate was added using a BioRAPTR FRD (Flying Reagent Dispenser, Aurora Discovery, San Diego, CA) and then the plates were incubated at room temperature for 2 hours, and fluorescence intensity was measured by an Envision plate reader (PerkinElmer, Shelton, CT). For cell viability readout that measures cytotoxicity, 4 uL/well of CellTiter-Glo reagent was added into the assay plates using a FRD. After 30 min incubation at room temperature, the luminescence intensity in the plates was measured using a ViewLux (PerkinElmer) plate reader.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000060039 uM-Replicate_1Activity at 0.0000137707 uM-Replicate_1Activity at 0.0000545120 uM-Replicate_1Activity at 0.0001296300 uM-Replicate_1Activity at 0.0003002588 uM-Replicate_1Activity at 0.0006197232 uM-Replicate_1Activity at 0.00170 uM-Replicate_1Activity at 0.00522 uM-Replicate_1Activity at 0.013 uM-Replicate_1Activity at 0.030 uM-Replicate_1Activity at 0.068 uM-Replicate_1Activity at 0.153 uM-Replicate_1Activity at 0.349 uM-Replicate_1Activity at 1.067 uM-Replicate_1Activity at 3.319 uM-Replicate_1Activity at 8.387 uM-Replicate_1Activity at 18.95 uM-Replicate_1Activity at 42.46 uM-Replicate_1Activity at 92.41 uM-Replicate_1Activity at 240.3 uM-Replicate_1Activity at 872.4 uM-Replicate_1Activity at 1849.0 uM-Replicate_1Activity at 4135.0 uM-Replicate_1Activity at 9246.0 uM-Replicate_1Activity at 20670.0 uM-Replicate_1Activity at 46230.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive00042.972.88326.47062.1363-2.16331.00464.59080.39126.5556-2.3474-0.87142.54870.08392.97QC'd by ACCInactive0-6.67514.95490.5442
Inactive00040.5350.01185.08236.6894-2.83886.60320.74213.06760.56843.59451.53423.35230.570.535QC'd by ACCInactive0
Cytotoxic16.785551.766341Partial curve; high efficacy-4.77511.96730.9511-49.21952.5468-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-41.8332.4553-0.79053.75880.61832.4096-2.95462.52637.23135.6149-0.8857-4.1307-32.4926-41.833QC'd by ACCCytotoxic13.333232.057720Complete curve; partial efficacy; poor fit-4.87512.40640.7816
Inactive00044.8742-3.77236.45560.81761.88280.1512-0.27585.45331.6155-1.0468-0.2131.92932.95324.8742QC'd by ACCInactive0
Inactive000415.6930.7183-0.11986.019711.490215.82621.48814.68990.4711-0.39296.8542.18441.328415.693QC'd by RTIInactive0
Cytotoxic67.057923.840120Single point of activity-4.17353.67720.7942-22.34011.5-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-16.53342.48473.661-0.05144.01271.90751.4476-1.57141.9265-2.00821.8603-1.5621-1.0884-16.5334QC'd by RTIInactive0-4.37351.3310.5963
Inactive0-4.07734.95490.37214.5-0.497440 0 0 0 0 0 0 0 0 0 0 0 0 0 011.27740.11051.968-2.97838.9088-6.2478-4.2038-6.1046-0.8717-2.1042.9505-0.50270.572811.2774QC'd by RTIInactive0
Inactive00044.65681.57610.0207-2.38942.68573.1295-4.55466.150.3227.31515.71780.74434.80294.6568QC'd by RTIInactive0
Inactive0004-2.69982.65840.05919.3073-1.98643.92790.55299.88943.8422.40784.21170.1276-0.0303-2.6998QC'd by RTIInactive0-3.73464.95490.8232
Cytotoxic69.934136.549620Single point of activity-4.15534.0950.8241-31.54965-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-25.4581.04496.28391.20649.97986.88734.03357.49861.33357.77021.21630.40650.0839-25.458QC'd by RTICytotoxic49.509535.543720Partial curve; partial efficacy-4.30533.06540.925
Inactive0-4.07871.92820.6237-19.95883.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-13.2998.99010.8006-0.74874.47387.44134.60514.95850.264-0.69926.3288-2.3747-1.9732-13.299QC'd by RTIInactive0-4.07872.30310.5512
Inactive0-4.64341.39870.4991-12.80922.540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-2.66416.02610.40390.58611.4723-1.45019.29322.6348-0.40822.4913-1.1963-3.4391-9.0076-2.6641QC'd by RTIInactive0-5.99340.80.6583
Cytotoxic48.969983.327541Partial curve; high efficacy-4.31012.25260.9888-84.6803-1.3528-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-71.3487-1.8036-0.34751.3619-1.8874-4.23380.8828-4.9722-3.3524-0.7752-3.7746-9.8462-40.2099-71.3487QC'd by RTICytotoxic61.649595.905641Partial curve; high efficacy-4.21012.40640.9558
Inactive0-8.79174.95490.4601-0.8071840 0 0 0 0 0 0 0 0 0 0 0 0 0 0-1.33585.9272-1.3207-4.42262.1299-1.38811.2216-2.64721.77090.2031.4426-1.3341-1.8084-1.3358QC'd by RTIInactive0
Cytotoxic4.432628.711921Partial curve; partial efficacy-5.35330.60.8795-25.21193.5-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-23.92669.9868-1.68771.30887.1854-1.39420.1808-1.6954-2.619-9.1625-16.8059-15.3337-16.6639-23.9266QC'd by RTIInactive0
Cytotoxic54.894727.749220Partial curve; partial efficacy-4.26052.33320.8047-28.7492-1-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-23.541-4.36030.0474.3742-3.65681.74160.5496-3.95381.7444-3.8059-5.328-0.3209-12.4078-23.541QC'd by RTIInactive0-6.21053.92950.6436
Inactive0-7.85262.33320.79081.360511.540 0 0 0 0 0 0 0 0 0 0 0 0 0 04.592910.846511.65123.99974.8938-0.4469-0.51530.3031-0.49631.45553.36172.73860.00424.5929QC'd by RTIInactive0
Cytotoxic71.462749.8741Partial curve; high efficacy-4.14592.58840.9524-50.3956-0.5256-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-38.17851.15271.5533-0.1776-0.017-0.94720.51311.0375-5.92151.1976-3.0279-5.9943-12.5012-38.1785QC'd by RTICytotoxic56.764836.732421Partial curve; partial efficacy-4.24593.06540.8003
Inactive0-4.79513.51170.82778-1.705940 0 0 0 0 0 0 0 0 0 0 0 0 0 1-1.0309-0.7532-2.5477-0.3524-2.1636-1.6162-0.1879-0.368-0.7614-1.7456-2.55596.65266.8055-1.0309QC'd by RTIInactive0-8.74514.95490.3472
Inactive0004-2.21011.56120.96470.50555.05080.2134-1.3456-0.70580.46312.03690.385-0.62421.5304-2.2101QC'd by RTIInactive0-4.06414.95490.3698
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: TSHR689
Protocol: Tox21 Assay Protocol Summary:

Hek293 cells (wild type) were dispensed at 800 cells/4 uL/well in 1536-well white plates using a Multidrop dispenser. After the assay plates were incubated at a 37 C/5% CO2 incubator for 18 hrs, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a pin tool, followed by 1 ul medium containing Ro20-1724. After 30 min of incubation at room temperature, 2.5 ul/well of cAMP-d2 and 2.5 ul/well of anti-cAMP-cryptate were added respectively into the assay plates using a Flying Reagent Dispenser. The plates were incubated at room temperature for 1 hr. The fluorescence intensity in the plates was measured using an Envision plate reader. Each test compound was measured at 15 concentrations and in triplicates.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000060039 uM-Replicate_1W530-Activity at 0.0000137707 uM-Replicate_1W530-Activity at 0.0000545120 uM-Replicate_1W530-Activity at 0.0001296300 uM-Replicate_1W530-Activity at 0.0003002588 uM-Replicate_1W530-Activity at 0.0006197232 uM-Replicate_1W530-Activity at 0.00170 uM-Replicate_1W530-Activity at 0.00522 uM-Replicate_1W530-Activity at 0.013 uM-Replicate_1W530-Activity at 0.030 uM-Replicate_1W530-Activity at 0.068 uM-Replicate_1W530-Activity at 0.153 uM-Replicate_1W530-Activity at 0.349 uM-Replicate_1W530-Activity at 1.067 uM-Replicate_1W530-Activity at 3.267 uM-Replicate_1W530-Activity at 8.386 uM-Replicate_1W530-Activity at 18.95 uM-Replicate_1W530-Activity at 42.51 uM-Replicate_1W530-Activity at 92.41 uM-Replicate_1W530-Activity at 240.3 uM-Replicate_1W530-Activity at 872.4 uM-Replicate_1W530-Activity at 1849.0 uM-Replicate_1W530-Activity at 4135.0 uM-Replicate_1W530-Activity at 9246.0 uM-Replicate_1W530-Activity at 20670.0 uM-Replicate_1W530-Activity at 46230.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inactive10004-3.0663-1.2139-0.0854-1.9823-2.1614-0.5201-1.8826-1.2822-0.358-0.1646-1.6798-1.1004-1.8736-3.066310-7.87514.95490.3303-1.71512.540 0 0 0 0 0 0 0 0 0 0 0 0 0 17.8365
Inactive10004-1.4036-0.26070.11340.5472-2.0544-1.225-1.3445-2.9525-2.1629-0.9379-2.38880.2341-1.927-1.4036100040.9961
Inactive10004-1.28153.01084.91375.45190.39644.91691.24584.93830.76061.44551.00620.24652.6887-1.2815100042.3404
Inactive10004-2.4213-3.9312-5.6275-3.4204-5.1213-1.1733-2.9641-3.4724-1.3431-5.4545-4.4871-0.3746-5.0849-2.4213100040.2407
Inactive100041.79982.5121-2.2673-1.4041.5388-0.0214-2.1265-2.1178-1.6925-1.9377-0.5952-2.716-1.8631.799810004-0.3545
Inactive10-5.07353.990.46114-1.243840 0 0 0 0 0 0 0 0 0 0 0 0 0 1-2.1109-1.5754-4.7865-0.47160.0872-2.16050.5655-1.7123-0.2686-0.2050.63497.04930.9843-2.110910-5.92353.67720.36830.5-2.927840 0 0 0 0 0 0 0 0 0 0 0 0 0 01.3637
Inactive100040.3166-5.9645-6.3846-4.40690.03450.4228-0.0605-0.5418-0.9331-2.4488-4.6795-0.90990.07940.316610004-5.9957
Inactive10004-0.2517-0.6611-3.3538-5.8187-0.4916-1.0524-1.711-0.5869-3.2531-3.18340.8537-1.33460.4483-0.251710-8.22994.95490.4694-0.5-6.255840 0 0 0 0 0 0 0 0 0 0 0 0 0 1-8.8034
Inactive100045.64691.8384-2.355-5.7250.1522.23876.97363.73474.057-5.7619-1.43253.7675.34195.6469100044.5869
Inactive100040.2889-0.9361-1.12030.3722-1.86460.7109-1.265-0.58692.1048-0.45170.0461.3396-2.7310.2889100042.7079
Inactive10-4.92873.51170.4249-8.2886-140 0 0 0 0 0 0 0 0 0 0 0 0 0 1-1.9442-0.6991-5.7405-0.48321.12930.0775-0.2255-2.5734-2.32541.0513-2.2996-13.9905-2.8369-1.944210004-4.2171
Inactive10-4.14343.51170.709-18.5941-2.014840 0 0 0 0 0 0 0 0 0 0 0 0 0 0-14.2451-1.5055-1.2677-8.616-0.9268-4.0357-0.0123-1.3467-0.9898-1.955-2.0906-1.3182-4.2466-14.245110-8.79344.95490.3326-3.6327740 0 0 0 0 0 0 0 0 0 0 0 0 0 0-5.487
Inactive10004-0.2845-4.8907-0.7431-4.3711-2.6769-1.6687-1.7184-0.50980.5747-6.2473-1.356-1.4775-3.2074-0.284510-8.76014.95490.44890.5-15.480340 0 0 0 0 0 0 0 0 0 0 0 0 0 04.312
Inactive10004-2.7219-7.45-2.7471-5.3639-1.75550.2107-2.2961-2.07670.3245-1.0144-2.9189-9.9156-1.556-2.721910004-3.652
Inactive100040.7555-1.896-0.1519-0.7503-1.6356-0.18940.5892-0.1494-1.8119-0.7221.8616-8.93711.69370.755510004-2.9671
Inactive100042.48020.4503-3.1263-0.704-0.86512.98830.1718-6.8956-0.217-1.53521.4170.55751.62192.480210-4.51054.95490.46359-1.116140 0 0 0 0 0 0 0 0 0 0 0 0 0 1-0.1427
Inactive10-6.30264.95490.5948-0.5-5.793540 0 0 0 0 0 0 0 0 0 0 0 0 0 01.0221-4.0115-8.0089-1.2192-6.7786-4.8261-8.0396-5.65730.2387-0.15620.0233-3.8476-0.71981.022110-8.00264.95490.4738-1.5-9.951840 0 0 0 0 0 0 0 0 0 0 0 0 0 0-3.0396
Inactive100049.10630.75840.99910.2579-2.8153-1.40326.80085.9618-1.33523.47070.9883-1.8677-0.91039.1063100043.426
Inactive10004-1.78354.8542-4.7980.2603-1.34121.2338-0.88077.01475.94072.5857.3437-0.696-2.4978-1.783510004-8.094
Inactive10004-4.3329-3.17571.873-1.8054-0.9814-15.25620.6444-0.76751.6708-8.5344-1.4479-1.03022.35-4.332910-7.61413.51170.3586-1.24333.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.9177
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: RAR458
Protocol: Tox21 Assay Protocol Summary:

C3RL4 cells were seeded at 1,000/well in 4 uL of assay medium into white solid 1,536-well tissue culture plates (Greiner Bio-One North America Inc. Monroe, NC) using a Multidrop Combi (Thermo Scientific, Waltham, MA) dispenser. After incubation at 37 C and 5% CO2 for an overnight, 23 nL of compounds dissolved in DMSO, positive control or DMSO only were transferred by a Pintool station (Kalypsys, San Diego, CA). One ul of 1 uM (final concentration) of Retinol was added right after the compound addition by using a Flying Reagent Dispenser (FRD) (Aurora Discovery, San Diego, CA). After 6 hr incubation at 37 C and 5% CO2, 5 uL of CellTiter-Glo reagent (Promega Corporation, Madison, WI) was added to each assay plate using an FRD. Luminescence was quantified on a ViewLux plate reader (PerkinElmer, Waltham, MA) after 30 min incubation at room temperature.
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000060039 uM-Replicate_1Activity at 0.0000137707 uM-Replicate_1Activity at 0.0000545120 uM-Replicate_1Activity at 0.0001296300 uM-Replicate_1Activity at 0.0003002588 uM-Replicate_1Activity at 0.0006197232 uM-Replicate_1Activity at 0.00170 uM-Replicate_1Activity at 0.00522 uM-Replicate_1Activity at 0.013 uM-Replicate_1Activity at 0.030 uM-Replicate_1Activity at 0.068 uM-Replicate_1Activity at 0.153 uM-Replicate_1Activity at 0.349 uM-Replicate_1Activity at 1.067 uM-Replicate_1Activity at 3.267 uM-Replicate_1Activity at 8.386 uM-Replicate_1Activity at 18.95 uM-Replicate_1Activity at 42.46 uM-Replicate_1Activity at 92.41 uM-Replicate_1Activity at 240.3 uM-Replicate_1Activity at 872.4 uM-Replicate_1Activity at 1849.0 uM-Replicate_1Activity at 4135.0 uM-Replicate_1Activity at 9246.0 uM-Replicate_1Activity at 20670.0 uM-Replicate_1Activity at 46230.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive044.19840.81740.61071.710.46743.44731.66050.58852.88011.54270.54160.28592.84574.1984QC'd by SigmaAldrichInactive0-4.15593.67720.4278
Inactive042.35792.38861.30431.895-0.2081.0111-1.25010.90453.49910.86383.51682.38145.06272.3579QC'd by SigmaAldrichInactive0-5.22810.80.3828
Inactive040.2744-0.58080.3848-0.44832.3657-0.89660.42280.1944-0.1731-0.5589-0.3414-0.63370.55930.2744QC'd by SigmaAldrichInactive0-4.41290.60.5114
Inactive046.38473.53381.3473.22054.52743.4665.98781.4531-0.88632.67991.5890.87493.53946.3847QC'd by SigmaAldrichInactive0
Inactive04-1.75591.8704-0.42220.14353.26874.99330.5039-0.0673-0.35783.93891.93520.25450.1757-1.7559QC'd by SigmaAldrichInactive0-4.9523.51170.5333
Inactive0-4.46294.95490.78434-0.509940 0 0 0 0 0 0 0 0 0 0 0 0 0 03.8411-0.7845-0.805-1.0956-0.5774-0.54050.2457-0.9217-0.5954-0.92550.6598-0.98343.01963.8411QC'd by SIGMAInactive0-4.56294.95490.8474
Inactive042.351.75622.23352.70980.7891-0.6221-0.37380.07163.07352.24645.7547-0.5813.16092.35QC'd by SIGMAInconclusive77.193712.228110Partial curve; partial efficacy; poor fit-4.11244.95490.7902
Inactive042.84370.49293.46461.36351.08784.60353.07480.68312.68684.8682.72730.67151.64932.8437QC'd by SIGMAInactive0-4.21734.0450.7607
Inactive040.63051.70170.68853.2432-0.86063.361-0.7545-0.32243.51422.76251.31425.89682.13050.6305QC'd by SIGMAInactive0
Inactive042.40252.33270.0176-0.33091.84172.4555-1.1503-0.95852.82551.81230.07514.58971.70762.4025QC'd by SIGMAInactive0-5.56643.06540.3718
Inactive04-2.07820.6506-9.47250.9701-0.94660.79570.33650.44370.8503-0.10152.1121-0.44020.7923-2.0782QC'd by Research BiochemicalInactive0-4.31513.92950.544
Inactive043.2138-0.1613-26.46152.77610.26411.46643.30912.68872.61263.419-0.80344.47052.70263.2138QC'd by SigmaAldrichInactive0-4.86683.92950.4464
Inactive042.77764.146200.2939-0.20375.81580.38834.29861.48242.47910.64592.74394.70822.7776QC'd by SIGMAInactive0
Inactive049.1785.48642.59015.24810.29281.57552.86492.89073.9912.75371.78624.23019.01699.178QC'd by ChromaDexInconclusive19.508212.318510Partial curve; partial efficacy; poor fit-4.70984.95490.7747
Inactive042.721-0.59541.15290.79470.248-1.14182.33511.58550.46120.6711-0.49172.55563.36622.721QC'd by SIGMACytotoxic68.659415.071420Partial curve; partial efficacy; poor fit-4.16334.95490.7753
Inactive042.46583.04981.39170.97233.14483.34690.08153.17310.08882.37131.46830.51872.50964.73082.4658QC'd by SigmaAldrichInactive0-4.23951.75290.4448
Inactive046.32162.259-1.35232.53611.79770.16691.3261-0.7698-0.93843.04862.2056-0.32272.66196.3216QC'd by SensientInactive0-4.1624.95490.6765
Inactive042.0501-0.39790.48361.45892.8555-0.06130.91930.96971.69930.51483.13773.88840.66272.0501QC'd by Pfaltz-BauerCytotoxic67.475118.559120Partial curve; partial efficacy; poor fit-4.17094.95490.9406
Inactive0-8.359310.38220.5-3.125740 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.325-1.9022-1.42190-1.43951.57381.0888-0.46842.246-0.6184-0.00642.4334-1.4676-0.325QC'd by SigmaAldrichInactive0
Inactive043.5892-1.78554.6233-0.41212.919-1.9374-0.09423.68940.6548-0.16411.90493.65050.42063.5892QC'd by SigmaAldrichInactive0-4.10764.95490.6284
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: RORG546
Protocol: Tox21 Assay Protocol Summary:

Tet-on ROR gamma CHO cells were dispensed at 1,000 cells in 4 uL of culture medium per well into white wall/solid bottom 1536-well plates using a Multidrop Combi (Thermo Scientific, Waltham, MA) dispenser. Following incubation at 37 C and 5% CO2 for 4 hr, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only were transferred by a Pintool station (Kalypsys, San Diego, CA) and after 2 hr incubation at 37 C, one ul of 1 uM (final concentration) of Doxycycline Hyclate was added to all the wells by using a Flying Reagent Dispenser (FRD) (Aurora Discovery, San Diego, CA). After 16 hr incubation at 37 C and 5% CO2, 5 uL of ONE-Glo reagent (Promega Corporation, Madison, WI) was added to each assay plate using FRD. After 30 min incubation at room temperature, luminescence was quantified on a ViewLux plate reader (Perkin Elmer, Waltham, MA).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000060039 uM-Replicate_1Activity at 0.0000137707 uM-Replicate_1Activity at 0.0000545120 uM-Replicate_1Activity at 0.0001296300 uM-Replicate_1Activity at 0.0003002588 uM-Replicate_1Activity at 0.0006197232 uM-Replicate_1Activity at 0.00170 uM-Replicate_1Activity at 0.00522 uM-Replicate_1Activity at 0.013 uM-Replicate_1Activity at 0.030 uM-Replicate_1Activity at 0.068 uM-Replicate_1Activity at 0.153 uM-Replicate_1Activity at 0.350 uM-Replicate_1Activity at 1.067 uM-Replicate_1Activity at 3.267 uM-Replicate_1Activity at 8.386 uM-Replicate_1Activity at 18.95 uM-Replicate_1Activity at 42.46 uM-Replicate_1Activity at 92.41 uM-Replicate_1Activity at 240.3 uM-Replicate_1Activity at 872.4 uM-Replicate_1Activity at 1849.0 uM-Replicate_1Activity at 4135.0 uM-Replicate_1Activity at 9246.0 uM-Replicate_1Activity at 20670.0 uM-Replicate_1Activity at 46230.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inhibitor49.05252.290510Partial curve; partial efficacy; poor fit-4.30933.51170.7447-53.4626-1.1721-2.40 0 0 0 0 0 0 0 1 0 0 0 0 0 0-48.4565-6.5655-0.21864.6059-0.08457.2703-4.3257-18.23898.80026.174.36268.2645-21.1759-48.4565QC'd by SigmaAldrichInactive0
Inhibitor4.402691.020884Complete curve; high efficacy-5.35632.40640.9509-87.06483.956-1.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-77.16530.1518-2.05291.349318.89120.529920.6956-12.79642.9114-37.9562-68.2271-89.3771-92.3342-77.1653QC'd by SIGMAInhibitor27.778875.086340Partial curve; high efficacy-4.55632.63840.8645
Inactive044.36181.9749-3.053514.1135-10.94872.31219.36143.82743.72247.0289-0.1024.10518.4444.3618QC'd by SIGMAInactive0
Activator38.178927.93990Partial curve; partial efficacy; poor fit-4.41820.50.693326-1.93992.40 0 0 0 0 0 0 0 0 0 0 0 0 0 019.3487-3.1547-4.4877-1.06876.6583-3.83090.49290.01373.0716-0.0479.004611.71736.706519.3487QC'd by SigmaAldrichInactive0
Inactive041.26710.7291-17.7921-18.43863.9638-18.1304-22.40611.170.6933-4.32975.7922-3.204712.15441.267QC'd by SIGMAInactive0
Inhibitor34.936353.603920Partial curve; partial efficacy-4.45670.60.7226-50.10393.5-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-39.57524.06274.74170.11663.331612.69693.3972-10.6185-6.2545-17.4730.0552-11.9775-23.8081-39.5752QC'd by SIGMAInhibitor0.621337.906710Single point of activity-6.20674.95490.4582
Inactive049.7169-12.61947.8434.54820.8821-6.25540.635-3.832-11.1834-1.9019-3.1185-9.77943.71639.7169QC'd by SIGMAActivator0.345242.50640Partial curve; partial efficacy; poor fit-6.4621.34430.9358
Inactive047.8302-1.65491.5524-10.50984.678617.914627.1116-9.54143.16018.9997-7.023714.326923.27627.8302QC'd by SIGMAInactive0
Inactive0-5.17584.95490.350213-1.60340 0 0 0 0 0 0 0 0 0 0 0 0 0 010.16469.31924.50262.2944-19.2525-0.3054-1.4947-0.585-8.0109-6.67269.620512.700416.320310.1646QC'd by SIGMAInactive0
Inactive047.48571.6547-2.1022-7.419-1.0147-3.574-11.28852.7224-9.2621-1.0362-0.41619.9475-2.61217.4857QC'd by SIGMAInactive0
Inactive04-3.15790.621921.70495.4859-4.45746.07514.95646.37136.277310.83084.364733.8872-1.7853-3.1579QC'd by SigmaAldrichInactive0
Inhibitor27.333881.747380Complete curve; high efficacy-4.56334.95490.8231-83.3148-1.5675-1.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-78.7881-20.89878.9543-7.8089-5.10046.201824.1834-4.4945-7.5451-0.24025.1765-0.0241-80.3142-78.7881QC'd by SIGMAInhibitor30.66981.982880Complete curve; high efficacy-4.51334.0950.8888
Inactive0-5.1123.92950.567316.1813-4.929540 0 0 0 0 0 0 0 0 0 0 0 0 0 021.0882-5.78993.0486-9.6822-14.0319-8.10110.9167-6.106-1.4768-6.05424.318928.6932-0.152121.0882QC'd by SigmaAldrichInactive0
Inactive04-7.451-12.7892-2.666-22.2199-23.57165.6413-28.211-6.5094-12.246.6205-25.0316-2.7113-23.7825-7.451QC'd by SensientInactive0-8.21421.98870.3398
Inhibitor60.013360.600221Partial curve; partial efficacy-4.22181.88510.7198-61.7176-1.1174-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-46.33351.9305-0.4958-1.46130.39956.8118-7.7557-6.71384.1637-1.281-17.5678-6.6178-18.0251-46.3335QC'd by ChemServiceInhibitor30.077941.837610Partial curve; partial efficacy; poor fit-4.52182.24810.5191
Inactive041.1852.41947.7431-8.6915-13.25924.166624.40538.0463-2.4083-5.2754-0.392-2.2415-2.21741.185QC'd by SigmaAldrichInactive0
Inactive0414.9196-1.6699-7.38511.58271.335521.274614.6941-22.1665-5.6177-1.6591-14.8760.624514.174614.9196QC'd by SigmaAldrichInactive0
Inactive0-5.68134.95490.62610.129-23.505640 0 0 0 0 0 0 0 0 0 0 0 0 0 07.1674-29.4543-29.2053-22.8439-32.1498-5.6986-23.3689-17.7264-22.708810.2778-1.251-1.9883-14.11247.1674QC'd by SigmaAldrichInactive0-7.08134.95490.4729
Inhibitor53.376438.45710Partial curve; partial efficacy; poor fit-4.27272.84730.6164-38.34320.1138-2.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0-31.21426.9587-2.56150.107611.41971.7188-2.11961.426-3.2247-17.01760.79460-12.047-31.2142QC'd by SigmaAldrichInactive0-6.22274.95490.4104
Inactive0414.4855-4.9827-1.5361-12.1699-0.551331.7187-6.478916.6704-5.02080.2532-5.05540.2144-8.916914.4855QC'd by SigmaAldrichInactive0-5.20764.95490.6159
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: RORG807
Protocol: Tox21 Assay Protocol Summary:

Tet-on ROR gamma CHO cells were dispensed at 1,000 cells in 4 uL of culture medium per well into white wall/solid bottom 1536-well plates using a Multidrop Combi (Thermo Scientific, Waltham, MA) dispenser. Following incubation at 37 C and 5% CO2 for 4 hr, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only were transferred by a Pintool station (Kalypsys, San Diego, CA) and after 2 hr incubation at 37 C, one ul of 1 uM (final concentration) of Doxycycline Hyclate was added to all the wells by using a Flying Reagent Dispenser (FRD) (Aurora Discovery, San Diego, CA). After 16 hr incubation at 37 C and 5% CO2, 5 uL of CellTiter-Glo reagent (Promega Corporation, Madison, WI) was added to each assay plate using FRD. After 30 min incubation at room temperature, luminescence was quantified on a ViewLux plate reader (Perkin Elmer, Waltham, MA).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000060039 uM-Replicate_1Activity at 0.0000137707 uM-Replicate_1Activity at 0.0000545120 uM-Replicate_1Activity at 0.0001296300 uM-Replicate_1Activity at 0.0003002588 uM-Replicate_1Activity at 0.0006197232 uM-Replicate_1Activity at 0.00170 uM-Replicate_1Activity at 0.00522 uM-Replicate_1Activity at 0.013 uM-Replicate_1Activity at 0.030 uM-Replicate_1Activity at 0.068 uM-Replicate_1Activity at 0.153 uM-Replicate_1Activity at 0.349 uM-Replicate_1Activity at 1.067 uM-Replicate_1Activity at 3.267 uM-Replicate_1Activity at 8.386 uM-Replicate_1Activity at 18.95 uM-Replicate_1Activity at 42.46 uM-Replicate_1Activity at 92.41 uM-Replicate_1Activity at 240.3 uM-Replicate_1Activity at 872.4 uM-Replicate_1Activity at 1849.0 uM-Replicate_1Activity at 4135.0 uM-Replicate_1Activity at 9246.0 uM-Replicate_1Activity at 20670.0 uM-Replicate_1Activity at 46230.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive04-19.1608-1.73761.9578-7.73362.54092.9490.0075-7.2196-6.0768-12.9605-0.8606-0.21330.3339-19.1608QC'd by SensientInactive0
Inactive04-1.9553-7.5019-11.6744-5.0823-11.6277-2.6848-3.5935-2.1944-8.57246.152-4.67440.6885-5.5821-1.9553QC'd by SIGMAInactive0
Inactive0-5.55854.95490.42692-5.270640 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.9853-6.2148-4.8285-7.0705-4.116-6.152-2.7114-0.871-8.91937.0137-3.99973.17034.7573-0.9853QC'd by SigmaAldrichInactive0
Inactive04-1.0568-3.5164-7.9877-13.4472-7.1786-6.2522-2.2235-4.5774-9.8155-4.7272-1.16210.1813-2.2502-1.0568QC'd by SigmaAldrichInactive0-8.81110.60.5691
Inactive04-3.9415-4.0839-8.8644-10.3094-5.0198-4.51523.6045-3.8915-3.7901-11.6178-5.9741.2583-4.2222-3.9415QC'd by SigmaAldrichInactive0
Inactive0-4.86553.06540.32861-8.45340 0 0 0 0 0 0 0 0 0 0 0 0 0 01.5238-10.4074-8.4375-15.5721-8.8024-4.407-8.5409-6.4118-5.6897-6.8166-7.789-1.02050.32871.5238QC'd by SigmaAldrichInactive0
Inactive0-5.78864.95490.4051-4.14652.540 0 0 0 0 0 0 0 0 0 0 0 0 0 11.5974-0.15921.63421.83692.99857.25020.2725-1.14726.5927-6.4795-6.03531.1265-1.01721.5974QC'd by Alfa AesarInactive0-7.63864.95490.5129
Inactive0-4.71553.06540.4493-11.2115-140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-13.093-3.9753-0.10680.52724.818-10.6870.8331-5.8571.35231.61440.7819-7.4719-8.0088-13.093QC'd by SigmaAldrichInactive0-7.71553.1320.9353
Inactive0-6.26070.20.459910-19.468640 0 0 0 0 0 0 0 0 0 0 0 0 0 1-4.8191-11.7345-12.5819-11.8859-3.2224-7.0785-11.1062-4.473-6.90033.2009-1.788-3.2996.622-4.8191QC'd by SIGMAInactive0-4.16073.67720.6326
Inactive04-3.9788-7.839-8.6602-6.4937-6.6707-2.4256-6.3094-4.9852-6.02375.2777-7.6631.0966-2.4416-3.9788QC'd by SIGMAInactive0-4.25021.88510.8295
Inactive04-3.6685-7.3987-8.0787-13.6148-8.775-1.3387-0.61-3.2054-9.4839-11.03122.49512.5033-5.2431-3.6685QC'd by SIGMAInactive0-4.70720.80.4468
Inactive0-4.96420.30.39175-12.193140 0 0 0 0 0 0 0 0 0 0 0 0 0 01.072-12.1359-8.956-13.3502-3.7408-7.5801-9.8498-7.5398-10.2212.8639-7.3688-4.5818-1.30251.072QC'd by SIGMAInactive0
Inactive0-7.68724.95490.52680.5-9.819840 0 0 0 0 0 0 0 0 0 0 0 0 0 04.189-7.4859-11.4068-13.18320.2936-4.54241.72962.5401-10.07617.70820.04610.5328-2.97784.189QC'd by SIGMAInactive0-7.087210.4454
Inactive0-8.29850.30.3573-1-19.845740 0 0 0 0 0 0 0 0 0 0 0 0 0 00.3784-12.941-12.0807-10.2141-1.5728-7.81411.5253-6.4465-7.3168-12.5144-1.9321-0.3956-1.09110.3784QC'd by SIGMAInactive0
Inactive04-22.43-2.7046-6.6594-2.5768-6.5957-6.29033.0738-6.7374-0.4009-7.1207-16.42455.3488-13.4947-22.43QC'd by SigmaAldrichCytotoxic21.227625.075820Complete curve; partial efficacy-4.67314.95490.801
Inactive0-4.31110.70.569616-6.420440 0 0 0 0 0 0 0 0 0 0 0 0 0 010.9365-5.1704-5.0985-8.8005-16.1837-0.6747-5.4926-6.0597-2.002-5.4729-0.4710.66470.425810.9365QC'd by SIGMAInactive0-4.86113.1320.7788
Inactive0-4.79514.44950.393.5-6.208340 0 0 0 0 0 0 0 0 0 0 0 0 0 05.5526-10.76851.3537-10.3751-8.4404-4.2311-6.0947-6.6736-3.055-1.38-13.551.81730.73145.5526QC'd by SigmaAldrichInactive0
Inactive0-8.2240.40.4786-2-14.195640 0 0 0 0 0 0 0 0 0 0 0 0 0 1-7.6365-10.2226-5.7741-5.7864-9.0325-3.8611-7.1297-3.7761-2.5278-3.20860.6227-9.34210.9299-7.6365QC'd by ChemServiceInactive0
Inactive042.3569-10.6376-11.749-9.7144-9.41032.1571-2.4598-7.83950.852-2.6894-3.4981-5.04524.54862.3569QC'd by SensientInactive0
Inactive0-8.36020.50.4212-4-26.054640 0 0 0 0 0 0 0 0 0 0 0 0 0 0-6.5299-17.5869-18.3789-6.8378-10.958-6.69991.9891-16.2805-6.0446-12.5391-3.29320.3896-7.367-6.5299QC'd by SigmaAldrichInactive0-7.86023.51170.3529
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:RAR-related orphan receptor gamma [Mus musculus]
External ID: RORG717
Protocol: Please refer to other AIDs 1159520 and 1159521 for detailed assay protocols.
Comment: This summary is written for the purposes of summarizing the compound activities from the project combining the results from both the ROR-gamma antagonist mode assay (AID 1159521) and cell viability counter screen (AID 1159520). For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Potency and efficacy were used for determining relative score. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 5 and 30 determined by phenotype.

Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).
Activity SummaryAntagonist ActivityAntagonist Potency (uM)Antagonist Efficacy (%)Viability ActivityViability Potency (uM)Viability Efficacy (%)Sample Source
active antagonistactive antagonist4.754895448-93.70255407active antagonist38.64924121-62.07337935SIGMA
active antagonistactive antagonist4.710999542-92.32323728active antagonist16.71525714-98.44005073Io-li-tec
active antagonistactive antagonist4.288133268-91.08634651inconclusive antagonist53.9843994-107.2882524SigmaAldrich
active antagonistactive antagonist3.736198769-84.11573594active antagonist61.53137782-88.98579439TCI
active antagonistactive antagonist5.025224321-92.52555069active antagonist27.19498265-92.6599053SigmaAldrich
active antagonistactive antagonist5.182082908-96.94797201inconclusive agonist22.2760246672.0002484SIGMA
active antagonistactive antagonist4.407052072-94.35370523inconclusive antagonist62.25126513-129.1341964SIGMA
active antagonistactive antagonist6.169049088-103.9876028inconclusive antagonist27.55613007-103.2695491TCI
active antagonistactive antagonist3.063785871-80.89880968active antagonist56.61416092-87.47545913ChemService
active antagonistactive antagonist4.85577337-92.2099245active antagonist17.90296963-75.53146279LightBiologicals
active antagonistactive antagonist2.342026161-74.22818922inactive0LightBiologicals
active antagonistactive antagonist5.448267331-99.05219016active antagonist24.33651622-71.81303901LightBiologicals
active antagonistactive antagonist2.010928837-74.97910195inconclusive antagonistSIGMA
active antagonistactive antagonist2.238381331-74.80654471inactive0Bosche
active antagonistactive antagonist3.616324628-86.08243335inconclusive antagonist26.60321198-71.22163292Vitas
active antagonistactive antagonist5.888886866-96.38804777active antagonist36.45019676-66.89481068SIGMA
active antagonistactive antagonist5.747886092-93.23580957active antagonist27.7230805-90.82172698SigmaAldrich
active antagonistactive antagonist3.745860149-82.44023546inconclusive agonist20.88382432SIGMA
active antagonistactive antagonist4.826160002-84.41102601inactive0Acros
active antagonistactive antagonist5.275151781-92.62012006active antagonist19.44919484-108.2899697Io-li-tec
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SHH820
Protocol: Tox21 Assay Protocol Summary:

3T3 Gli1-Luc cells were dispensed at 2,000 per well in 5uL of culture medium into white solid bottom 1536-well plates (Greiner Bio-One, Monroe, NC) using a Multidrop Combi (Thermo Scientific, Waltham, MA) dispenser. The assay plates were incubated at 37 C and 5% CO2 for 4hr, and then 23nL of compounds dissolved in DMSO and positive control were transferred using a Pintool station (Wako, San Diego, CA). The compound transfer was followed by the addition of 1ul conditioned medium or assay buffer using two separate tips of Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA). The assay plates were incubated at 37C and 5% CO2 for 24hr. For viability read, after 23hr of compound treatment, 1uL of CellTiter-Fluor reagent (Promega Corporation, Madison, WI) was added to each well of the assay plates using Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA) and incubated the assay plates at 37C for 1hr. The fluorescence signal was quantified using a ViewLux plate reader (Perkin Elmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000060039 uM-Replicate_1Activity at 0.0000137707 uM-Replicate_1Activity at 0.0000545120 uM-Replicate_1Activity at 0.0001296300 uM-Replicate_1Activity at 0.0003002588 uM-Replicate_1Activity at 0.0006197232 uM-Replicate_1Activity at 0.00170 uM-Replicate_1Activity at 0.00522 uM-Replicate_1Activity at 0.013 uM-Replicate_1Activity at 0.030 uM-Replicate_1Activity at 0.068 uM-Replicate_1Activity at 0.153 uM-Replicate_1Activity at 0.349 uM-Replicate_1Activity at 1.067 uM-Replicate_1Activity at 3.267 uM-Replicate_1Activity at 8.386 uM-Replicate_1Activity at 18.95 uM-Replicate_1Activity at 42.46 uM-Replicate_1Activity at 92.41 uM-Replicate_1Activity at 240.3 uM-Replicate_1Activity at 872.4 uM-Replicate_1Activity at 1849.0 uM-Replicate_1Activity at 4135.0 uM-Replicate_1Activity at 9246.0 uM-Replicate_1Activity at 20670.0 uM-Replicate_1Activity at 46230.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Cytotoxic76.958855.280820Single point of activity-4.11374.95490.6859-56.9654-1.6846-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-47.4711-3.53062.47411.35780.24962.0302-5.42725.24230.72630.44-13.356-20.17599.3746-47.4711QC'd by LightBiologicalsCytotoxic24.336549.901620Partial curve; partial efficacy-4.61371.24750.972
Inactive0-4.81370.70.77538-2.119840 0 0 0 0 0 0 0 0 0 0 0 0 0 05.6366-1.0523-3.3454-2.4869-5.0998-2.7014-0.5910.20740.14140.48070.7522.04256.56675.6366QC'd by SIGMAInactive0
Cytotoxic61.130640.627620Single point of activity-4.21373.62720.9712-38.62762-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-30.93972.48610.68594.04171.20760.53074.2033.72551.15941.10933.91281.2024-6.0525-30.9397QC'd by SIGMACytotoxic48.557739.196520Partial curve; partial efficacy-4.31373.06540.9495
Inactive00042.06063.5472.72692.9935-0.24363.91921.74444.09152.0810.49797.43213.3694-0.35762.0606QC'd by TCIInactive0
Inactive00044.48325.60185.33883.91021.7965.10795.08341.02234.27944.85840.95673.99664.34924.4832QC'd by LightBiologicalsInactive0
Inactive0004-5.20217.3742-3.79745.54614.4126-3.954-3.56317.86351.25745.6113-4.16645.85284.155-5.2021QC'd by LightBiologicalsInactive0-4.21372.09370.6337
Inactive00047.50393.3339-1.24030.90681.3378-0.00452.8015.89513.49132.21175.77086.33965.54597.5039QC'd by SIGMAInactive0-6.76373.990.3154
Cytotoxic68.589650.616820Single point of activity-4.16374.95490.9583-45.61685-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-36.14465.05932.04223.9797.2865.07613.98718.71936.79573.41553.10911.35210.3624-36.1446QC'd by SIGMACytotoxic24.336554.507920Complete curve; partial efficacy-4.61371.62590.9586
Inactive00048.08744.68292.31410.61762.88543.50261.98685.20951.34591.03482.96724.68423.63878.0874QC'd by SIGMACytotoxic0.216932.786520Complete curve; partial efficacy; poor fit-6.66374.95490.6746
Inactive00046.52251.27468.19773.58744.05113.18815.12956.386914.64823.35043.30666.69696.85336.5225QC'd by EnamineInactive0
Inactive000416.117812.596711.66116.107315.859213.556214.695313.55772.685511.202313.874215.4185-7.788316.1178QC'd by SIGMAInactive0-4.11374.95490.7314
Inactive0004-1.51951.45693.20771.9131-0.5313-2.0759-0.2401-1.2015-0.2342-1.2834-18.6886-0.37814.1756-1.5195QC'd by SIGMAInactive0
Cytotoxic68.589647.77220Single point of activity-4.16374.95490.9347-43.7724-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-34.65971.23973.5812.19782.77025.60838.41394.3332.02770.12145.94638.94740.6183-34.6597QC'd by SIGMACytotoxic68.589661.996620Single point of activity-4.16374.95490.9756
Inactive00042.4355-0.64593.01487.23072.36777.50691.76611.06293.06872.48284.51913.13388.0032.4355QC'd by SIGMACytotoxic68.589633.029920Partial curve; partial efficacy; poor fit-4.16374.95490.8542
Inactive00047.32172.46561.16683.36518.03945.87431.861514.00363.3025-0.07953.30992.878714.61237.3217QC'd by SIGMAInactive0
Inactive0-4.61374.95490.54639.50.891640 0 0 0 0 0 0 0 0 0 0 0 0 0 07.88590.04911.7582-0.8465-0.92372.3312-0.91459.02852.116-0.777-0.12061.575811.01597.8859QC'd by EnamineInactive0
Inactive00046.98963.32372.9636-0.47087.07794.52173.33594.5172.97747.55215.12234.02348.63316.9896QC'd by SIGMAInactive0
Inactive00049.26573.93440.1743.18227.63392.5093.18546.51072.48996.19313.06823.336114.02669.2657QC'd by SIGMAInactive0
Inactive00044.97115.46853.5672-0.51777.13114.76043.01832.70954.16991.97063.08723.56985.85354.9711QC'd by SIGMAInactive0
Inactive0004-0.10981.4274-0.40161.34340.8252.74681.50257.56761.15211.11550.7943.37914.1008-0.1098QC'd by LightBiologicalsInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: AP1639
Protocol: Tox21 Assay Protocol Summary:

2500 cells/5uL in Opti-MEM medium containing 0.5% dialyzed FBS, 0.1 mM NEAA, 1 mM sodium pyruvate and 10 mM HEPES was dispensed into 1536-well black wall/clear bottom plates using a Multidrop dispenser and cells were cultured at 37 degrees Celsius overnight. Next day 23 nL of compounds dissolved in DMSO, positive controls or DMSO were delivered to each well using a pin tool. The plates were incubated at 37 degrees Celsius for 5 hours. 1 uL of LiveBLAzerTM B/G FRET substrate (Solution A+B+C+D) was added to each well using a Flying Reagent Dispenser. After incubated at room temperature for 2.5 hours the plates were measured on an EnVision plate reader at Excitation 405nm, Emission1=460nm and Emission 2=530nm. The %Activity was determined from the ratio of 460nm/530nm.
After the plates were read for Beta-Lactamase assay on Envision; 3 ul Cell Titer Glo (Promega) was added to measure the cytotoxicity and the plates were then incubated at RT in dark for 30 min. The luminescence was read on ViewLux (Perkin Elmer, Shelton, CT) using 6 sec exposure. ViewLux data was expressed as relative luminescence units.
For primary data analysis, raw plate reads for each titration point were first normalized relative to 39.129 ug/ml EGF control (100%) and DMSO only wells (basal, 0%).
For primary data analysis for viability assay, raw plate reads for each titration point were first normalized Tetra n-octyl ammonium bromide control (-100%) and DMSO (control, 100%).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000049913 uM-Replicate_1Activity at 0.0000114526 uM-Replicate_1Activity at 0.0000453222 uM-Replicate_1Activity at 0.0001077752 uM-Replicate_1Activity at 0.0002496487 uM-Replicate_1Activity at 0.0005152025 uM-Replicate_1Activity at 0.00141 uM-Replicate_1Activity at 0.00434 uM-Replicate_1Activity at 0.011 uM-Replicate_1Activity at 0.025 uM-Replicate_1Activity at 0.057 uM-Replicate_1Activity at 0.127 uM-Replicate_1Activity at 0.290 uM-Replicate_1Activity at 0.887 uM-Replicate_1Activity at 2.716 uM-Replicate_1Activity at 6.973 uM-Replicate_1Activity at 15.76 uM-Replicate_1Activity at 35.30 uM-Replicate_1Activity at 76.83 uM-Replicate_1Activity at 199.8 uM-Replicate_1Activity at 725.3 uM-Replicate_1Activity at 1537.0 uM-Replicate_1Activity at 3438.0 uM-Replicate_1Activity at 7687.0 uM-Replicate_1Activity at 17190.0 uM-Replicate_1Activity at 38440.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive041.6708-3.0840.6587-1.8062.5861-9.37521.47693.0296-3.85494.3139-0.27453.6903-10.49921.6708QC'd by ACCInactive0
Inactive04-0.85998.78461.4658-5.8365-8.07541.60060.11435.37864.17263.37215.06560.90530.9988-0.8599QC'd by ACCInactive0
Inactive042.73596.29630.8365-1.70496.062-18.73530.4-7.8712-8.16781.6467-2.16-4.7522-4.31982.7359QC'd by ACCInconclusive6.0E-420.045310Complete curve; partial efficacy; poor fit-9.22134.95490.7072
Inactive04-18.56590.6005-0.1971-11.0378-19.1609-4.195-10.6369-3.0216-7.5098-5.8461-12.467613.0859-0.9512-18.5659QC'd by ACCInactive0
Inactive041.371-0.69133.4497-0.790811.3165-0.7705-3.01542.78422.045610.9407-2.42591.5088-2.93131.371QC'd by RTIInactive0
Inactive040.662-0.95231.63641.60355.8662.04910.32328.23692.97080.75891.1525-1.84830.21740.662QC'd by RTIInactive0
Inactive046.24775.3837-2.08728.64570.01480.23794.30370.5075-0.5688-0.4992-0.47943.04722.30176.2477QC'd by RTIInactive0
Inactive043.2242.70151.60526.33328.19184.2227-1.86092.91729.13091.70461.02690.0248-2.0973.224QC'd by RTIInactive0
Inactive045.03910.9438-2.46690.4884-0.99914.96015.0087-1.5661-1.3945.77031.699417.93120.44875.0391QC'd by RTIInactive0
Inactive0-7.05132.40640.3276-4.6347140 0 0 0 0 0 0 0 0 0 0 0 0 0 1-0.69110.40091.24363.5673-3.33163.1455-5.2379-7.5177-7.9517-7.52314.6309-6.65880.2205-0.6911QC'd by RTIInactive0
Inactive0-4.4250.80.4143-13.3861-240 0 0 0 0 0 0 0 0 0 0 0 0 0 0-8.40460.68411.0885-2.5734-2.7478-5.5003-0.5737-8.7122-3.37670.7036-3.0014-6.2079-10.7384-8.4046QC'd by RTIInactive0-7.5254.95490.3293
Inactive04-11.2549-3.134-3.07550.51811.3497-2.3019-7.6641-10.0751-2.1175-7.2755-2.6704-2.8975-9.7435-11.2549QC'd by RTIInactive0-4.83974.95490.3447
Inactive0-4.65651.46410.6576-18.1324-240 0 0 0 0 0 0 0 0 0 0 0 0 0 0-13.7107-6.8824-4.5626-3.1251-4.39540.6780.184-0.5816-1.0794-3.349-3.6272-5.1106-18.027-13.7107QC'd by RTIInactive0-4.75654.95490.6344
Inactive04-6.4326-0.8469-7.0383-5.6304-4.0245-5.47950.1315-14.44860.7658-7.3058-6.40140.6393-3.715-6.4326QC'd by RTIInactive0
Inactive0-5.349910.4444-8.2075-140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-6.4956-3.9512-2.10771.72972.1127-2.6485-1.96480.4817-3.4319-3.3843-2.2401-13.5063-5.4198-6.4956QC'd by RTIInactive0
Inactive04-0.02338.17681.9722-18.78727.85730.59384.6262-0.89433.26067.46856.744.711-6.7748-0.0233QC'd by RTIInactive0
Inactive04-1.27634.37294.7138-14.169610.1941.8534-1.306812.07313.48666.9948-1.20540.88721.226-1.2763QC'd by RTIInactive0
Inactive0-6.79194.44950.44241-3.50440 0 0 0 0 0 0 0 0 0 0 0 0 0 1-6.4723-2.9077-0.5531-5.8097-4.8517-7.92-1.5888-0.11962.50130.15852.52511.3966-0.972-6.4723QC'd by RTIInactive0
Inactive040.81951.5095-2.8169-6.4928-4.21371.3369-2.8682-2.1982-1.4878-4.3533-5.04240.1943-8.29830.8195QC'd by RTIInactive0-8.74144.95490.3404
Inactive046.2298-0.92270.0097-2.48951.3341-0.97320.72712.7127-2.5371-1.9151-1.5144.56241.99656.2298QC'd by RTIInactive0-6.96044.95490.4293
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: SHH437
Protocol: Tox21 Assay Protocol Summary:

3T3 Gli1-Luc cells were dispensed at 2,000 per well in 5uL of culture medium into white solid bottom 1536-well plates (Greiner Bio-One, Monroe, NC) using a Multidrop Combi (Thermo Scientific, Waltham, MA) dispenser. The assay plates were incubated at 37 C and 5% CO2 for 4hr, and then 23nL of compounds dissolved in DMSO and positive control were transferred using a Pintool station (Wako, San Diego, CA). The assay plates were incubated at 37C and 5% CO2 for 24hr. For viability read, after 23hr of compound treatment, 1uL of CellTiter-Fluor reagent (Promega Corporation, Madison, WI) was added to each well of the assay plates using Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA) and incubated the assay plates at 37C for 1hr. The fluorescence signal was quantified using a ViewLux plate reader (Perkin Elmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000060039 uM-Replicate_1Activity at 0.0000137707 uM-Replicate_1Activity at 0.0000545120 uM-Replicate_1Activity at 0.0001296300 uM-Replicate_1Activity at 0.0003002588 uM-Replicate_1Activity at 0.0006197232 uM-Replicate_1Activity at 0.00170 uM-Replicate_1Activity at 0.00522 uM-Replicate_1Activity at 0.013 uM-Replicate_1Activity at 0.030 uM-Replicate_1Activity at 0.068 uM-Replicate_1Activity at 0.153 uM-Replicate_1Activity at 0.349 uM-Replicate_1Activity at 1.067 uM-Replicate_1Activity at 3.267 uM-Replicate_1Activity at 8.386 uM-Replicate_1Activity at 18.95 uM-Replicate_1Activity at 42.46 uM-Replicate_1Activity at 92.41 uM-Replicate_1Activity at 240.3 uM-Replicate_1Activity at 872.4 uM-Replicate_1Activity at 1849.0 uM-Replicate_1Activity at 4135.0 uM-Replicate_1Activity at 9246.0 uM-Replicate_1Activity at 20670.0 uM-Replicate_1Activity at 46230.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive0-4.87513.06540.3807-2.96742.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-2.47284.32632.20151.57453.40080.3799-1.21222.65732.42174.32754.0752.1859-2.3969-2.4728QC'd by ACCInactive0
Inactive00041.17221.80871.41585.94452.91766.27436.43354.62135.50521.75160.13761.301-1.55681.1722QC'd by ACCInactive0
Inconclusive21.1317513.053510Partial curve; high efficacy-4.67511.50950.9965518.78275.72912.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0411.73234.0821-2.12332.10713.87941.59741.81819.45188.243716.447738.6279117.7981244.6946411.7323QC'd by ACCInconclusive23.7101155.753510Partial curve; high efficacy-4.62511.62660.9932
Inactive0-4.47514.95490.46562-10.612240 0 0 0 0 0 0 0 0 0 0 0 0 0 00.6436-9.4144-6.799-8.9434-11.503-12.0609-7.7564-18.8435-12.6532-10.3281-12.3862-7.2135-11.61580.6436QC'd by ACCInactive0
Inactive0-4.74013.92950.4263-6.6254740 0 0 0 0 0 0 0 0 0 0 0 0 0 0-7.604511.064113.12069.19159.41450-6.02484.931812.0235-2.604611.7454-6.235-4.0452-7.6045QC'd by RTIInactive0
Inactive0-5.07350.40.7042-21.42699.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-14.52254.440812.013917.948410.477500.996-3.33542.7963-1.142-7.6818-6.8826-9.7189-14.5225QC'd by RTIInactive0-4.47351.47810.7526
Inactive0-4.47731.59360.8555-22.71661.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-20.5971-0.38024.38466.03732.32021.5126-1.2943-5.0267-0.65370.6883-0.2452-7.5593-12.7755-20.5971QC'd by RTICytotoxic74.600433.319720Partial curve; partial efficacy; poor fit-4.12733.29750.8039
Inactive0004-21.04423.375.91566.28357.3135-33.1555-3.6621-3.51111.7185-3.8818-3.4034-6.2344-14.9681-21.0442QC'd by RTICytotoxic33.1219102.133780Complete curve; high efficacy-4.47994.95490.98
Inactive0-5.23460.80.9584-26.112040 0 0 0 0 0 0 0 0 0 0 0 0 0 1-5.7901-0.357-0.23682.4131-0.3707-4.272-4.0507-4.1881-7.4941-19.0026-18.1272-22.0783-23.01-5.7901QC'd by RTIInactive0-5.48461.46410.8481
Cytotoxic35.050134.768620Partial curve; partial efficacy; poor fit-4.45530.60.7732-33.76861-2.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0-24.80711.60712.391603.0669-0.6819-9.07352.1886-9.252-2.4014-10.0734-16.222-12.6381-24.8071QC'd by RTICytotoxic31.2384122.660740Partial curve; high efficacy-4.50531.69240.9567
Cytotoxic41.810832.545120Partial curve; partial efficacy-4.37871.78850.8689-33.5451-1-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-34.94283.78423.1682-0.585-1.1901-3.1902-3.1296-3.3519-6.73913.4576-3.5987-11.2765-16.0093-34.9428QC'd by RTICytotoxic41.810885.542740Partial curve; high efficacy-4.37872.33320.9502
Cytotoxic28.616369.249940Partial curve; partial efficacy-4.543410.959-69.7335-0.4837-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-58.1113-1.46081.72530.9562-3.12220.5011-1.862-4.4024-0.6657-9.4821-19.4716-32.9479-33.4672-58.1113QC'd by RTICytotoxic28.616395.871240Partial curve; high efficacy-4.54341.22210.9649
Cytotoxic34.668113.086340Partial curve; high efficacy-4.460110.9585-117.0078-3.9215-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-97.5065-7.5872-3.4598-1.2180.37111.709-11.19360.48-13.3909-15.7448-27.5273-44.124-60.4317-97.5065QC'd by RTICytotoxic27.537895.296480Complete curve; high efficacy-4.56012.53340.9767
Inactive0-4.54172.24810.6119-14.4382-140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-14.5318-3.4357-4.1067-1.6712-6.8939-4.12591.57213.6573.81992.0448-1.1685-6.6087-10.1372-14.5318QC'd by RTIInactive0-5.24174.95490.7468
Cytotoxic70.252132.599620Partial curve; partial efficacy; poor fit-4.15333.51170.9343-34.0996-1.5-2.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0-27.1664-1.86820.0169-2.0609-6.475-0.529-1.1313-2.3176-3.3009-0.0588-1.2616-0.1413-8.3387-27.1664QC'd by RTICytotoxic78.824182.726420Single point of activity-4.10334.95490.9645
Inactive0-4.46050.70.5606-15.6335340 0 0 0 0 0 0 0 0 0 0 0 0 0 0-10.1112-0.65081.05132.19527.735912.8331-1.0384-2.22590.58480.1677-1.7617-4.4718-7.179-10.1112QC'd by RTICytotoxic77.540933.797920Partial curve; partial efficacy; poor fit-4.11054.50450.9395
Inactive0-7.00260.70.3402-3.50688.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.59165.19417.166413.40621.492-0.05710.6662-0.6080.53662.7155-21.2557-1.37020.8399-0.5916QC'd by RTIInactive0-4.10264.0450.7991
Cytotoxic80.182434.975420Partial curve; partial efficacy; poor fit-4.09591.10.7104-37.4754-2.5-2.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0-27.8962-1.862-0.606-4.3184-5.1202-2.34192.3528-6.1975-4.2482-5.101-4.5143-12.3237-5.5913-27.8962QC'd by RTICytotoxic71.462773.856241Partial curve; partial efficacy-4.14593.29750.9373
Inactive0-4.04514.95490.4414-11.9488-140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-9.1240.25572.0576-2.87790.0034-1.6064-5.05711.1978-3.8272-0.7141-4.8757-0.1580.0539-9.124QC'd by RTIInactive0-4.09514.95490.8915
Inactive0-4.16412.63840.8547-16.7796140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-12.3164-0.5760.22515.0920.25611.22831.4596-0.67661.39251.75170.07230.0076-3.1432-12.3164QC'd by RTIInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: HDAC108
Protocol: Tox21 Assay Protocol Summary:

HCT-116 cells were dispensed at 1,500 per well in 5uL of culture medium into white solid bottom 1536-well plates (Greiner Bio-One, Monroe, NC) using a Multidrop Combi (Thermo Scientific, Waltham, MA) dispenser. The assay plates were incubated at 37 C and 5% CO2 for an overnight, and then 23nL of compounds dissolved in DMSO and positive control were transferred using a Pintool station (Wako, San Diego, CA). The assay plates were incubated at 37C and 5% CO2 for 2hr. After compound treatment, 4uL of CellTiter-Glo reagent (Promega Corporation, Madison, WI) was added to each well of the assay plates using Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA) and incubated the assay plates at room temperature for 30min. The luminescence signal was quantified using a ViewLux plate reader (Perkin Elmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000060039 uM-Replicate_1Activity at 0.0000137707 uM-Replicate_1Activity at 0.0000545120 uM-Replicate_1Activity at 0.0001296300 uM-Replicate_1Activity at 0.0003002588 uM-Replicate_1Activity at 0.0006197232 uM-Replicate_1Activity at 0.00170 uM-Replicate_1Activity at 0.00522 uM-Replicate_1Activity at 0.013 uM-Replicate_1Activity at 0.030 uM-Replicate_1Activity at 0.068 uM-Replicate_1Activity at 0.153 uM-Replicate_1Activity at 0.349 uM-Replicate_1Activity at 1.067 uM-Replicate_1Activity at 3.267 uM-Replicate_1Activity at 8.386 uM-Replicate_1Activity at 18.95 uM-Replicate_1Activity at 42.46 uM-Replicate_1Activity at 92.41 uM-Replicate_1Activity at 240.3 uM-Replicate_1Activity at 872.4 uM-Replicate_1Activity at 1849.0 uM-Replicate_1Activity at 4135.0 uM-Replicate_1Activity at 9246.0 uM-Replicate_1Activity at 20670.0 uM-Replicate_1Activity at 46230.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive0-5.71374.95490.32993.5-0.286840 0 0 0 0 0 0 0 0 0 0 0 0 0 1-1.5604-1.2726-0.37914.7427-1.3287-0.6548-0.347-2.3224-0.15537.1196-0.34970.16617.7806-1.5604QC'd by SIGMAInactive0
Inactive00045.99771.0318-0.21333.33552.3359-0.75440.51364.09810.7656-4.20721.8126-0.08552.50225.9977QC'd by EnamineInactive0
Inactive0004-5.9584-0.5672-1.76570.1937-3.263-1.2434-5.1658-1.51740.022-6.0938-0.0943-0.5467-0.5208-5.9584QC'd by SIGMAInactive0-4.81374.95490.5005
Inactive0004-6.1069-0.12190.2221-3.7064-0.6753-0.381-3.7570.3272-0.50432.90210.29890.4180.0102-6.1069QC'd by SIGMAInactive0-8.01374.95490.6568
Inactive00041.0714-1.7923-3.6637-0.73952.2656-0.1717-0.0254-1.8288-0.7532-2.34931.6005-0.2419-0.23631.0714QC'd by RocheInactive0
Inactive0-4.26372.72020.7981-21.0612-1.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-17.13440.8508-6.21060.4576-1.523-3.2999-1.2141-1.0183-1.3776-5.0652-1.860.2922-8.3385-17.1344QC'd by ChemosInactive0-4.81371.210.617
Inactive0-5.21374.95490.6393-7.4614440 0 0 0 0 0 0 0 0 0 0 0 0 0 0-7.67671.9689-4.62230.33423.88826.33497.21027.88566.01495.5912-6.2467-3.5288-10.3845-7.6767QC'd by RocheInactive0-6.91373.1320.4734
Inactive0004-8.059-0.73731.6462-2.6487-2.0476-2.8571-4.71662.6933-1.4519-1.99440.6153-3.2753-0.0097-8.059QC'd by LightBiologicalsInactive0
Inactive0004-2.4495-1.3725-3.1689-0.7017-0.4356-0.06642.28551.52480.2371-8.82125.4167-1.18474.8034-2.4495QC'd by RocheInactive0
Inactive0004-0.37380.12330.40130.2472-1.987-2.69260.1315-0.2643-2.08365.36874.2426-0.5743-1.9439-0.3738QC'd by SIGMAInactive0
Inactive0004-0.2538-1.66458.2859-2.2098-1.85212.3986.50340.21580.0443-0.4205-2.5338-0.43943.086-0.2538QC'd by SIGMAInactive0
Inactive00044.6026-0.34211.1574-0.0973-4.91260.89632.0363.2289-0.3715-0.1984.83893.37651.5064.6026QC'd by SIGMAInactive0
Inactive00040.6238-2.09780.8918-0.04391.15810.1844-6.2214-0.0685-0.3281-0.1058-2.74663.1833-0.42210.6238QC'd by LightBiologicalsInactive0
Inactive0004-3.9732-2.3988-4.3099-0.2942-0.4301-7.5097-3.331.7546-0.65034.0301-0.303-7.37670.4929-3.9732QC'd by SIGMAInactive0
Inactive0004-0.21190.29480.3814-1.189-1.5154-0.4509-0.9366-1.3786-1.2166-0.54672.8707-5.2924-0.7862-0.2119QC'd by Astellas PharmaInactive0
Inactive0004-1.17360.42764.3513-0.65473.3539-1.9101-2.1632-0.3337-2.5393-0.8734.8167-0.22851.5585-1.1736QC'd by LightBiologicalsInactive0
Inactive0004-4.7824-0.6387-8.53150.5765-0.6232-0.5186-0.62630.17721.147-0.18470.0275-1.2929-0.312-4.7824QC'd by SIGMAInactive0
Inactive0-5.61374.95490.587-4.877040 0 0 0 0 0 0 0 0 0 0 0 0 0 1-1.4398-1.05721.05261.03840.70651.22451.8985-0.3031-1.3867-4.261-8.6475-4.4916-1.1378-1.4398QC'd by SIGMAInactive0
Inactive0004-2.18780.27771.11040.2229-2.31830.3529-1.1915-1.90621.2558-3.7194-1.32860-4.0267-2.1878QC'd by SIGMAInactive0-4.41371.34370.5328
Inactive0004-0.01311.95461.8368-0.70.5289-2.02220.7112-0.87610.6894-0.5082-1.109-6.6773-1.2681-0.0131QC'd by LightBiologicalsInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: RXR315
Protocol: Tox21 Assay Protocol Summary:

RXR-alpha HEK 293T cells were dispensed at 2,000 cells/6 uL of assay medium containing 2% charcoal-stripped FBS using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. The assay was performed in black wall/clear-bottom 1536-well plates (Greiner Bio-One North America Inc. Monroe, NC). 9-cis retinoic acid was used as a positive control in the agonist mode screen. After the assay plates were incubated at 37 C and 5% CO2 for 5 hr, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only were transferred to the assay plate by a Pintool station (Kalypsys, San Diego, CA). The assay plates were incubated at 37 C and 5% CO2 for 16 hr. One uL of LiveBLAzer B/G FRET substrate (Life Technologies) was added using a Flying Reagent Dispenser (Aurora Discovery, San Diego, CA) and the plates were incubated at room temperature for 2 hr. Fluorescence intensity (405 nm excitation, 460/530 nm emission) was measured using an Envision plate reader (PerkinElmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000049913 uM-Replicate_1W530-Activity at 0.0000114526 uM-Replicate_1W530-Activity at 0.0000453222 uM-Replicate_1W530-Activity at 0.0001077752 uM-Replicate_1W530-Activity at 0.0002496487 uM-Replicate_1W530-Activity at 0.0005151188 uM-Replicate_1W530-Activity at 0.00141 uM-Replicate_1W530-Activity at 0.00432 uM-Replicate_1W530-Activity at 0.011 uM-Replicate_1W530-Activity at 0.025 uM-Replicate_1W530-Activity at 0.057 uM-Replicate_1W530-Activity at 0.127 uM-Replicate_1W530-Activity at 0.290 uM-Replicate_1W530-Activity at 0.887 uM-Replicate_1W530-Activity at 2.714 uM-Replicate_1W530-Activity at 6.976 uM-Replicate_1W530-Activity at 15.76 uM-Replicate_1W530-Activity at 35.30 uM-Replicate_1W530-Activity at 76.83 uM-Replicate_1W530-Activity at 199.8 uM-Replicate_1W530-Activity at 725.3 uM-Replicate_1W530-Activity at 1537.0 uM-Replicate_1W530-Activity at 3438.0 uM-Replicate_1W530-Activity at 7687.0 uM-Replicate_1W530-Activity at 17190.0 uM-Replicate_1W530-Activity at 38440.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inconclusive1047.96914.47130.90985.2207-2.32023.99810.1754.42945.75634.54662.6557-0.10293.0127.96911041.3105
Inactive10-7.67131.50950.3107-2.938440 0 0 0 0 0 0 0 0 0 0 0 0 0 0-2.505-0.858111.83041.74182.7883-0.85870.9336-9.53173.5109-0.81-3.3148-8.2813-1.6182-2.50510-5.67134.95490.63995-1.300440 0 0 0 0 0 0 0 0 0 0 0 0 0 05.2732
Inconclusive9.5205101.749610Partial curve; high efficacy-5.02131.41630.982105.41973.672.10 0 0 0 0 0 0 0 0 0 0 0 0 0 094.9727-0.64053.16945.95143.961211.81232.6774.2110.95821.444716.347848.389771.031294.97270Partial curve; partial efficacy-5.02131.37230.9841-64.3552-1.8086-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-57.7677
Inactive10-6.12131.22210.705-13.1989140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-10.68070.4041.79832.49540.5962-3.53552.05983.2927-10.61812.4672-12.8604-10.1448-15.1657-10.680710-5.77134.95490.90247-0.843940 0 0 0 0 0 0 0 0 0 0 0 0 0 07.0054
Inactive104-1.7619-4.30424.833-1.8403-13.51321.3351-1.10454.17641.5301-5.96923.4149-0.2356-2-1.761910-5.68624.95490.4262-6.0115340 0 0 0 0 0 0 0 0 0 0 0 0 0 16.5904
Inactive1040.4181-0.04980.9166-0.5702-6.2053-3.27270.5069-0.5214-2.1428-6.51915.84480.0328-0.73340.41811040.161
Inactive10-5.72354.95490.5732-8.9621.540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-0.53873.5498-0.63622.41142.99265.3669-0.22896.0528-4.5557-7.03870.1707-13.873-8.5286-0.538710-5.02352.72020.455180.349340 0 0 0 0 0 0 0 0 0 0 0 0 0 12.9037
Inactive104-1.0374-5.5014-3.8386-2.7107-0.7911-2.3714-1.40212.8144-1.4047-0.5425-0.03483.4421-10.6563-1.037410-6.27634.95490.6673-2.9326.540 0 0 0 0 0 0 0 0 0 0 0 0 0 15.7238
Inactive104-8.7122-1.521610.7-8.47150.95971.52822.1371.35181.2183-11.31290.88083.83924.2371-8.71221040.5971
Inactive104-4.554.8799-4.2237-4.9405-6.69655.8093-8.24884.6874-4.0578-0.3911-5.46719.65881.0592-4.5510-5.85131.62660.6866-5.5933840 0 0 0 0 0 0 0 0 0 0 0 0 0 0-10.4944
Inactive10411.5033-3.7354-6.3082-3.03961.7425-9.5785-4.52087.7927-12.30270.07981.28184.5387-6.619111.503310-4.1752.78680.5875-33.2759-1.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-25.6466
Inconclusive10-4.73972.95230.778516.5-4.580540 0 0 0 0 0 0 0 0 0 0 0 0 0 017.1795-1.726-3.5034-4.5478-12.9837-6.3873.3479-7.9659-3.2086-6.2718-4.2265.183712.821117.17950Partial curve; partial efficacy-4.58974.0950.9475-37.01540.3612-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-41.1282
Inconclusive62.154928.358410Partial curve; partial efficacy; poor fit-4.20654.95490.780126.5-1.85842.40 0 0 0 0 0 0 0 0 0 0 0 0 0 021.8544-4.2759-2.0127-1.6429-1.2748-4.46530.5591-1.8548-4.3812-4.0758.03380.1165-1.192321.85440Partial curve; partial efficacy-4.55651.210.9517-48.6621.0594-2.20 0 0 0 0 0 0 0 0 0 0 0 0 0 0-45.0574
Inactive1045.5519-1.0968-5.4622-6.482-7.9274-6.6565-10.8296-0.0409-13.6212-0.99995.6636-8.9225-5.63245.551910-4.13824.95490.545-7.5241440 0 0 0 0 0 0 0 0 0 0 0 0 0 0-4.6034
Inactive104-0.0339-4.9002-0.2272-2.3643-4.99351.3028-3.843614.3585-6.1563-5.0390.88194.19021.9098-0.033910-4.24990.80.666-26.68070.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-18.9006
Inactive1046.4157-9.645-1.0054-0.9143-9.0511-5.2924.734-0.663-6.4038-2.67820.53634.0441-7.0346.415710-4.8570.30.6521-26.42865.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-22.0238
Inactive10-6.39894.95490.334-4.2253140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-6.9135-4.45962.3463-0.2789-0.11217.8544-0.85812.8147-9.3544-3.7335-3.7247-5.11133.6014-6.9135104-7.0062
Inactive10-8.84194.95490.6457-1.46231040 0 0 0 0 0 0 0 0 0 0 0 0 0 11.08427.6118-2.9807-2.5559-0.977-1.9399-0.0419-0.045-1.9468-2.732-1.47671.70381.60241.0842104-2.1386
Inactive10-5.09143.51170.4447-8.07710.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-9.4416-4.33334.69510.49270.4590.2982-0.25-0.4526-0.5979-1.1703-2.2153-15.06430.1239-9.441610-6.74142.24810.3396-3.108140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-1.9532
Inconclusive1040.4549-3.4508-0.39160.69015.56822.84613.4763-1.5429-3.38432.84159.83480.0226.33830.454910-4.56041.47810.702113-2.376240 0 0 0 0 0 0 0 0 0 0 0 0 0 012.4836
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: HDAC401
Protocol: Tox21 Assay Protocol Summary:

HCT-116 cells were dispensed at 1,500 per well in 5uL of culture medium into white solid bottom 1536-well plates (Greiner Bio-One, Monroe, NC) using a Multidrop Combi (Thermo Scientific, Waltham, MA) dispenser. The assay plates were incubated at 37 C and 5% CO2 for an overnight, and then 23nL of compounds dissolved in DMSO and positive control were transferred using a Pintool station (Wako, San Diego, CA). The assay plates were incubated at 37C and 5% CO2 for 2hr. After compound treatment, 4uL of HDAC-Glo reagent (Promega Corporation, Madison, WI) was added to each well of the assay plates using Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA) and incubated the assay plates at room temperature for 30min. The luminescence signal was quantified using a ViewLux plate reader (Perkin Elmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000060039 uM-Replicate_1Activity at 0.0000137707 uM-Replicate_1Activity at 0.0000545120 uM-Replicate_1Activity at 0.0001296300 uM-Replicate_1Activity at 0.0003002588 uM-Replicate_1Activity at 0.0006197232 uM-Replicate_1Activity at 0.00170 uM-Replicate_1Activity at 0.00522 uM-Replicate_1Activity at 0.013 uM-Replicate_1Activity at 0.030 uM-Replicate_1Activity at 0.068 uM-Replicate_1Activity at 0.153 uM-Replicate_1Activity at 0.349 uM-Replicate_1Activity at 1.067 uM-Replicate_1Activity at 3.267 uM-Replicate_1Activity at 8.386 uM-Replicate_1Activity at 18.95 uM-Replicate_1Activity at 42.46 uM-Replicate_1Activity at 92.41 uM-Replicate_1Activity at 240.3 uM-Replicate_1Activity at 872.4 uM-Replicate_1Activity at 1849.0 uM-Replicate_1Activity at 4135.0 uM-Replicate_1Activity at 9246.0 uM-Replicate_1Activity at 20670.0 uM-Replicate_1Activity at 46230.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive0004-1.80112.7774-1.8415-0.20742.7522-0.58952.2696-1.87020.36331.97610.7325-0.62932.6956-1.8011QC'd by ACCInactive0
Inactive00041.84833.49911.85170.0694.28781.41343.3664.7712-2.07911.75263.14184.66314.51411.8483QC'd by ACCInactive0
Inactive0-7.47513.92950.3365-0.967640 0 0 0 0 0 0 0 0 0 0 0 0 0 1-3.3859-0.2903-2.473-1.03721.8415-0.336714.570310.50252.40981.32621.40154.21083.9298-3.3859QC'd by ACCInactive0
Inactive0-6.67514.95490.41733-1.510740 0 0 0 0 0 0 0 0 0 0 0 0 0 05.7748-3.38013.5596-3.64571.0242-1.1873-0.2967-2.61166.7289-0.91762.06034.31662.6515.7748QC'd by ACCInactive0
Inactive00040.821415.126210.76545.17620.98484.21421.60221.59273.5668-0.24458.4795-0.33643.71260.8214QC'd by RTIInactive0
Inactive0-8.27350.80.58571.5811840 0 0 0 0 0 0 0 0 0 0 0 0 0 00.325614.203712.86892.27481.04793.86723.45882.70043.96859.13082.8612-1.18253.82280.3256QC'd by RTIInactive0
Inactive0-8.22730.50.42541.79981940 0 0 0 0 0 0 0 0 0 0 0 0 0 04.147212.8615.27520.5452-0.166912.29494.30323.456.29712.10033.67693.72713.30024.1472QC'd by RTIInactive0
Inactive0-8.02994.95490.65511.09021240 0 0 0 0 0 0 0 0 0 0 0 0 0 02.377912.98510.8072-0.76210.8362.92821.5232-6.59154.82592.41771.3890.21573.45762.3779QC'd by RTIInactive0
Inactive0-7.58464.95490.7932-1.413211.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-6.177710.755912.84851.224-2.0033-2.13760.9409-2.4535-1.3238-0.14681.4794-1.54391.9228-6.1777QC'd by RTIInactive0
Inactive00044.65840.72047.13053.67618.023412.3146-0.68080.91437.8761.0419.42773.51713.94574.6584QC'd by RTIInactive0
Inactive00042.39930.1101-0.17863.46812.7045.12813.55235.57333.5687-2.47080.49656.2858-1.53522.3993QC'd by RTIInactive0
Inactive0-8.14344.95490.34752.5-4.902740 0 0 0 0 0 0 0 0 0 0 0 0 0 0-2.9871-4.5136-3.45694.91796.2122-1.37070.72045.45623.20312.39815.9538-3.90638.5969-2.9871QC'd by RTIInactive0
Inactive00044.03264.6641.92334.267211.58863.251211.63689.8176-1.76532.88027.3668-0.12997.64764.0326QC'd by RTIInactive0
Inactive00046.77710.99752.24016.42691.95675.9749.940.990312.49784.70394.10053.97636.89266.7771QC'd by RTIInactive0
Inactive00044.3559-0.70140.03779.83890.167513.78120.07542.602910.64392.33397.33364.9954-0.28634.3559QC'd by RTIInactive0
Inactive0-8.160510.49761.850116.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-2.456512.991512.61155.09391.41642.40563.5063.08778.64233.76650.6266-2.07421.516-2.4565QC'd by RTIInactive0
Inactive0-8.15262.33320.68271.60241740 0 0 0 0 0 0 0 0 0 0 0 0 0 01.918516.500612.96341.24540.91290.5904-1.05050.56727.08161.6863.29451.80831.63131.9185QC'd by RTIInactive0
Inactive000413.19287.78641.460610.34518.847610.10484.58182.93891.98562.58544.9710.47150.210213.1928QC'd by RTIInactive0
Inactive0-5.79513.51170.4753-1.9099540 0 0 0 0 0 0 0 0 0 0 0 0 0 15.00334.4911.5981-0.2388.56656.28165.67667.248812.2092-0.8555-1.9609-2.8416-2.72135.0033QC'd by RTIInactive0
Inactive0-8.41414.0950.4031-1.59097.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-2.30797.69552.4916-5.9091-4.8419-3.7145-0.1685-2.82750.9145-3.8991.51358.1761-4.1605-2.3079QC'd by RTIInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: AP1247
Protocol: Tox21 Assay Protocol Summary:

2500 cells/5uL in Opti-MEM medium containing 0.5% dialyzed FBS, 0.1 mM NEAA, 1 mM sodium pyruvate and 10 mM HEPES was dispensed into 1536-well black wall/clear bottom plates using a Multidrop dispenser and cells were cultured at 37 degrees Celsius overnight. Next day 23 nL of compounds dissolved in DMSO, positive controls or DMSO were delivered to each well using a pin tool. The plates were incubated at 37 degrees Celsius for 5 hours. 1 uL of LiveBLAzerTM B/G FRET substrate (Solution A+B+C+D) was added to each well using a Flying Reagent Dispenser. After incubated at room temperature for 2.5 hours the plates were measured on an EnVision plate reader at Excitation 405nm, Emission1=460nm and Emission 2=530nm. The %Activity was determined from the ratio of 460nm/530nm.
For primary data analysis, raw plate reads for each titration point were first normalized relative to 39.129 ug/ml EGF control (100%) and DMSO only wells (basal, 0%).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent activators are ranked higher than compounds that showed apparent inhibition.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000049913 uM-Replicate_1W530-Activity at 0.0000114526 uM-Replicate_1W530-Activity at 0.0000453222 uM-Replicate_1W530-Activity at 0.0001077752 uM-Replicate_1W530-Activity at 0.0002496487 uM-Replicate_1W530-Activity at 0.0005152025 uM-Replicate_1W530-Activity at 0.00141 uM-Replicate_1W530-Activity at 0.00434 uM-Replicate_1W530-Activity at 0.011 uM-Replicate_1W530-Activity at 0.025 uM-Replicate_1W530-Activity at 0.057 uM-Replicate_1W530-Activity at 0.127 uM-Replicate_1W530-Activity at 0.290 uM-Replicate_1W530-Activity at 0.887 uM-Replicate_1W530-Activity at 2.716 uM-Replicate_1W530-Activity at 6.973 uM-Replicate_1W530-Activity at 15.76 uM-Replicate_1W530-Activity at 35.30 uM-Replicate_1W530-Activity at 76.83 uM-Replicate_1W530-Activity at 199.8 uM-Replicate_1W530-Activity at 725.3 uM-Replicate_1W530-Activity at 1537.0 uM-Replicate_1W530-Activity at 3438.0 uM-Replicate_1W530-Activity at 7687.0 uM-Replicate_1W530-Activity at 17190.0 uM-Replicate_1W530-Activity at 38440.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inactive104-0.34320.4882-3.9902-1.8278-2.6388-4.0761-0.2834-3.925-0.8811-0.118-2.0248-1.7566-6.3328-0.343210-4.66014.95490.799313-0.438340 0 0 0 0 0 0 0 0 0 0 0 0 0 1-1.2767
Inactive10-5.32130.60.3371-10.3976-140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-10.3314-4.8781-7.19081.23496.3561-0.4658-1.0922-4.0891-3.6058-6.6447-3.7684-6.5072-4.3611-10.331410-4.67134.0950.38588.5-2.655740 0 0 0 0 0 0 0 0 0 0 0 0 0 07.6824
Inactive1042.6882-2.9195-0.5357-4.57750.8593-0.79280.3453-0.26140.8312.25350.1398-0.4896-0.60962.6882104-2.9029
Activator24.541223.164910-4.46012.40640.8876-19.07321.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-16.3112.25824.7132-1.2624-0.58641.43752.23122.2829-0.13732.24672.2032.3753-10.092-16.3110Complete curve; partial efficacy; poor fit-4.61014.95490.852240.83511.40 0 0 0 0 0 0 0 0 0 0 0 0 0 024.5331
Inactive10-7.16012.04370.5556-4.0062240 0 0 0 0 0 0 0 0 0 0 0 0 0 0-9.17181.33990.40155.61051.6237-1.629-0.5278-7.0006-0.9294-5.2799-3.031-4.0565-2.001-9.17181040 0 1 0 0 0 0 0 0 0 0 0 0 0 019.4939
Inconclusive1040.17361.2744-2.2629-1.4052-0.0634-0.4421-6.23050.37550.99341.80430.74112.01090.150.173610-4.37130.80.5909282.22540 0 0 0 0 0 0 0 0 0 0 0 0 0 020.5085
Inactive1040.93150.4673-0.08734.45990.4776-2.6062-0.03173.20570.57912.01585.91540.1913-1.94810.931510-4.86014.95490.612311-0.366140 0 0 0 0 0 0 0 0 0 0 0 0 0 09.4135
Inactive104-0.14120.28791.1958-2.0437-0.545-0.02691.8403-0.54861.05061.35112.76530.65010.5481-0.1412104-0.7351
Inactive10-8.11014.95490.4383-0.5-5.241940 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.8119-4.1471-8.07441.777-0.1077-1.6299-0.2416-2.0803-1.1151-1.98822.01480.44881.6546-0.8119104-5.3915
Inactive1042.6008-1.1946-1.67251.3391-1.3947-0.288-0.4735-2.2643-1.0237-0.36311.6140.37860.02072.6008104-3.7937
Inactive1042.7658-0.8849-2.5266-2.7864-3.89960.154-3.0724-1.1102-0.0861-1.2059-4.2435-1.27880.32052.76581041.0908
Inconclusive104-5.1946-9.7228-1.14872.88610.1387-2.3645-3.9192-1.2052-2.62790.4272-6.6707-5.8286-3.2852-5.19460Partial curve; partial efficacy; poor fit-8.81014.50450.844-1.054519-2.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0-1.2127
Inactive104-3.7358-0.80981.2025-0.6836-0.4114-3.60381.1685-0.2531-0.19460.9182-2.6543-12.28891.8754-3.735810-5.21013.51170.32818-0.460740 0 0 0 0 0 0 0 0 0 0 0 0 0 11.7915
Inactive104-5.3169-0.7134-4.6223-5.9057-1.05750.43281.4275.2814-3.9477-3.987-8.48370.8519-6.3953-5.31691040.3169
Inactive1043.7298-3.69052.07664.6335-1.563-1.5597-3.82890.72712.28080.0643-0.5264-1.84977.33873.7298104-8.4453
Inactive10-4.61014.95490.5065-0.807240 0 0 0 0 0 0 0 0 0 0 0 0 0 03.8205-2.8073-1.6288-2.1151.3-1.6442-2.00091.01150.6569-1.36641.0862-2.2116.05183.820510-4.61014.95490.8062-9.45150.540 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0713
Inactive1042.74394.44983.81610.98024.08465.0430.44260.30981.63730.3447-4.73043.32137.50432.7439104-0.8632
Inactive1041.1431.9495-0.09610.1498-0.38910.8641-1.0748-0.8918-0.28286.07472.52781.47022.0031.143104-1.1033
Inactive1040.4798-1.7995-2.67232.5421-0.82330.30470.94633.7652-0.5520.92415.02740.69463.62830.4798104-2.4779
Inactive10-6.01012.40640.36422.5-1.173340 0 0 0 0 0 0 0 0 0 0 0 0 0 01.7085-2.8351-1.6070.21414.64630.0575-5.9778-1.19750.78381.64344.02251.84412.77831.708510-6.16013.92950.4065-3.23473.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-6.1634
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: TGF527
Protocol: Tox21 Assay Protocol Summary:

SBE-bla HEK 293T cells were dispensed at 4,000/well in 5 uL of assay medium into black wall/clear-bottom 1536-well plates using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. After the assay plates were incubated at 37 C and 5% CO2 for an overnight, 23 nL of compounds dissolved in DMSO, positive controls or DMSO only was transferred to the assay plate by a Pintool station (Kalypsys, San Diego, CA). Compound transfer was followed by the addition of 1 uL of 0.25 ng/mL TGF-beta1 or assay buffer using two separate tips of Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA). The assay plates were incubated at 37 C and 5% CO2 for 5 hr. One uL of LiveBLAzer B/G FRET substrate (Life Technologies) was added using FRD and the plates were incubated at room temperature for 2 hr. Fluorescence intensity (405 nm excitation, 460 nm and 530 nm emissions) was measured using an Envision plate reader (PerkinElmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1W530-Activity_Score-Replicate_1W530-Curve_Description-Replicate_1W530-Fit_LogAC50-Replicate_1W530-Fit_HillSlope-Replicate_1W530-Fit_R2-Replicate_1W530-Fit_InfiniteActivity-Replicate_1W530-Fit_ZeroActivity-Replicate_1W530-Fit_CurveClass-Replicate_1W530-Excluded_Points-Replicate_1W530-Max_Response-Replicate_1W530-Activity at 0.0000049913 uM-Replicate_1W530-Activity at 0.0000114526 uM-Replicate_1W530-Activity at 0.0000453222 uM-Replicate_1W530-Activity at 0.0001077752 uM-Replicate_1W530-Activity at 0.0002496487 uM-Replicate_1W530-Activity at 0.0005152025 uM-Replicate_1W530-Activity at 0.00141 uM-Replicate_1W530-Activity at 0.00434 uM-Replicate_1W530-Activity at 0.011 uM-Replicate_1W530-Activity at 0.025 uM-Replicate_1W530-Activity at 0.057 uM-Replicate_1W530-Activity at 0.127 uM-Replicate_1W530-Activity at 0.290 uM-Replicate_1W530-Activity at 0.887 uM-Replicate_1W530-Activity at 2.716 uM-Replicate_1W530-Activity at 6.973 uM-Replicate_1W530-Activity at 15.76 uM-Replicate_1W530-Activity at 35.30 uM-Replicate_1W530-Activity at 76.83 uM-Replicate_1W530-Activity at 199.8 uM-Replicate_1W530-Activity at 725.3 uM-Replicate_1W530-Activity at 1537.0 uM-Replicate_1W530-Activity at 3438.0 uM-Replicate_1W530-Activity at 7687.0 uM-Replicate_1W530-Activity at 17190.0 uM-Replicate_1W530-Activity at 38440.0 uM-Replicate_1Ratio-Activity_Score-Replicate_1Ratio-Curve_Description-Replicate_1Ratio-Fit_LogAC50-Replicate_1Ratio-Fit_HillSlope-Replicate_1Ratio-Fit_R2-Replicate_1Ratio-Fit_InfiniteActivity-Replicate_1Ratio-Fit_ZeroActivity-Replicate_1Ratio-Fit_CurveClass-Replicate_1Ratio-Excluded_Points-Replicate_1Ratio-Max_Response-Replicate_1
Inactive10004-15.4448-17.829-14.7011-9.82310.5002-15.8028-2.7076-14.9549-5.4773-4.8963-15.9725-2.60831.3352-15.444810-5.52133.06540.4094-10.42664.540 0 0 0 0 0 0 0 0 0 0 0 0 0 12.4696
Inactive10004-2.08245.1683-8.32381.40357.51822.8391-7.85766.33177.70660.9570.1414-10.93370.317-2.082410004-1.7982
Inactive100040.5212-0.7578-3.1457-3.58579.9306-9.09228.6578-0.8604-6.0829-2.6264-0.01361.1374-1.72130.521210-4.82130.90.3635-18.6716-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-13.893
Inhibitor21.313869.5125100046.99898.41271.04394.09081.19219.13684.52525.17574.16645.55016.64581.70963.17586.99890Partial curve; high efficacy-4.67134.44950.9181-68.93630.5762-2.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-63.6969
Inconclusive10004-0.3211.50570.0445-2.6090.3044-3.5435-2.150801.6390.2469-2.0136-4.8091-6.1169-0.3210Single point of activity-5.57134.95490.8922-36.85962-30 0 0 0 0 0 0 0 1 0 0 0 1 1 1-1.1271
Inactive10-5.07131.11050.57373-5.479940 0 0 0 0 0 0 0 0 0 0 0 0 0 01.4255-3.6266-7.8398-6.7962-4.3579-3.3311-6.7482-6.9451-1.6151-3.6067-4.2635-2.74931.13651.4255100046.031
Inconclusive23.914535.986710Partial curve; partial efficacy; poor fit-4.62132.40640.829733.5-2.48672.40 0 0 0 0 0 0 0 0 0 0 0 0 0 025.4725-0.4603-5.9521-4.4118-2.2203-1.3826-1.24032.07321.7182-6.0884-5.42015.94315.298225.472510-8.82134.95490.4923-1.6948640 0 0 0 0 0 0 0 0 0 0 0 0 0 0-0.9429
Inactive10-5.27134.95490.38555-1.824540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-5.55351.0513-3.6872-3.4997-0.74440.95772.9029-1.4667-5.27040.1402-4.02417.20312.2067-5.5535100040.3159
Inactive100040.889713.62015.29218.83340.3541-0.59463.17796.3444-2.5075-3.99235.258-1.65138.03440.88971000412.6308
Inconclusive10Partial curve; partial efficacy-5.02131.59360.878830-2.92312.20 0 0 0 0 0 0 0 0 0 0 0 0 0 030.2727-1.53680.3332-3.42190.7754-1.0275-1.226-7.5734-8.2693-4.6322-1.164617.051615.070830.272710-4.62130.40.5096-35.37950.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-26.1496
Inactive100041.4065-2.3371-1.3586-0.9315-1.875-2.39130.2634-0.372-3.596-1.4312-2.2162-3.27320.93971.406510-5.17134.95490.614312.50.873440 0 0 0 0 0 0 0 0 0 0 0 0 0 015.0039
Inactive10004-4.3355-1.17940.6791-6.7308-4.3365-5.83860.5449-4.6235-9.1470.4814-7.93388.66420.5341-4.3355100042.9974
Inactive10004-2.7347-0.9378-1.5837-2.1953-5.0708-0.554-3.6401-1.2353-0.1057-1.7284-0.6766-1.9577-1.5679-2.734710004-3.3454
Inactive10-4.82132.72020.5665-12.2422140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-10.61851.91711.9725-2.2227-0.43051.48161.9276-1.09751.52111.79992.74461.118-8.0476-10.618510004-1.9812
Inactive10004-3.6617272.68630.22482.1789-0.4797-2.128-2.318-4.46263.09724.59821.21017.5265-3.5721-3.661710-7.47132.72020.47818-1.808840 0 0 0 0 0 0 0 0 0 0 0 0 0 11.6895
Inconclusive100040.284-2.5083-1.4317-1.7288-3.86971.1292-0.331-2.2511-5.3544-1.3038-0.3114-2.1567-0.09680.28410-4.62131.75290.5407-29.8727640 0 0 0 0 0 0 0 0 0 0 0 0 0 0-21.5606
Inactive10-5.72134.95490.48578.5-2.831940 0 0 0 0 0 0 0 0 0 0 0 0 0 12.0911-0.4682-7.3264-6.5377-0.21892.6133-5.4727-2.3790.78360.24237.7560.31969.18242.091110004-2.9022
Inactive10004-2.3777-1.31260.4395-0.8984-2.8529-2.1047-1.6455-1.7526-1.2919-4.1825-1.9178-4.92310.4778-2.3777100043.5461
Inactive10004-0.5281-0.78955.32570.5856-0.47190.077-6.7661-0.4385-2.8184-4.33441.9832-9.53950.0359-0.528110004-6.7568
Inactive10-4.97132.40640.5164-9.77241.540 0 0 0 0 0 0 0 0 0 0 0 0 0 1-1.6017-0.55444.51570.846-0.7049-0.05631.49982.1958.46930.51810.21140.7395-8.977-1.601710-6.07134.95490.4267-11.0614-0.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-16.6809
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:N/A
External ID: RXR192
Protocol: Tox21 Assay Protocol Summary:

RXR-alpha HEK 293T cells were dispensed at 2,000 cells/6 uL of assay medium containing 2% charcoal-stripped FBS using a Multidrop Combi (ThermoFisher Scientific, Waltham, MA) dispenser. The assay was performed in black wall/clear-bottom 1536-well plates (Greiner Bio-One North America Inc. Monroe, NC). Tetraoctyl ammonium bromide was used as a positive control in the cytotoxicity screen. After the assay plates were incubated at 37 C and 5% CO2 for 5 hr, 23 nL of compounds dissolved in DMSO, positive control or DMSO only were transferred to the assay plate by a Pintool station (Kalypsys, San Diego, CA). The assay plates were incubated at 37 C and 5% CO2 for 16 hr. One uL of LiveBLAzer B/G FRET substrate (Life Technologies) was added using a Flying Reagent Dispenser (FRD) (Aurora Discovery, San Diego, CA) and the plates were incubated at room temperature for 2 hr. Fluorescence intensity (405 nm excitation, 460/530 nm emission) was measured using an Envision plate reader (PerkinElmer, Shelton, CT). For cytotoxicity, 4 uL/well of CellTiter-Glo reagent was added into the assay plates using an FRD. After 30 min incubation at room temperature, the luminescence intensity was measured using a ViewLux plate reader (PerkinElmer).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000049913 uM-Replicate_1Activity at 0.0000114526 uM-Replicate_1Activity at 0.0000453222 uM-Replicate_1Activity at 0.0001077752 uM-Replicate_1Activity at 0.0002496487 uM-Replicate_1Activity at 0.0005152025 uM-Replicate_1Activity at 0.00141 uM-Replicate_1Activity at 0.00434 uM-Replicate_1Activity at 0.011 uM-Replicate_1Activity at 0.025 uM-Replicate_1Activity at 0.057 uM-Replicate_1Activity at 0.127 uM-Replicate_1Activity at 0.290 uM-Replicate_1Activity at 0.887 uM-Replicate_1Activity at 2.716 uM-Replicate_1Activity at 6.973 uM-Replicate_1Activity at 15.76 uM-Replicate_1Activity at 35.30 uM-Replicate_1Activity at 76.83 uM-Replicate_1Activity at 199.8 uM-Replicate_1Activity at 725.3 uM-Replicate_1Activity at 1537.0 uM-Replicate_1Activity at 3438.0 uM-Replicate_1Activity at 7687.0 uM-Replicate_1Activity at 17190.0 uM-Replicate_1Activity at 38440.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive043.562-9.6645-0.1578-1.0837-2.33655.6395-5.6809-5.9357-0.48355.54850.11433.70811.87873.562QC'd by ACCInactive0-6.82134.95490.6738
Inactive0-7.22134.95490.33087.5-0.949740 0 0 0 0 0 0 0 0 0 0 0 0 0 05.8842-0.34931.21092.8866-6.3507-7.45813.54228.965315.5525-3.40658.86870.97114.52165.8842QC'd by ACCInactive0
Inactive04-2.4791-6.699211.2232-4.9926-5.534-3.92543.271912.60362.60522.91961.25180.2835-6.8749-2.4791QC'd by ACCCytotoxic4.771635.089520Partial curve; partial efficacy; poor fit-5.32132.33320.7517
Inactive040.41635.12349.33871.5309-2.21765.66343.24313.8586-0.334611.40184.66888.237-1.17170.4163QC'd by ACCInactive0
Inactive0-4.73624.95490.3414-4.0365440 0 0 0 0 0 0 0 0 0 0 0 0 0 0-5.03041.4028-1.14412.478514.73033.6222.9436-0.02461.27665.57248.1586-0.7754-2.2943-5.0304QC'd by RTIInactive0-4.78623.51170.3784
Inactive0-4.51952.72020.5101-18.2805240 0 0 0 0 0 0 0 0 0 0 0 0 0 0-14.80771.3355-0.7675-8.4998.5445-1.0072-1.2959-0.77233.841310.58062.30478.8588-14.8171-14.8077QC'd by RTIInactive0
Inactive0-5.02351.10.5109243.841640 0 0 0 0 0 0 0 0 0 0 0 0 0 021.46464.228313.3672-2.18320.48153.8276-3.46531.548915.2585.15768.581924.063519.087321.4646QC'd by RTIInactive0-4.92352.40640.6703
Inactive044.4009-12.95143.9644-17.14413.69442.2035-2.146-2.0041-21.26142.03812.3643.8628-0.69824.4009QC'd by RTIInactive0
Inactive042.22914.03552.45478.93810.77762.16052.73881.51832.1843-1.325611.8323-2.00253.55812.2291QC'd by RTIInactive0-5.28094.95490.4972
Inactive04-12.9986-9.68584.03930.7698-9.0544-11.3226-5.3279-0.36134.91243.1628-10.3813-1.3372-9.3185-12.9986QC'd by RTIInactive0
Inactive0-4.3250.50.5908-35.3884140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-26.1579.59246.2647-1.0279-8.9148-4.50273.7255-7.9441-0.1816-7.0122-8.6937-6.5728-16.8919-26.157QC'd by RTIInactive0-4.1254.95490.6686
Inactive04-9.9746-9.7565-11.0525-3.2535-0.90145.4630.017-1.62942.6179-14.0981-3.0362-8.2644-12.3168-9.9746QC'd by RTIInactive0-6.88971.62590.5476
Cytotoxic62.154972.463320Single point of activity-4.20654.95490.871-74.2731-1.8097-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-61.7247-10.217-1.12527.07141.2542-1.165711.3726-2.89-1.7761-5.7083-6.0329-8.3109-7.8344-61.7247QC'd by RTICytotoxic44.002376.017741Partial curve; partial efficacy-4.35651.50950.9311
Inactive04-9.3385-6.5164-3.1505-7.7242-0.877-7.7942-4.4066-1.1996-3.281-2.6574-5.3721-1.0287-9.409-9.3385QC'd by RTIInactive0
Inactive0-8.49990.70.4588-10.21811240 0 0 0 0 0 0 0 0 0 0 0 0 0 0-7.41218.8804-3.0871-1.5924-5.5551-4.1428-11.1164-16.8811-7.7757-9.2673-4.5522-6.6996-18.0984-7.4121QC'd by RTICytotoxic0.316322.358822Complete curve; partial efficacy-6.49993.92950.7436
Inactive0-4.2074.95490.584-33.9576240 0 0 0 0 0 0 0 0 0 0 0 0 0 0-27.88137.50448.78755.90111.86116.8878-1.11950.0457-3.7646-7.656-0.13944.08320.1987-27.8813QC'd by RTICytotoxic43.953732.19420Single point of activity-4.3571.10.7384
Inactive0-8.74891.75290.366314-4.968440 0 0 0 0 0 0 0 0 0 0 0 0 0 1-1.006-0.8077.742216.138325.092713.877418.60498.456510.468112.629710.216911.83116.2017-1.006QC'd by RTIInactive0
Inactive0-5.44190.80.4311-7.19783.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-6.8315-0.09926.4534-0.77542.08169.96721.65992.2904-0.7737-1.3658-1.0207-5.875-5.1426-6.8315QC'd by RTIInactive0-4.59194.95490.5801
Inactive04-3.68586.3685-1.22130.3419-12.0993-1.33213.5285-0.1143-2.1292-0.2924-0.7975-7.3158-3.086-3.6858QC'd by RTIInactive0-8.64140.40.3852
Inactive042.81786.041.2024-1.1505-0.9257-0.91896.85872.56660.7244.34526.458214.0163-1.01112.8178QC'd by RTIInactive0-4.410410.4736
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:v-jun sarcoma virus 17 oncogene homolog (avian) [Homo sapiens]
External ID: AP1805
Protocol: Please refer to other AIDs 1159526, 1159525, 720687, 720685, 720678 and 720681, for detailed assay protocols.
Comment: This summary is written for the purposes of summarizing the compound activities from the project combining the results from both the AP-1 agonist mode assay (AID 1159526), cell viability counter screen (AID 1159525), and auto fluorescence counter screens (AIDs 720687, 720685, 720678 and 720681). For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Potency and efficacy were used for determining relative score. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 5 and 30 determined by phenotype.

Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).
Activity SummaryRatio ActivityRatio Potency (uM)Ratio Efficacy (%)530 nm Activity530 nm Potency (uM)530 nm Efficacy (%)460 nm Activity460 nm Potency (uM)460 nm Efficacy (%)Viability ActivityViability Potency (uM)Viability Efficacy (%)Blue (46 nm) auto fluorescence outcomeSupplier
active agonistactive agonist11.4370427665.8546974active antagonist14.96168173-29.22063996active agonist5.10873934643.85469057inactive0inactiveFisher
active agonistactive agonist11.9856213765.14940301inconclusive antagonist10.08464359-21.14481039active agonist9.16207593859.49294851inactive0inactiveMicrosource
active agonistactive agonist12.3907031171.68466025inactive0active agonist10.3739933266.73579939inactive0inactiveSIGMA
active agonistactive agonist12.454526570.43035593inconclusive antagonist15.08900332-26.50653641active agonist11.1001084365.12531059inactive0GVK
active agonistactive agonist12.9417762570.32076983active antagonist16.93014018-61.25890926inconclusive agonist8.98794805931.49104199inactive0inactiveEnzo
active agonistactive agonist13.4480883668.82084786inconclusive antagonist14.24493769-30.54877479active agonist11.5343702254.39208219inactive0inactiveBosche
active agonistactive agonist13.7448536276.09735132active antagonist23.52195707-87.88246137inconclusive agonist17.10528908active antagonist31.97472264-110.1809047inactiveSIGMA
active agonistactive agonist14.0467236173.09977614active antagonist42.74726859-87.70457178active agonist3.95890460534.24358203active antagonist44.41964026-90.65272003inactiveAcros
active agonistactive agonist14.077687169.93151732active antagonist25.03406111-87.6342514active agonist6.05152234247.94719974active antagonist35.36155121-104.734175inactiveChemService
active agonistactive agonist14.1774560369.99871021inconclusive antagonist12.15994591-24.42138772inconclusive agonist14.452122875.66336801active antagonist17.17638013-58.84057919inactiveNCGCChem
active agonistactive agonist16.285356279.53143676active antagonist26.82031838-86.62582769active agonist8.16201262133.89481329active antagonist32.49355751-94.67572994inactiveToronto Research
active agonistactive agonist16.4019902375.53399511active antagonist19.49380193-37.26633731active agonist15.4844772771.15364739active antagonist48.96621656-51.53693854inactiveLightBiologicals
active agonistactive agonist17.0830597584.62764914active antagonist21.50629804-33.70621021active agonist14.3736034874.36378073active antagonist58.3309424-78.78735315inactiveRTI
active agonistactive agonist17.5924862882.75815796active antagonist21.3137837-34.39159914active agonist15.0890033279.77323838inactive0GVK
active agonistactive agonist17.9453960780.32124687active antagonist30.71046427-100.352222active agonist7.14419085446.70124744active antagonist37.20657684-117.374731inactiveSIGMA
active agonistactive agonist18.5159746383.30438527active antagonist17.48020723-45.7893104active agonist18.8746935969.71672347inactive0inactiveSIGMA
active agonistactive agonist18.7598724889.78985055active antagonist19.49380193-32.83873888active agonist18.0535750279.6909909inactive0inactiveMaybridge
active agonistactive agonist18.8872066989.11495153active antagonist17.49179585-30.5944205active agonist13.8942273268.73259047inactive0inactiveSIGMA
active agonistactive agonist19.8784224189.1067022active antagonist22.30395679-37.76045213active agonist17.7166626279.72515673inconclusive antagonist49.93233953-98.10856857inactiveSIGMA
active agonistactive agonist20.6488823187.94630228active antagonist23.16842701-40.43096788inconclusive agonist19.4938019373.21398568inconclusive antagonist43.64118645-60.91733811inactiveLightBiologicals
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:
External ID: SHH296
Protocol: Tox21 Assay Protocol Summary:

3T3 Gli1-Luc cells were dispensed at 2,000 per well in 5uL of culture medium into white solid bottom 1536-well plates (Greiner Bio-One, Monroe, NC) using a Multidrop Combi (Thermo Scientific, Waltham, MA) dispenser. The assay plates were incubated at 37 C and 5% CO2 for 4hr, and then 23nL of compounds dissolved in DMSO and positive control were transferred using a Pintool station (Wako, San Diego, CA). The compound transfer was followed by the addition of 1ul conditioned medium or assay buffer using two separate tips of Flying Reagent Dispenser (FRD, Aurora Discovery, San Diego, CA). The assay plates were incubated at 37C and 5% CO2 for 24hr. For luciferase read, 4uL of Amplite Luciferase reporter gene assay reagent (AAT Bioquest, Inc. Sunnyvale, CA) was added to each well of the assay plates using FRD and incubated at room temperature for 30min. The luminescence signal was measured using a ViewLux plate reader (Perkin Elmer, Shelton, CT).
Comment: Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).

Compound Ranking:

1. Compounds are first classified as having full titration curves, partial modulation, partial curve (weaker actives), single point activity (at highest concentration only), or inactive. See data field "Curve Description". For this assay, apparent inhibitors are ranked higher than compounds that showed apparent activation.
2. For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. For all active compounds, a score range was given for each curve class type given above. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 1 and 39. Fit_LogAC50 was used for determining relative score and was scaled to each curve class' score range.
Phenotype-Replicate_1Potency-Replicate_1Efficacy-Replicate_1Analysis Comment-Replicate_1Activity_Score-Replicate_1Curve_Description-Replicate_1Fit_LogAC50-Replicate_1Fit_HillSlope-Replicate_1Fit_R2-Replicate_1Fit_InfiniteActivity-Replicate_1Fit_ZeroActivity-Replicate_1Fit_CurveClass-Replicate_1Excluded_Points-Replicate_1Max_Response-Replicate_1Activity at 0.0000060039 uM-Replicate_1Activity at 0.0000137707 uM-Replicate_1Activity at 0.0000545120 uM-Replicate_1Activity at 0.0001296300 uM-Replicate_1Activity at 0.0003002588 uM-Replicate_1Activity at 0.0006197232 uM-Replicate_1Activity at 0.00170 uM-Replicate_1Activity at 0.00522 uM-Replicate_1Activity at 0.013 uM-Replicate_1Activity at 0.030 uM-Replicate_1Activity at 0.068 uM-Replicate_1Activity at 0.153 uM-Replicate_1Activity at 0.349 uM-Replicate_1Activity at 1.067 uM-Replicate_1Activity at 3.267 uM-Replicate_1Activity at 8.386 uM-Replicate_1Activity at 18.95 uM-Replicate_1Activity at 42.46 uM-Replicate_1Activity at 92.41 uM-Replicate_1Activity at 240.3 uM-Replicate_1Activity at 872.4 uM-Replicate_1Activity at 1849.0 uM-Replicate_1Activity at 4135.0 uM-Replicate_1Activity at 9246.0 uM-Replicate_1Activity at 20670.0 uM-Replicate_1Activity at 46230.0 uM-Replicate_1Compound QC-Replicate_1Phenotype-Replicate_2Potency-Replicate_2Efficacy-Replicate_2Analysis Comment-Replicate_2Activity_Score-Replicate_2Curve_Description-Replicate_2Fit_LogAC50-Replicate_2Fit_HillSlope-Replicate_2Fit_R2-Replicate_2
Inactive0-7.95784.95490.37164-4.310240 0 0 0 0 0 0 0 0 0 0 0 0 0 010.50761.0754-0.04-14.84190.3958.114.83152.76361.18520.9238-2.46995.95846.30963.74710.5076QC'd by LightBiologicalsInactive0
Inhibitor68.589662.330810Single point of activity-4.16374.50450.6576-62.8416-0.5108-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-49.65529.77741.0516-1.9274-9.5019-2.7662-5.42451.3015.25841.8966-10.8088-10.372-6.0308-49.6552QC'd by LightBiologicalsInhibitor68.589664.537610Single point of activity-4.16374.95490.7963
Inactive0-4.91373.06540.760818.5-1.358440 0 0 0 0 0 0 0 0 0 0 0 0 0 10-1.5013-10.2987-0.9381-2.22951.8313-0.6133.03931.442-3.232-0.139416.763416.74770QC'd by LightBiologicalsInhibitor15.355359.43210Single point of activity-4.81374.44950.7442
Inactive0-4.51370.60.5808-24.626-240 0 0 0 0 0 0 0 0 0 0 0 0 0 0-18.855-1.2266-7.9052-1.96360.4216-2.1457-12.6919-3.8213-2.4136-3.0568-11.9221-15.062-10.108-18.855QC'd by LightBiologicalsInactive0
Activator27.30647.60630Single point of activity-4.56374.95490.656948.8391.232730 0 0 0 0 0 0 0 0 0 0 0 0 0 10-1.878810.36553.17559.34918.7816-5.228512.1727-6.0134-12.88819.79243.756646.83410QC'd by LightBiologicalsInactive0-6.46370.40.3647
Inactive00048.7904-0.66156.1391-4.22877.2183-0.9406-3.6825.4366-2.23319.65153.12528.3517.90798.7904QC'd by LightBiologicalsInactive0
Inhibitor68.589642.056610Single point of activity-4.16374.95490.7856-45.7215-3.6649-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-37.8742-4.35050.2798-5.5877-10.6254-6.2968-9.1373-0.8779-3.2409-6.3150.73523.7744-6.6905-37.8742QC'd by LightBiologicalsInhibitor24.336542.096520Complete curve; partial efficacy-4.61374.95490.9165
Inactive0-5.08660.20.313224240 0 0 0 0 0 0 0 0 0 0 1 0 0 018.277310.58743.11262.55262.40789.280718.3633.00219.01589.950315.734161.77065.749817.569218.2773QC'd by LightBiologicalsInactive0
Inhibitor61.130648.297210Partial curve; partial efficacy; poor fit-4.21372.84730.6517-50.1074-1.8103-2.40 0 0 0 0 0 0 0 0 0 0 0 0 0 0-38.581-2.00660.2722-1.1166-25.068-0.05291.988-1.66921.30129.5219-1.7216-3.7728-13.9659-38.581QC'd by LightBiologicalsInhibitor61.1306129.132742Partial curve; high efficacy-4.21372.63840.8862
Inactive0-5.01371.80790.354211-6.469940 0 0 0 0 0 0 0 0 0 0 0 0 0 013.0196-8.50920.3813-7.0601-11.37113.2466-12.2656-5.0707-15.48553.0642-2.495910.32545.301313.0196QC'd by LightBiologicalsActivator68.589643.01760Single point of activity-4.16374.95490.8414
Inactive0004-15.25663.4583-2.09415.95650.143910.1189-5.2185-8.5110.7879-7.44644.397111.64372.2463-15.2566QC'd by LightBiologicalsInhibitor61.130639.224810Single point of activity-4.21374.95490.3937
Inactive0-7.66370.40.5057-9.47091.540 0 0 0 0 0 0 0 0 0 0 0 0 0 0-8.0592-0.1517-5.0933-5.1214-4.3886-2.9978-4.299-8.9168-7.3778-7.5004-5.544-15.8091-7.2579-8.0592QC'd by LightBiologicalsInactive0-5.31374.95490.4063
Inactive0-4.11374.95490.5096-25.2387140 0 0 0 0 0 0 0 0 0 0 0 0 0 0-19.36562.82090.84820.2694-2.3095.6233-8.8808-4.14394.9512-1.09851.2695-0.59119.3133-19.3656QC'd by LightBiologicalsInactive0-8.51371.0310.4013
Inhibitor2.46931.062710Single point of activity-5.60754.95490.6676-35.0627-4-30 0 0 0 0 0 0 0 0 0 0 1 1 1 16.3775-9.93623.6627-14.1092-8.9473-10.0393-5.35750.6405-2.24280.8053-34.3752-20.574-14.5414-5.39146.3775QC'd by LightBiologicalsInactive0
Inhibitor9.688580.299182Complete curve; high efficacy-5.01371.88510.9451-84.9993-4.7002-1.10 0 0 0 0 0 0 0 0 0 0 0 0 0 0-79.824-5.7037-10.422212.1777-2.7885-1.5422-11.6676-10.6496-8.436-16.3449-33.2125-76.6584-78.1349-79.824QC'd by LightBiologicalsInhibitor7.695980.028282Complete curve; high efficacy-5.11372.24810.9594
Inactive00042.433814.57568.398511.83714.31375.36842.9131.921110.72966.04114.004710.30270.9082.4338QC'd by LightBiologicalsInactive0
Inactive0004-11.91010.378715.1812-4.0746-2.827716.134211.5039-22.55413.0886-5.92115.4484-7.6167-14.3002-11.9101QC'd by LightBiologicalsInhibitor2.4337120.342110Single point of activity-5.61374.95490.926
Inhibitor76.958856.515910Single point of activity-4.11374.95490.5969-53.8782.6379-30 0 0 0 0 0 0 0 0 0 0 0 0 0 0-42.0966-0.71677.29161.9481.3314-18.8984-3.49034.58580.80211.94156.603825.14619.2783-42.0966QC'd by LightBiologicalsInhibitor61.130689.468610Single point of activity-4.21374.95490.8157
Inactive00042.9368-11.8025-10.638-14.2775-2.3007-2.7906-15.6256-5.174-3.7421-8.9845-10.9165-8.6029-22.56562.9368QC'd by LightBiologicalsInactive0-4.54134.95490.4361
Inactive000404.8931-9.76074.89825.28215.234610.50894.2033.05796.28540.407-0.56065.51880QC'd by LightBiologicalsInactive0
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:824 靶标:retinoid X nuclear receptor alpha [Homo sapiens]
External ID: RXR355
Protocol: Please refer to other AIDs 1159527, 1159529, 720687, 720685, 720678 and 720681, for detailed assay protocols.
Comment: This summary is written for the purposes of summarizing the compound activities from the project combining the results from both the RXR agonist mode assay (AID 1159527), cell viability counter screen (AID 1159529), and auto fluorescence counter screens (AIDs 720687, 720685, 720678 and 720681). For all inactive compounds, PUBCHEM_ACTIVITY_SCORE is 0. Active compounds have PUBCHEM_ACTIVITY_SCORE between 40 and 100. Potency and efficacy were used for determining relative score. Inconclusive compounds have PUBCHEM_ACTIVITY_SCORE between 5 and 30 determined by phenotype.

Disclaimer:

Although all reasonable efforts have been made to ensure the accuracy and reliability of the data, caution should be exercised when interpreting the results as artifacts are possible from nonspecific effects such as assay signal interference. The curve fitting and activity calls presented here are based on the NCATS analysis methods. Alternative analysis methods and interpretations of the data are available at EPA (http://actor.epa.gov) and NTP (http://tools.niehs.nih.gov/cebs3/ui/).
Activity SummaryRatio ActivityRatio Potency (uM)Ratio Efficacy (%)530 nm Activity530 nm Potency (uM)530 nm Efficacy (%)460 nm Activity460 nm Potency (uM)460 nm Efficacy (%)Viability ActivityViability Potency (uM)Viability Efficacy (%)Blue (46 nm) auto fluorescence outcomeSupplier
inconclusive antagonistinconclusive antagonist27.53909606-31.79541431active agonist7.76157182928.01117168inconclusive antagonist54.94772057-35.53879602active antagonist13.80224337-83.91676247inactiveLightBiologicals
inconclusive antagonistinconclusive antagonist14.01357645-31.58981775inconclusive agonistinconclusive antagonist10.50869983-36.66618314inactive0inactiveSIGMA
inconclusive antagonistinconclusive antagonist11.39894455-31.51994137inconclusive antagonist38.18252467-50.3518341active antagonist18.06610962-53.32214579active antagonist18.41611317-99.87158224inactiveChemService
inconclusive antagonistinconclusive antagonist9.520517464-31.46139982inactive0inconclusive antagonist25.3314794-33.8366806inconclusive antagonistinactivePharmaron
inconclusive antagonistinconclusive antagonist22.38452494-31.4254219inactive0inconclusive antagonist22.38452494-47.32501083inactive0inactiveSIGMA
inconclusive antagonistinconclusive antagonist23.91445864-31.37195479inactive0inconclusive antagonist14.24493769-28.7047749inactive0inactiveLabotest
inconclusive antagonistinconclusive antagonist8.485170121-31.16863023inconclusive antagonist28.42238736-53.41937627inconclusive antagonist21.3137837-65.29207683active antagonist21.3137837-116.9874374inactiveTocris
inconclusive antagonistinconclusive antagonist15.08900332-31.02924751inactive0inconclusive antagonist13.44808836-67.34344005active antagonist24.85004737-112.8231432inactiveEnzo
inconclusive antagonistinconclusive antagonist4.896621656-31.00273509active agonist6.52974992456.6887905inconclusive antagonist4.364118645-32.88013005active antagonist5.494099862-77.61537417inactivePharma
inconclusive antagonistinconclusive antagonist4.623840121-31.00119819inactive0inconclusive antagonist10.96485288-55.45928429inconclusive antagonistinactiveSigmaAldrich
inconclusive antagonistinconclusive antagonist20.65140867-30.9257685inconclusive agonistinconclusive antagonist20.65140867-30.90164574inactive0inactiveSIGMA
inconclusive antagonistinconclusive antagonist6.194662472-30.91667709inactive0inconclusive antagonistinconclusive antagonist49.20595306-96.96923741inactiveBayville
inconclusive antagonistinconclusive antagonist18.99592971-30.90727011inactive0inconclusive antagonistinactive0inactivePrestwick Chemical, Inc.
inconclusive antagonistinconclusive antagonist1.302856395-30.81191069inconclusive antagonistactive antagonist2.454124262-52.65686561inconclusive antagonist29.16732152-52.73087816Sigma Chemical Company
inconclusive antagonistinconclusive antagonist-30.65074981inconclusiveactive antagonist0.564553791-42.23064836active antagonist0.411344153-97.80153998inactiveSIGMA
inconclusive antagonistinconclusive antagonist23.46354088-30.54190358inactive0inconclusive antagonist20.91190282-34.47743935inactive0inactiveSIGMA
inconclusive antagonistinconclusive antagonist3.010651969-30.41235079inconclusive agonistactive antagonist9.162075938-30.39422743active antagonist26.83246392-50.14418848inactiveSequoia
inconclusive antagonistinconclusive antagonist36.5578082-30.23175763inactive0inconclusive antagonistinconclusive antagonistinactiveSIGMA
inconclusive antagonistinconclusive antagonist1.643410377-30.22729945active antagonist24.58929204-45.60039631inconclusive antagonist1.382757507-36.1644637active antagonist14.93067211-101.7347553inactiveIo-li-tec
inconclusive antagonistinconclusive antagonist1.899592971-30.11310745inactive0active antagonist6.740010203-42.97711937inactive0inactiveEnzo